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TUGGING ON THE HEARTSTRINGS: DETERMINING THE FUNCTION OF TBX5 
IN EARLY CARDIAC DEVELOPMENT 
 
During cardiac morphogenesis, the vertebrate heart acquires a characteristic three 
dimensional shape well-suited for efficient function. The morphology of the developing 
cardiac organ reflects a series of changes in the cardiomyocytes themselves, which must 
become specified, migrate, proliferate, grow in size, alter their shape and adhesive 
properties, and develop ultrastructure, among other differentiated characteristics. 
Mutation of the T-box transcription factor tbx5 leads to embryonic lethal cardiac 
phenotypes and forelimb malformations in vertebrate models. Haploinsufficiency of 
Tbx5 results in Holt-Oram Syndrome (HOS), a human congenital disease characterized 
by cardiac and forelimb defects. Homozygous mutation of zebrafish tbx5a in heartstrings 
(hst) embryos also leads to lethal defects in cardiac looping morphogenesis and prevents 
initiation of pectoral fin formation. Here I describe a new hst mutant allele (tbx5as296) 
which encodes a premature stop codon within the tbx5a T-box region, a location likely to 
generate a full loss-of-function allele. Data from comparative genetics and immunoblot 
analyses indicate that both alleles are null. I find that mutants completely lacking Tbx5a 
generated normal cardiomyocyte numbers in early chamber morphogenesis stages. 




differentiation is not seriously impaired in zebrafish mutants, in contrast to mouse. 
However, cardiac cell size was significantly smaller in both chambers of tbx5a mutants. 
Hearts stalled early in the process of cardiac looping, but cell shape changes associated 
with chamber ballooning surprisingly still occurred. These studies point to a critical role 
for Tbx5a in growth-related aspects of cardiac differentiation, and suggest that 
morphologic events of cardiac looping morphogenesis and chamber ballooning are 
genetically separable. A second zebrafish tbx5 paralog was recently described, termed 
tbx5b, which showed a lower amount of sequence conservation than is typical for a T-box 
gene. Based on overlapping expression patterns within the embryonic heart, I 
hypothesized that functional redundancy between tbx5a and tbx5b might reduce the 
severity of cardiac phenotypes for tbx5a mutant embryos. I here report that the cardiac 
phenotypes in tbx5b-depleted fish were similar, but not identical, to those of homozygous 
tbx5a mutants. In addition, tbx5b-depletion led to defects in the timing and 
morphogenesis of pectoral fin outgrowth. Somewhat surprisingly, simultaneous depletion 
of both Tbx5 gene paralogs did not lead to more severe cardiac phenotypes, and injection 
of wild-type mRNA was not sufficient to cross-rescue the phenotypes of the paralogous 
gene. In the heart, tbx5a and tbx5b appear to have related essential functions that are 
nevertheless independently required. In the fin, tbx5a alone was required for fin bud 
initiation, but both genes are independently required for patterning and morphogenesis. 
Therefore, this work demonstrates a functional divergence between the two zebrafish 
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CHAPTER 1: INTRODUCTION 
 
Organogenesis involves a complex series of steps, including spatio-temporal regulation 
of gene expression and protein function, progenitor cell differentiation, and organized 
cell movement, that combine to create a complex, specialized, functional tissue.  
Transcription factors (TFs) play an essential role in organogenesis by regulating 
embryonic gene expression essential for embryonic patterning, cell specification, 
differentiation, and morphogenesis.  Tbx5, a T-box transcription factor, is a positive 
regulator of gene expression and is critical in vertebrate heart and forelimb formation.  
The heart is the first organ to function in development, and for many vertebrates it is 
critical that it function even before morphogenesis has completed (Bakkers 2011). 
Haploinsufficiency of Tbx5 can cause Holt-Oram Syndrome, a human congenital disease 
characterized by cardiac and forelimb defects. Homozygous mutation of zebrafish tbx5a 
in heartstrings (hst) embryos also leads to lethal defects in cardiac looping 
morphogenesis and prevents initiation of pectoral fin formation. Conservation of gene 
functions with mammals means that zebrafish provide an excellent model system for 
human disease. Investigation of zebrafish gene function with both forward and reverse 
genetic tools provides novel insights into human cardiovascular disease mechanisms that 
ultimately translate into a broader understanding of human diseases. The overarching aim 




Zebrafish and Developmental Biology 
 
Taxonomic classification  
 
Table 1.1: Zebrafish taxonomic classification (see www.itis.gov: Danio rerio). At the 
1993 Zebrafish Meeting at Cold Spring Harbor Laboratory a consensus vote determined 
that the official zebrafish name would be changed from Brachydanio rerio to Danio rerio 
(Westerfield 1995). The name Danio derives from the Bengali name “dhani,” meaning 


































Order of cyprins, minnows, suckers 
     






Zebrafish Natural History 
Zebrafish are small, bony fish that belong to the Teleostei infraclass along with 
pufferfish, trout, and carp (Gu et al. 2002). The natural habitat of zebrafish is warm, 
freshwaters of the Indian subcontinent (Fig. 1.1) (Engeszer et al. 2007, Spence et al. 
2008).  Adult zebrafish are generally smaller than two inches in length and have a striped 
appearance, although pigmentation can vary widely (Fig. 1.2).  Zebrafish are moderately 
sexually dimorphic, with the males having a more fusiform, linear shape and pinker 






















Fig. 1.1: The habitat of wild zebrafish includes slow moving, shallow rivers and 
swamps on the Indian Subcontinent. A. Seinpoh stream in Meghayala is an example of 
a high elevation, slow moving meadow stream habitat. B. Historical zebrafish range on 
















Fig. 1.2: Adult zebrafish morphology.  A. An example of a “typical” wildtype 
zebrafish female; i.e. rounded white belly and dark blue pigment stripes on a white 
background color. (www.diszhal.info) B. Pigment polymorphism demonstrated in a 
“leopard” male, where the pigment is distributed in spots along the body. Note the 





season for these fish extends from April to August, during which time they congregate in 
shallow rice paddies to spawn.  Zebrafish spawn in early morning, when they undergo a 
ritualized mating dance in which the male rapidly pursues a female, attempting to nudge 
her sides. If the female is receptive she will release eggs which the males will then 
fertilize. The fertilized embryos sink to the silty substrate, away from potentially 
predatory adults, and begin a period of rapid development. After roughly 48 hours post 
fertilization (hpf) embryos hatch out of a protective, optically opaque chorion and begin 
feeding by 5 days post fertilization (dpf) (Kimmel et al. 1995). For the first few days of 
their development, embryonic zebrafish survive on their yolk mass and acquire necessary 




Zebrafish are omnivorous, eating primarily insects, larvae, zooplankton, and 
phytoplankton (Spence et al. 2008).  Because zebrafish feed in both the water column and 
surface it is possible that they are beneficial for mosquito control (Dutta 1993).  Natural 
predators of adult zebrafish include larger fish such as snakeheads (Channa) (Fig. 1.3) 
and catfish as well as predatory birds like herons (Engeszer et al. 2007).  The average 
lifespan of wild zebrafish is unknown, but in a laboratory setting they live an average of 
42 months (Gerhard 2002).  After two years they tend to develop symptoms of 
senescence including a curved spine, lethargy and even muscle degeneration.  Because 
wild zebrafish do not demonstrate these symptoms of old age, it appears that they may 
die at younger ages, before these symptoms can develop (Spence et al. 2007).  The oldest 
known zebrafish reared in captivity died at an amazing 66 months (Gerhard et al. 2002). 
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Fig. 1.3: Closely related species that cohabitate with wild Danio rerio.  Danio 
meghalayensis displays similar sexual dimorphic traits as D. rerio. Channa are known 
zebrafish predators. Reproduced/adapted with permission, Engeszer et al., 2007. 
7 
 
Zebrafish as a model organism 
Because zebrafish naturally school in shallow freshwater pools, they readily adapt to a 
laboratory environment where many fish can be maintained in relatively small areas. The 
ability of females to produce large clutches of eggs, upwards of 200 eggs per batch, is 
ideal for many biological studies. An additional trait that lends itself to laboratory use is 
that because zebrafish undergo external fertilization, egg and sperm can be isolated from 
individual fish and used for in vitro fertilization (Westerfield 1995). Zebrafish were only 
occasionally used as a model organism for decades before becoming prevalent in 
molecular genetics and cell differentiation studies (Streisinger et al. 1981, Kimmel et al. 
1989, 1990). With the advent of new tools and techniques, zebrafish are now a powerful 
model organism relevant for many biological fields including developmental biology, 
genetic models of human disease, regeneration, neurophysiology, and even behavior (Li 
et al. 1997, Nguyen 2001, Yelon 2001, Dooley et al. 2008, Brittijn et al. 2009, Palastra et 
al. 2010, Ebarasi et al. 2011, Pavlidis et al. 2011, Shao et al. 2011).  
 
Zebrafish is the ideal system for use in my studies for several reasons. First, ex utero 
development in transparent eggs allows for easy observation of cardiac development in 
situ. Second, due to their small size, zebrafish are well-suited for studying cardiovascular 
disorders because they do not initially depend on a functional circulatory system to 
facilitate gas exchange. Furthermore, there are several cardiac mutant lines available, 
thereby facilitating study of cardiac development. Finally, the ease of creating transgenic 
animals along with new technologies to drive tissue-specific expression of fluorescently 




The zebrafish genome is comprised of 25 chromosomes and totals 1.7 gigabases in size 
(Nusslein-Volhard et al. 2002). To put this in perspective, the human genome is 3.2 Gb, 
while the smallest vertebrate genome (0.39 Gb) belongs to the Tetraodon nibroviridis 
pufferfish, and the largest belongs to another fish: the marbled lungfish’s genome is an 
impressive 130 Gb. Although a genome-wide duplication event occurred in the teleost 
lineage, it was followed by a rapid divergence and loss of genes, so that only roughly 
20% of zebrafish genes are duplicated.  Thus, paralogs of zebrafish genes are often highly 
diverged, making it relatively easy to study individual gene function (Jaillon et al. 2004). 
Interestingly, several genes that arose from individual gene duplication events prior to 
genome-wide duplications have remained clustered in vertebrate genomes including 
zebrafish, human, and mouse. One example occurs in the T-box transcription factor 
family, where Tbx2 and Tbx4 are tightly linked and closely related genes Tbx3 and Tbx5 
are similarly linked on a separate chromosome.  These clusters appear to have resulted 
from a duplication of an ancestral gene and/or unequal cross-over more than 600 million 




The following is a list of critical zebrafish strains and transgenic lines used in my studies.  
  
Tubingen long fin (TL): Homozygous for two genes: leo1, a recessive mutation causing 
spotting in adult fish, and lof dt2 a dominant homozygous viable mutation causing long 
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fins. This is not the line used in the Sanger zebrafish sequencing project. It is genetically 
different from TU because it was not bred as stringently (i.e. not sufficiently backcrossed 
to remove embryonic lethal mutations). Therefore, this strain retains more 
polymorphisms than TU, but fewer than the WIK line. 
 
WIK: Derived from wild catch in India; used for genome mapping (Spence et al., 2008). 
 
Tg(myl7:GFP)f1: Formerly: Tg(cmlc2:GFP), Tg(myl7:GFP). The myl7 promoter drives 
GFP expression throughout the cardiomyocytes of both chambers. Although the GFP 
localization in these transgenics is not consistent (it varies with age and chamber), it is 
useful for identifying cardiac-specific tissue.  
 
Tg(myl7:EGFP-HsHRAS):  Formerly:  Tg(cmlc2:Ras-GFP). This construct contains the 
last 20 amino acids from the C-terminus of human HRAS fused to the C-terminal end of 
enhanced green fluorescent protein (EGFP). It is a useful line for visualizing cardio-
myocyte morphology as the GFP is localized to the membrane through the RAS tag. 
 
Tg(-5.1myl7:nDsRed2): This line was formally Tg(cmlc2:DsRed-nuc), a transgenic line 
in which DsRed2 is expressed in cardiomyocyte nuclei of both chambers, visible after 48 
hpf. This line is useful for quantification of total cardiomyocytes, and is best used with 
Tg(myl7:GFP) for ease of visualization. 
 





Importance of heart development 
The heart is critical for survival and yet, despite its importance, we still lack basic 
understanding of mechanisms regulating its formation. Understanding cardiac 
development is valuable because anomalies in cardiac formation are one of the leading 
causes of prenatal and infant mortality (Kochanek et al. 2004).  The patterning, 
differentiation and morphogenesis of the heart tube, as well as its assimilation of rhythm, 
involve complex processes requiring large numbers of genes.  Dysregulation or mutation 
of cardiac genes often results in a loss of form and/or function of the heart (Olson 2006). 
A complete understanding of the contributions of individual genes in creating the 
functional heart requires researchers to synthesize insights obtained from more than one 
model system (Bryson-Richardson and Currie 2008, Chien et al. 2008).   
 
Cardiac morphogenesis 
In both mammals and fish heart formation begins during early segmentation stages when 
bilateral cardiac precursors are specified within the lateral plate mesoderm (LPM) (Table 
1.2) (Yutzey and Bader 1995, Yelon et al. 2002).  In zebrafish, atrial and ventricular 
precursors are distinct prior to heart tube formation (Fig. 1.4) (Stainier and Fishman 
1992, Bakkers 2011).  At the 6-8 somite stage, expression of the homeobox transcription 
nkx2.5 is required for the continued development of cardiomyocytes (Thomas et al. 
2008).  Nkx2.5 plays a role in determining the size of the bilateral heart fields.  If nkx2.5 
expression is altered (either increased or decreased), through modulation of one of its 
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regulators, the resulting heart size is also similarly altered (Reiter el al. 1999, Marques et 
al. 2008). Three of the known positive regulators of nkx2.5 expression include fellow 
transcription factor gata5, and paracrine factors fgf8, and bmp2b. Increasing the 
expression of any of these four genes in zebrafish results in a larger heart field and, 
ultimately, a larger heart (Reiter et al. 2001). 
Table 1.2: Selected morphological events in zebrafish development 
11-12 hpf Bilateral cardiac precursors are being specified 
18 hpf Cardiac progenitor cells migrate to midline; fuse to create a linear heart 
tube 
22-36 hpf Rhythmic contractions of cardiomyocytes begin; chambers differentiating 
28 hpf Nascent pectoral fin bud observed 
36-40 hpf Circulation begins; heart tube “loops” (the tube folds back on itself, to 
bring the two chambers adjacent to one another) 
48+ hpf Unidirectional blood flow is robust; hst cardiac phenotypes observed; 
cardiac function progressively worsens until mutant embryos die ~7 dpf. 
 
The bilateral precursor populations migrate to the embryonic midline and fuse to form a 
heart cone (zebrafish, Bakkers 2011) or cardiac crescent (mammal, Moorman et al. 
2003).  The cells within the heart cone have already established positions to aid in the 
chamber formation, where atrial myocytes mantle the ventricular and endocardial cells 
(see Fig. 1.4D; orange cells surround the purple and green cells).  Cardiomyocyte 
differentiation begins even before the bilateral precursor cells fuse to form the heart cone 
(Yelon et al. 1999). Atrial cells are determined later, with expression of atrial myosin 
heavy chain beginning at the 19 somite stage (Berdougo et al. 2003). Between 22 and 24 
hpf the heart cone elongates, acquires a left-of-center displacement (termed “jogging”) as 






Fig. 1.4: Early zebrafish cardiac development. A. Just prior to gastrulation the heart 
progenitor cells are located on lateral regions of the embryo. B. After involution, these 
cells converge towards the embryonic axis and reach their destination at the level of the 
future hindbrain by the five-somite stage. Two rows of cells are represented at this stage, 
with ventricular myocytes (dark blue) present most medially and the atrial precursors 
most laterally (pink). C. By the 16-somite stage, the atrial myocytes have differentiated 
and endocardium is now present (green). D. Starting at 19 hpf, the myocardial precursors 
merge posteriorly to form a horseshoe-shaped structure. By 19.5 hpf, as anterior cells 
migrate medially, the horseshoe transforms into a cone with the ventricular cells (dark 
blue) at its center, and the atrial cells (orange) at its base. The endocardial cells (green) 
line the inside of the cone. E. Next, the cone telescopes out to form a tube. The 
ventricular end of the heart tube assembles first, followed by the atrial end. F. By 36 hpf, 
visibly distinct ventricular and atrial chambers have begun to form, and the heart begins 
to undergo looping morphogenesis G. After 48 hpf, valuve cushions begin to form at the 
AV canal. (Figure reproduced/adapted with permission from Bakkers 2011, text modified 
from Stainier 2001). 
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then functions as a pump as the heart tube undergoes chamber morphogenesis (Bakkers 
2011). Around 36 hpf, the chambers begin the process of cardiac looping at 36 hpf, in 
which the atrium migrates anteriorly to lay adjacent to the ventricle. Contributions of 
cells from the second heart field, which migrate from the pharyngeal mesoderm, add to 
the heart tube at either the arterial or venous poles (de Pater et al. 2009, Dyer and Kirby 
2009, Greulich et al. 2011, Lazic et al. 2011). Additionally, chamber ballooning (regional 
differentiation and expansion of cardiomyocytes) is an important morphological change 
that ensures the correct size and placement of chambers during formation (Christoffels et 
al. 2000, Forouhar et al. 2006). The specific effects of cell morphogenesis on chamber 
development will be discussed in later chapters. Ultimately, valves differentiate from 
endocardial cushion tissue, facilitating unidirectional circulation (Bartman et al. 2004).  
The heartbeat continues to increase in force and frequency over the next few days (Beis 
et al. 2005, Yelon 2001).   
 
Several differences exist among vertebrates regarding cardiac formation.  The most 
obvious difference is that zebrafish hearts are comprised of two chambers, while human 
hearts contain four chambers (Thisse 2002). Therefore, blood flow is abridged in 
zebrafish. In fish, low-oxygen blood is pumped through the atrium to the ventricle, which 
pumps the blood to the gills for gas-exchange before it flows out to the rest of the body 
(Isogai et al. 2001). In contrast, mammals utilize two separate sets of chambers, one 
exclusively pumps deoxygenated blood to the lungs, the other for circulation to the body.  
During one cardiac cycle, low-oxygen blood is returned to the right atrium and is pumped 
out of the right ventricle to the lungs for gas exchange.  Oxygen-rich blood returns to the 
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left atrium, and the powerful left ventricle pumps blood out to the head and body (Harvey 
1889). Because zebrafish hearts have fewer chambers, they do not undergo septation and 
are therefore not a viable model for septation disorders seen in humans (Li 1997, Basson 
et al. 1997, Schott 1998, Sakata et al. 2002). Despite these differences, many of the major 
morphogenetic events in cardiac development, such as chamber formation, cardiac 
looping and onset of rhythm, occur in parallel with tetropods and in many instances the 
genes regulating these events are conserved (Thisse and Zon 2002). 
 
T-box Genes in Developmental Biology 
 
T-box genes 
Genes of the T-box superfamily are present throughout nearly all of the Animal 
Kingdom, from Cnidarians (including Hydra and jellyfish) through the highest Chordates 
(Agulnik et al. 1995, Technau and Bode 1999). They are so named because the original 
“T” transcription factor, isolated from the Brachyury mouse, contained a region 
important for binding DNA (Kispert and Herrmann, 1993).  This “T-box,” known as the 
proteins “T-domain,” is found in the N-terminus of T-box genes of 20+ genes including 
(but not limited to): TBR1, TBX1-6, TBX10, TBX15, TBX18, TBX19, TBX20-22, no-
tail (ntl), and VegT (Naiche et al. 2005). T-box genes are classified into 5 subfamilies: 
Brachyury, T-brain1, Tbx1, Tbx2 and Tbx6 (Papaioannou 2001). Members of the same 
family are more related in sequence, and most likely arose from duplication events 
throughout evolution. As found in other gene families, the intron-exon boundaries of T-
box homologs are conserved throughout evolution, but intron length varies between 
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species (Wattler et al. 1998). Most T-box family members encode a single transcript that 
is not subjected to alternative splicing (Wilson and Conlon et al. 2002).  One exception is 
the VegT gene in Xenopus, which encodes alternate 3’ splice forms that are either 
maternally or zygotically expressed (Stennard et al. 1999). Additional regions of T-box 
genes essential for transcriptional regulation include the transcriptional activation 
domain, located in the C-terminus of T-box proteins (Zaragoza et al. 2004), and the 
interaction domain in the N-terminus, upstream of the T-domain (Wilson and Conlon 
2002). The C-terminus of T-box genes are important for the strength an induction 
response, but not for the specificity (Marcellini et al. 2002). Specificity arises from 
interactions of the T-box protein with other transcriptional regulators and is regulated by 
the interaction domain (Wang et al. 2011, Wilson and Conlon 2002).  
 
T-box genes are significant to developmental biology because T-box genes have diverse 
and critical functions in development, beginning with regulation of gastrulation (and 
thereby anterior-posterior (AP) axis formation) and organ development. A general theme 
among T-box genes is that they are all required for specification of the tissue in which 
they are expressed (Smith 1997, Stennard 2005). T-box genes have been associated with 
human disorders including Holt-Oram Syndrome, DiGeorge syndrome, and small-patella 
syndrome (SPS), among others (Greulich et al. 2011, Smith 1997). T-box genes may 
even play a role in metastasis of certain cancers, possibly by promoting epithelial-
mesenchymal transition. Moreover, expression of Brachyury in early tumor stages 




In cardiac development, members of two T-box subfamilies are required for normal heart 
formation (Hoogars et al. 2007, Plageman and Yutzey 2005). Tbx1, Tbx18 and Tbx20 of 
the Tbx1 subfamily, and Tbx2, Tbx3 and Tbx5 of the Tbx2 subfamily are expressed in 
cardiac development (Greulich et al. 2011). With the exception of Tbx2, Tbx3, and 
Tbx20, T-box genes are primarily activators of gene expression (Carreira et al. 1998).  
Within the Tbx1 subfamily, Bmp/SMAD1 directly regulates tbx20 expression in cardiac 
development (Mandel et al. 2010). In turn, Tbx20 negatively regulates tbx2 (which 
consequently negatively regulates chamber-specific genes) (Singh et al. 2009). Therefore, 
tbx20 plays a role in chamber specification. tbx1 and tbx18 are required for the elongation 
of the heart tube. tbx1 is expressed in the pharyngeal mesoderm and promotes the 
proliferation of mesenchymal precursor cells that contribute to the secondary heart field.  
Therefore, Tbx1 ensures elongation of the outflow tract (Greulich et al. 2011). For proper 
formation of the inflow area, tbx18 expression is required in the sinus venosus and is a 
marker of proepicadium.  
 
Members of the Tbx1 subfamily are associated with human disorders. Mutations in tbx20 
are associated with congenital heart defects, including dilated cardiomyopathy (DCM), 
atrial septal defects (ASD), and mitral valve disorders (Kirk et al. 2007). Tbx1 has been 
associated with DiGeorge Syndrome, in which affected individuals display thyroid, 
facial, cardiac outflow tract, and vertebrae abnormalities (Jerome et al. 2001, Lindsay et 




Within the Tbx2 subfamily, Tbx2 interacts with the Nkx2-5 and Gata4 transcription 
factors to bind to the mouse Nppa (natriuretic peptide type A, formerly Anf) promoter, 
thereby blocking Tbx5 activation (Habets et al. 2002). Overexpression of tbx2 leads to 
ectopic formation of cardiac jelly, leading to an expansion of cushion tissue, and thus 
affects valve formation in mice (Shirai et al. 2009). Tbx2 and its close homolog Tbx3 are 
both expressed in the margins of both fore- and hind-limb buds (Chapman et al. 1996b). 
Tbx3 regulates limb formation through repression of osteoblast differentiation and 
promoting cell proliferation (Govoni et al. 2009). In mouse heart development, Tbx3 
controls the formation of the sinoatrial node as well as specifying the location of the 
pacemaker within the atrium (Hoogars et al. 2007).  Loss of Tbx3 increases second heart 
field proliferation, thereby negatively affecting outflow tract morphogenesis and heart 
tube extension (Mesbah et al. 2008). Overall, Tbx2 and Tbx3 are important for repression 
of chamber myocardial genetic programs, thereby promoting the alternative fates of 
valve, septa, and conduction system formation (Wilson and Conlon 2002). Tbx2 is also 
upregulated in some types of breast cancers (Jacobs et al. 2000). Mutations in Tbx3 can 
result in human ulnar-mammary syndrome (Bamshad et al. 1997, He et al. 1999).   
 
Tbx5 in Development 
 
Significance: 
The organogenic functions of the Tbx5 T-box transcription factor (a Tbx2 subfamily 
member) in cardiac development and forelimb formation are conserved among 
vertebrates (Basson et al. 1999, Showell et al. 2004).  Based on Pairwise Alignment 
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Scores of RefSeq protein sequences, zebrafish Tbx5a shares 74.6% overall amino acid 
identity to human TBX5 isoform 1 (see Fig. 1.5).  Despite the relative lack of overall 
protein sequence conservation, the Tbx5 T-box domain is highly conserved across 
species, with over 95% similarity between human TBX5 and zebrafish tbx5a T-box 
protein sequences (Tamura et al. 1999).   
 
Role of Tbx5 in higher animals: 
Tbx5 plays a role in the formation of the embryonic heart, limb, eye, and pro-epicardium 
(PE, a collection of progenitor cells that contributes to the venous pole of the heart and 
also forms the epicardium (Serluca 2008)). Prior to heart tube formation, tbx5 is 
expressed in the cardiac mesoderm (Camarata et al. 2010, Chapman et al., 1996; Bruneau 
et al., 1999; Horb and Thomsen, 1999).  One of the earliest roles of Tbx5 is to regulate 
PE formation; in zebrafish, tbx5a is required in early segmentation stages for proper PE 
morphogenesis and may regulate migration of PE cells to the epicardium (Liu and 
Stainier 2010).  Also during somite stages, tbx5a expression in the anterior lateral plate 
mesoderm confers competence to later bmp signaling which is required for proper cardiac 
differentiation and ventricular formation (Liu and Stainier 2010). During heart tube 
formation, tbx5a functions to promote myogenic and conduction system gene programs 
(Greulich et al. 2011, Moorman and Christoffels 2003).  
 
By the completion of cardiac looping in chick, mouse, and frog, tbx5 mRNA is expressed 
as a gradient, with the highest levels in the posterior heart, including the two atria and the 
left ventricle (Li et al. 1997, Bruneau et al. 1999, Horb and Thomsen 1999, Christoffels  
19 
 
Fig. 1.5: Relative percent identities of Tbx5a proteins. Relationship tree created using 
the neighbor joining method indicating percent identity. Although this tree is not intended 
to infer evolutionary relationship, it is useful for diagraming that zebrafish Tbx5a 
sequence is most similar to that found in the green spotted puffer fish (T. nigroviridis).  
Percents given are overall identities (top number) and T-box identities (bottom number) 











et al..2000, Hatcher et al. 2000, Liberatore et al. 2000). A similar tbx5a mRNA 
expression gradient is present in the nascent heart tube at 26 hpf in zebrafish (Fig. 1.6), 
but then appears to reverse and is present primarily in the ventricle by 48 hpf (Begemann 
and Ingham 2000, Garrity et al. 2002).  It may be that graded tbx5a expression 
functionally contributes to the definition or implementation of the anterior/posterior axis 
of the vertebrate heart.  Consistent with this hypothesis, others have noted that, in mice, 
graded tbx5 expression plays a role in chamber differentiation and valve formation, and 
that tbx5 expression levels remained high in the caudal region (atria) through later stages 
of embryonic development (Bruneau et al. 1999).  While previous work suggested that 
precise levels of tbx5 mRNA expression within the heart tube are important for general 
morphology (Bimber et al. 2007, Garrity et al. 2002, Horb and Thomsen 1999), no 
studies have so far reported how slight alterations in tbx5 levels impact expression of 
target genes in the heart, or affect cardiomyocyte growth or morphology.   
 
Tbx5 also displays dynamic changes in cellular localization during development. As 
expected for a transcription factor, initial expression is restricted to the nucleus (Hatcher 
et al. 2000). Remarkably, studies in chick indicate that Tbx5 protein is dynamically 
localized in either the nucleus or the cytoplasm depending on the developmental stage 
and individual cardiac cell type (Bimber et al. 2007). The cytoplasmic localization is due 
to an association with structural PDZ-LIM protein Pdlim7 and the actin cytoskeleton, and 
is hypothesized to sequester tbx5a away from the nucleus to promote atrioventricular 
junction (AVJ) cell fates (Camarata et al. 2006, Kulisz and Simon 2008).  At these later 
stages of chamber morphogenesis tbx5 is expressed in the cardiac trabeculae but not the  
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Fig. 1.6: tbx5 expression in zebrafish and mouse embryos. Whole mount in situ 
hybridization illustrating the presence of tbx5a mRNA in A, B) 26hpf zebrafish embryos 
eye and heart tube; C, D) 48hpf zebrafish larvae and Tbx5 mRNA in E) E8.5 mouse 
nacent heart, F) E11.5 mouse heart. For panels A-D) black arrowhead or “a”: atrium;  
white arrowhead or “v”: ventricle. In panel F) ra = right atrium, la = left atrium, rv = 
right ventricle, lv = left ventricle, and ot = outflow tract. Reproduced/modified with 









compact layer of the ventricular myocardium (Bruneau et al. 1999). Although tbx5 is 
expressed throughout cardiac development, it is still unknown at which developmental 
timepoints Tbx5 function is most critical for later cardiac function.  Nor is it understood 
how disrupting the graded expression in the heart tube may affect expression or 
distribution of downstream target genes.  
 
Loss of Tbx5 function: 
Mutation of Tbx5 in mammals produces dominant phenotypes affecting cardiac septation 
as well as electrophysiological defects including atrioventricular conduction block 
(Newbury-Ecob et al. 1996, Bruneau et al. 2001).  Mice with targeted mutations in tbx5 
display a retardation of growth and morphogenesis in the inflow tract and atria; in many 
cases the left ventricle shows a decrease in the total cardiac cell number (Bruneau et al. 
2001).  Mutations in human tbx5 lead to Holt-Oram Syndrome (HOS), a disease 
characterized by congenital heart defects as well as malformed upper limbs (Basson et al. 
1999, Li et al. 1997).  Haploinsufficient effects of Tbx5 mutations in mammals suggest 
that Tbx5 functions are sensitive to dose (Basson et al., 1999, Bruneau et al., 2001). 
Interestingly, both loss- and gain-of-function mutations in tbx5 can result in HOS 
(Hatcher and Basson 2001, Postma et al. 2008, Vaughan and Basson 2000).  The extent 
of limb deformity can range from mild distortion of the fingers to nearly complete 
absence of the arm (Basson et al. 1994, Newbury-Ecob et al. 1996, Simon 1999). These 
hypo- and hypermorphic tbx5 phenotypes hint that small changes in Tbx5 dose might 
dramatically impact morphology of the embryonic heart and limb.  Overexpression of 
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tbx5 through the use of the beta-myosin heavy chain promoter in mice results in 
decreased ventricular development and embryonic lethality (Liberatore et al. 2000). 
 
Role of Tbx5 in zebrafish: 
The zebrafish is an ideal system for cardiac development studies for several reasons: 1) 
zebrafish cardiac development is rapid, with formation of the heart tube completed by 26 
hpf.  Embryos that lack a functional heart, such as hst, do not die from heart failure until 
roughly 7 dpf, because embryos acquire oxygen by diffusion from the surrounding water 
(Bakkers 2011).  Therefore, zebrafish embryos with lethal cardiac malformations may be 
evaluated without secondary complications due to hypoxia.  2) Zebrafish provide superb 
experimental access to the developing heart since embryos develop externally to the 
mother.  One may observe severe cardiac defects at developmental timepoints not readily 
accessible in other models (Thisse and Zon 2002).  3) Efficient transgenesis tools for 
zebrafish exist.  4) The zebrafish heartstrings/tbx5a mutant line is published (Garrity et 
al. 2002).  The hst loss-of-function phenotype (see Fig. 1.7) results from a nonsense 
mutation in tbx5a that likely creates a null allele.  This mutation results in overtly normal 
heart tube formation, accompanied by a slight bradycardia.  Several early cardiac markers 
were expressed normally at 16 hpf in hst embryos, indicating that myocardial tissue 
specification occurred despite the absence of functional Tbx5a.  Despite overtly normal 
heart tube formation, the hst heart later failed to loop and progressively deteriorated 
morphologically. The hst mutation is homozygous lethal due to heart failure, but 
heterozygous fish appear fully wildtype (Garrity et al. 2002). An apparently independent 




 Fig. 1.7: Cardiac and pectoral fin abnormalities in 72 hpf hst mutant embryos. 
(A,C) Wildtype embryos; (B,D) homozygous hst mutant siblings have mild to severe 
pericardial edema and an unlooped, dysmorphic heart. (A) Wildtype pectoral fins 
elongate, but (B) hst mutant embryos lack pectoral fin buds (brackets).  (A,B) dorsal 
views. (C-D) Lateral views; a, atrium, v, ventricle. Reproduced/modified with 




feature in human HOS and in mouse models (Basson et al. 1994, Bruneau et al. 2001). 
Using a conditional knockout strategy in mouse, homozygous deletion of Tbx5 in the 
developing forelimb resulted in a complete lack of forelimb bud formation (Rallis et al. 
2003). A newly discovered zebrafish tbx5 paralog, tbx5b, is also expressed in lateral plate 
mesoderm in development (Albalat et al. 2010), but no experiments have yet identified 
functions for this gene. 
 
Targets of Tbx5 regulation: 
The transcription factor Tbx5 regulates a number of downstream targets.  T-box 
transcription factors interact with their DNA target genes by binding a conserved site 
termed the T-box Binding Element (TBE), found in the promoter sequences of target 
genes (Kispert and Herrmann 1993, Ghosh et al. 2001).  Mutation of TBEs found in the 
promoter of atrial natriuretic factor (ANF), fibroblast growth factor 10 (Fgf10) and 
connexin40 (Cx40), as well as gel shift and transfection assays, provided evidence that 
these sites mediate the direct regulation by Tbx5 (Bruneau et al. 2001, Hiroi et al. 2001, 
Koshiba-Takeuchi et al. 2006, Plageman and Yutzey 2004, Showell et al. 2004).  
Molecular genetic studies provide evidence that Tbx5 acts synergistically in vivo and in 
vitro with other transcription factors, including Nkx2.5, GATA4, MEf2c, Sall4, TAZ, and 
Myocardin to bind to target TBEs and activate cardiac gene expression (Garg et al. 2003, 
Ghosh et al. 2009, Hiroi et al. 2001, Koshiba-Takeuchi et al. 2006, Plageman and Yutzey 




Tbx5 binds individual TBEs as a monomer (Bruneau et al. 2001, Hiroi et al. 2001). 
Wang et al. (2011) tested whether Tbx5 binds with Myocardin (Myocd), a transcriptional 
co-activator of myocyte differentiation, via electrophoretic mobility shift assay (EMSA) 
to determine that Myocd and Tbx5 do not form a stable ternary complex on the TBE. 
However, Myocd does form such a complex with CArG and Serum Response Factor to 
regulate smooth muscle expression (via CArG boxes) (Wang et al. 2001). Interestingly, 
of known Tbx5 mutations that result in HOS, only the G80R mutation within the T-box 
abolished synergistic interaction with Myocd, further supporting that the Tbx5-Myocd 
protein interaction is mediated by the T-box region of tbx5. These studies also suggest 
that additional co-factors are needed for binding of tbx5 to the TBE (Wang et al. 2011).  
 
Additional known target genes of Tbx5 include other transcription and paracrine factors 
such as bone morphogenic protein 4 (Bmp4) and hairy/enhancer-of-split related with 
YRPW motif 2 (Hey2) (Mori et al. 2006; Plageman and Yutzey 2006) and N-myc 
downstream-regulated gene (Ndrg4).  Ndrg4, a novel member of the NDRG family, is 
thought to regulate the proliferation and growth of cardiomyocytes during zebrafish 
development.  As assayed by in situ hybridization, Ndrg4 mRNA is down-regulated in 
hst mutant embryos (Qu et al. 2008). Although Ndrg4 has been identified by in situ 
studies as a downstream target of Tbx5, no quantitative studies have been completed on 
its expression in hst embryos during development.  Microarray experiments using 
cardiac-derived mice cell line (1H) identified several genes with altered expression in 
response to induced Tbx5 expression (Table 1.3) which include genes that would make 
good targets for further quantitative analysis. 
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Table 1.3: Tbx5a target genes. A list of putative downstream targets of Tbx5 was 
identified by a literature search, including microarray data of tbx5 mutants1. As positive 
controls, we included genes with known altered expression in tbx5 mutants. We will 
investigate expression patterns of these genes by both quantitative PCR and in situ 
hybridization techniques. TF: Transcription Factor.  PC: Paracrine Factor. E: Enzymatic 
activity. *Tbx5 shows evidence of autoregulation.  
Thesis Aims: 
 
Based on the previous discussion, an outstanding question in the field of Tbx5 biology 
remains as to how and when Tbx5 is required to create a functional heart. In this thesis, I 
exploit the zebrafish model system to examine the cellular basis of tbx5 cardiac 
phenotypes. In particular, I determine the phenotypic effects of a nonsense mutation with 
the T-box of tbx5a, I investigate the impact of a lack of Tbx5b on heart and fin 
development, and I address the potential for genetic redundancy between the two 
paralogous Tbx5 genes.  This work tests the overarching hypothesis that Tbx5 is 
dispensable for early cardiac morphogenesis (cardiomyocyte specification and 
migration), but operates in an essential, dose-responsive fashion from the heart tube stage 
onward to facilitate volumetric growth of cardiomyocytes, thereby affecting cardiac 
looping.   
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Chapter 2: To test the hypothesis that Tbx5a activity is critical in morphogenetic events 
occurring after heart tube formation.  
 
Homozygous mutation of zebrafish tbx5a in heartstrings (hst) embryos leads to lethal 
defects in looping morphogenesis. The tbx5am21 hst allele encodes a stop codon within the 
C-terminal region, downstream of the T-box DNA-binding domain. In Chapter 2, I 
describe a new hst mutant allele (tbx5as296) which encodes a premature stop codon within 
the tbx5a T-box, a location likely to generate a full loss-of-function allele. Specifically: 
1) I use immunoblot technology to investigate whether these alleles generate truncated 
proteins, or encode null alleles; and I determine whether zebrafish tbx5a regulates 2) 
cardiomyocyte cell number or 3) volumetric growth.  
 
Chapter 3: To test the hypothesis that the cardiac dysgenesis observed in hst embryos 
results from decreased cell adhesion and/or myofibrillogenesis during early chamber 
morphogenesis stages.  
 
Mutation of tbx5 leads to embryonic lethal cardiac phenotypes in vertebrate models. I 
systematically investigate the cellular basis for tbx5a cardiac phenotypes using the 
zebrafish hst mutant line, which is informative for the etiology of HOS. In Chapter 3, I 
investigate the effects of tbx5a mutation at chamber morphogenesis stages on 1) cell 
adhesion using transgenic zebrafish lines, and 2) myofibril formation, using fluorescent 




Chapter 4: To elucidate the role of Tbx5b in cardiac and pectoral fin development. 
 
The goal of Chapter 4 is to describe the loss-of-function phenotype of the newly 
discovered tbx5b gene.  Because there is substantial overlap in the gene expression 
patterns between tbx5a and tbx5b, I hypothesize that functional redundancy exists 
between these zebrafish paralogs. I take several experimental approaches: 1) I 
characterize the loss-of-function phenotypes for tbx5b; 2) I test whether it is possible to 
rescue, or even cross-rescue morpholino knockdown phenotypes by co-injection of the 
cognate or paralogous mRNA; 3) I investigate whether zebrafish development is sensitive 
to tbx5b over-expression. 
 
The study of congenital cardiac diseases is significant because more than 1% of live 
births are affected by congenital heart defects (CHD) (Clark et al. 2006).  Although HOS 
accounts for only a fraction of these birth defects (1 in 100,000, Mori and Bruneau 2004), 
the disease is useful as a model for characterizing how mutations in transcription factors 
active early in cardiac development lead to heritable defects. HOS is also a useful model 
for the study of progressive cardiac conduction disease. Ultimately, a better 
understanding of the genetic control of Tbx5 during cardiac development will positively 
impact therapeutic approaches.  Animal models of HOS in mouse and zebrafish 
(including the tbx5a mutant heartstrings/hst) indicate an essential role for tbx5 in cardiac 










CHAPTER 2: ZEBRAFISH TBX5A IS DISPENSABLE IN THE HEART FOR 
NORMAL CARDIOMYOCYTE NUMBER BUT REQUIRED FOR CELL GROWTH. 
 
Introduction 
The patterning, differentiation and morphogenesis of the heart tube, as well as its 
assimilation of rhythm, is a complex process requiring large numbers of genes.  
Understanding cardiac formation is important because anomalies in heart development 
are one of the leading causes of prenatal and infant mortality (Minino et al., 2007). Many 
of the major events in vertebrate cardiac morphogenesis, such as chamber formation, 
cardiac looping and onset of rhythm, occur in parallel and in several instances the genes 
regulating these events are conserved (Bakkers, 2011, Dahme et al., 2009, MacRae and 
Fishman, 2002, Thisse and Zon, 2002).  Members of the T-box family of transcription 
factors share a highly conserved DNA-binding motif, known as the T-domain, containing 
about 200 amino acid residues. T-box genes are expressed in a variety of tissues during 
embryogenesis, and mutations in several T-box genes are associated with human 
developmental disorders (Greulich et al., 2011, Hoogaars et al., 2007). T-box genes with 
roles in the heart include tbx1, tbx2, tbx3, tbx5, tbx18 and tbx20 (Hoogaars et al., 2007). 
Haploinsufficiency for Tbx5 can cause Holt-Oram Syndrome (HOS), a human congenital 
disease (reviewed in (Mori and Bruneau, 2004, Piacentini et al., 2007)). HOS is 
characterized by cardiac and forelimb morphological defects, and progressive cardiac 
conduction disease (Basson et al., 1997, Basson et al., 1999, NewburyEcob et al., 1996). 
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Heterozygous mutation of Tbx5 in mice produces dominant phenotypes remarkably 
similar to HOS, including deficiencies in cardiac septation as well as electrophysiological 
defects such as atrioventricular conduction block (Bruneau et al., 2001). Homozygous 
mutation of Tbx5 in mice led to lethal defects in cardiac morphogenesis, especially 
affecting the posterior domain of the heart (Bruneau et al., 2001) and prohibited forelimb 
outgrowth (Hasson et al., 2007). In zebrafish two tbx5 genes, designated tbx5a and tbx5b, 
have remained in the genome since a teleost-specific genome duplication approximately 
300 million years ago (Albalat et al., 2010, Hurley et al., 2007, Jaillon et al., 2004). 
Homozygous mutation of zebrafish tbx5a in heartstrings (hst) embryos led to lethal 
defects in looping morphogenesis, heart morphology and early function, and blocked the 
initiation of pectoral fins (Garrity et al., 2002). While heterozygous hst fish appeared 
fully wildtype, graded morpholino knockdown studies indicated tbx5a is also required for 
pectoral fin outgrowth (Ahn et al., 2002, Garrity et al., 2002). Functions for tbx5b have 
not yet been described.  
 
The multiple mechanisms by which the Tbx5 transcription factor functions as a key 
morphogenetic driver in heart development are still being defined. Retinoic acid appears 
to restrict the expression of Tbx5 primarily to the posterior portion of the heart tube 
(Sirbu et al., 2008). Hence, graded levels of Tbx5 may serve as cues for positional 
information along the anterior-posterior cardiac axis (Liberatore et al., 2000). Tbx5 
interacts with a variety of transcription factors and co-factors to differentially regulate 
expression of target genes including Nppa, Chisel, Hey2 and Cx40 to promote chamber 
myocardial cell fates (Bruneau et al., 2001, Hiroi et al., 2001, Ieda et al., 2010, Takeuchi 
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and Bruneau, 2009). Tbx5 has additional functions in the endocardium and epicardium 
(Hoogaars et al., 2007). 
 
Here we describe a new hst mutant allele (tbx5as296) which encodes a premature stop 
codon within the T-box region of the tbx5a gene, a location likely to generate a complete 
loss-of-function allele.  A previously described allele, tbx5am21, encodes a stop codon 
within the C terminal domain at amino acid 316 out of 485 (Garrity et al., 2002). We 
present a comparative molecular genetic analysis of embryos homozygous for either 
mutant allele, and determine the status of both alleles as null alleles. We find that 
(surprisingly) Tbx5a was dispensable for establishing cardiac cell number and for 
differentiation of the venous pole of the heart. Mutants lacking Tbx5a were still able to 
initiate the process of chamber ballooning by altering cell shape in atrium and ventricle. 
Conversely, our data underscore that Tbx5a is needed for cell growth. Cardiomyocytes 
lacking Tbx5a were smaller in both ventricle and atrium at early chamber morphogenesis 
stages. Since tbx5a mutant hearts never complete looping, but do undergo cell shape 
changes, our studies further suggest that the processes leading to chamber ballooning are 
genetically separable from processes underlying cardiac looping.  
 
Results: 
Identification of a new tbx5a mutant allele 
We identified an ENU-induced mutant (s296) in a large-scale screen for recessive lethal 
mutations that disrupt cardiac function. Homozygous mutant embryos have severe 
cardiac deformities, a complete absence of pectoral fin bud initiation (Fig. 2.1H-K), and  
33 
 
Fig. 2.1: Cardiac deformities in tbx5a mutant larvae. Wildtype larvae. (D-G) 
Homozygous mutant tbx5am21 (H-K) or tbx5as296 larvae. (L-O) tbx5am21/tbx5as296
mutant larvae. As indicated, larvae displayed either a “mild” or “severe” heartstrings
phenotype at 72 hpf. (C, G, K, O) Fluorescent hearts of Tg(myl7:EGFP-HsHRAS) 
embryos, demonstrating the dysmorphic form of hearts in the mutants. 
 
 
48 hpf 72 hpf 
mild severe
A B 





























M N L O 
34 
 
die between 6 and 8 days post-fertilization (dpf). Heterozygous embryos have normal 
anatomy, and adults are viable as well as fertile. Because these phenotypes strongly 
resembled those seen in homozygous hst mutant embryos (Fig. 2.1D-G), we performed a 
complementation test by intercrossing heterozygous fish from the s296 and tbx5am21 lines 
to determine if the s296 mutation is allelic to tbx5am21.  Complementation failed to occur 
(Fig. 2.1L-O), with 24.9% of resulting embryos demonstrating hst-like cardiac and 
pectoral fin phenotypes and 75.1% of resulting offspring appearing completely wildtype 
(see Table 2.1). Failure to complement indicates that the m21 and s296 mutations are 
allelic.  
Table 2.1: Analysis of Mendelian inheritance patterns of embryos resulting from 
wildtype and mutant intercrosses. Phenotypes were assessed at 72 hpf to determine 
presence of pectoral fins and status of cardiac looping. The number and relative 






Sequencing of tbx5s296 allele reveals a nonsense mutation 
To determine the molecular location of the tbx5as296 mutation we cloned and sequenced 
cDNA from homozygous tbx5as296 embryos.  Sequencing revealed a G to A transition at 
basepair 527, which would introduce a nonsense mutation at amino acid 120 within the 
T-box region of the coding sequence (Fig. 2.2). If translated, the predicted Tbx5as296 
mutant protein would include only the first half of the T-box DNA-binding domain. In 
contrast, the previously described tbx5am21 mutation was located in the carboxyl-terminus  
Genotype: 






m21/m21 54/215 25.1% 
m21/s296 58/233 24.9% 
s296/s296 48/204 23.5% 
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Fig. 2.2: Sequencing of the zebrafish tbx5as296 allele. (A) Sequencing of tbx5a cDNA 
indicated a G to A nucleotide change at base pair 527 in tbx5as296 mutant embryos.  The 
tbx5as296 mutation changes residue 120 (tryptophan) to a premature stop codon within the 
T-box DNA binding domain. (B) A schematic diagram of the tbx5a transcript showing 
exons, including the locations of the start and stop sites (blue arrow and arrowhead 
respectively) and the two hst nonsense mutations (red arrows). Blue boxes indicate the 
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36 
 
(Garrity et al., 2002), a region that in mammals contains elements that positively regulate 
DNA binding (Hiroi et al., 2001). Therefore, the potential existed that each allele could 
encode truncated proteins with unique cellular interactions or dominant-negative effects.  
 
To investigate whether dominant-negative effects occurred, we examined the percentage 
of affected offspring obtained from a tbx5as296 heterozygous cross. At 72 hpf, 23.5% of 
embryos displayed the hst phenotype, while 76.5% were completely wildtype (Table 2.1).  
This ratio indicated a lack of dominant-negative effects. Dominant negative effects were 
likewise not observed for homozygous tbx5am21 mutant embryos (Garrity et al., 2002).   
 
Comparison of tbx5a mutant phenotypes 
In order to investigate the relative severity of the tbx5am21and tbx5as296 alleles, we 
compared the phenotypes of homozygous tbx5am21/tbx5am21, tbx5as296/tbx5as296 or 
tbx5am21/tbx5as296 embryos. In all three hst genotypes, the formation and contractility of 
the heart tube in mutant embryos at 24-26 hours post fertilization (hpf) was 
indistinguishable from wildtype (data not shown). By 48 hpf, mutant hearts of all three 
hst genotypes had failed to loop and fluid began to accumulate in the pericardium (Fig. 
2.1D,H,L). tbx5as296/tbx5as296 or tbx5am21/tbx5as296 mutant embryos within a clutch 
exhibited variable expressivity similar to that previously reported for tbx5am21/tbx5am21 
embryos (Fig. 2.1) (Garrity et al., 2002). “Mild” homozygous hst embryos showed 
moderate defects in cardiac looping and reduced blood flow (Fig. 2.1E,I,M), whereas 
“severe” homozygous hst embryos developed an enlarged pericardial edema, an extended 
heart tube, and completely lacked blood flow (Fig. 2.1F,G,J,K,N,O).  Lethality occurred 
37 
 
for all hst embryos by approximately 7 dpf, whether the cardiac phenotypes were mild or 
severe. Looping morphogenesis was quantified in homozygous tbx5am21or tbx5as296 
mutant larva by measuring the angle of the AVJ relative to the anterior/posterior axis of 
the larva; we term this rubric the “looping angle” (Fig. 2.3). Wildtype larvae 
demonstrated an average looping angle of 13° by 48 hpf. In contrast, both homozygous 
tbx5am21 hearts and tbx5as296 hearts showed average looping angles greater than 50°, 
indicating that significantly less looping had occurred relative to wildtype hearts (p<0.05 
for both mutants). Indeed, looping angles for hst mutant hearts at 48 hpf were similar to 
those of 34 hpf wildtype hearts (48° ± 2.5 SEM; Chernyavskaya and Garrity, unpublished 
data), suggesting that, on average, hst mutant hearts barely initiate looping, if at all. Thus, 
overt cardiac and fin phenotypes appeared indistinguishable among tbx5am21/tbx5am21, 
tbx5am21/tbx5as296 or tbx5as296/tbx5as296 embryos. Moreover, tbx5a morpholinos described 
by us and others have produced the identical phenotype (Ahn et al., 2002, Garrity et al., 
2002, Ghosh et al., 2009). These data indicate that both the tbx5am21and tbx5as296 
mutations generate strong loss-of-function alleles.  
 
Chamber specification is unaffected in tbx5as296embryos 
To more rigorously test our hypothesis that tbx5am21and tbx5as296 represent equivalently 
strong alleles, we performed molecular studies to examine specification and 
differentiation in the heart and fins of homozygous embryos by whole mount in situ 
hybridization. In vertebrate species such as mice, chick and frog, tbx5 plays an important 
role in the assignment of chamber formation fates (Bruneau  et  al.,  2001,  Goetz  et  al., 
2006, Liberatore et al., 2000).  In zebrafish, atrial and ventricular cell myocardial lineages 
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Fig. 2.3: Absence of functional tbx5a results in a lack of cardiac looping. (A) 48 hpf 
hearts in wildtype or tbx5a mutant Tg(myl7:EGFP-HsHRAS) embryos. (B) Diagram 
outlining chamber looping, in which the “looping angle”, representing the degrees 
between the embryonic A/P axis (blue line) and the plane of the AVJ (red line), was 
calculated. (C) The mean looping angle ± SEM (n=14-15 hearts per genotype). Angles 










































can be distinguished with molecular markers well before the chambers become 
morphologically discrete. To investigate the proportion and specification of chambers as 
they formed within the heart tube, we examined the expression of atrial-specific myosin 
heavy chain (amhc) and ventricle-specific myosin heavy chain (vmhc) (Berdougo et al., 
2003, Yelon et al., 1999). At 30 hpf, the presumptive atrium expresses amhc just under 
the left eye.  Early atrium specification proceeded normally in both tbx5am21and tbx5as296 
homozygous mutant embryos as seen by appropriate amhc expression (Fig. 2.4A-C).  At 
42 hpf, wildtype, tbx5am21 and tbx5as296 embryos all expressed vmhc in the ventricle only 
(Fig. 2.4D-F). One previous report describing a morpholino-targeted tbx5a phenotype 
indicated that vmhc can show ectopic expression within the presumptive atrium of the 
heart tubes at 36 hpf (Lu et al., 2008), but here we find that homozygous tbx5am21 and 
tbx5as296 mutant embryos expressed vmhc in a region strictly similar to wildtype by the 
onset of chamber ballooning (~42 hpf). Endocardial specification occurred normally in 
hst embryos as indicated by the expected fli1 expression in the heart at 48 and 72 hpf 
(data not shown) (Brown et al., 2000).  While the initial steps of chamber formation were 
normal, tbx5as296 mutant embryos did show later defects in cardiac differentiation. In 
wildtype embryos, versican (vcana) expression becomes restricted to the atrioventricular 
(AV) boundary after 37 hpf ((Thisse et al., 1993), Fig. 2.4G) and bmp4 to the same 
region by 48 hpf (Fig. 2.4J).  However, in both homozygous tbx5am21 and tbx5as296 
embryos, restriction of these markers did not occur (Fig. 2.4H, I, K, L) but remained 
expanded throughout the entire ventricle. Therefore, cells of the first heart field segregate 
normally into atrial and ventricular precursors in tbx5am21and tbx5as296 mutant embryos, 
but by 48 hpf have arrested or slowed further differentiation. 
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Fig. 2.4: Chamber and myocardial differentiation in tbx5a mutant embryos and 
larvae. A developmental series of in situ hybridization experiments examining (A-C) 
atrial-specific amhc expression (30 hpf), (D-F) ventricular-specific vmhc expression (42 
hpf), (G-I) vcana expression after the onset of cardiac looping (42 hpf), and (J-L) bmp4 
cardiac expression at 48 hpf in wildtype and tbx5a mutant embryos. a: atrium; v: 
ventricle;  arrows: gene expression restricted to the atrial-ventricular junction; arrowhead: 
sinus venosus. 
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Venous differentiation in hst embryos 
Within the vertebrate heart, tbx5 may play a key role in recruitment or expansion of the 
population of sinoatrial precursors. For example, Tbx5 regulates the expression of myosin 
heavy chain 6, a gene required for development of the sinoatrial region (Ching et al., 
2005). To investigate the potential impairment of sinoatrial development in zebrafish 
embryos lacking tbx5a, we employed in situ hybridization and functional studies. 
Wildtype embryos express BMP4 in a population of cells marking the sinus venosus (SV) 
at 48 hpf. In contrast, islet-1 mutants, which show reduced differentiation at the venous 
pole, failed to express BMP4 in the venous region of the heart (de Pater et al., 2009). In 
addition, mutation of the Bmp type 1 receptor alk8 in laf embryos led to hearts with a 
reduced atrium but normal-sized ventricle, further supporting the role of BMP signaling 
in differentiation of the venous pole of the heart (Chocron et al., 2007; Marques and 
Yelon, 2009). We therefore selected bmp4 as an appropriate marker for evaluating 
differentiation of posterior (venous) cell fate in the 48 hpf heart tube. Homozygous 
tbx5am21and tbx5as296 embryos did not differ from wildtype in that both expressed a 
similar patch of bmp4 at the venous pole at this stage (Fig. 2.4J-L), suggesting 
differentiation was normal in this region.  
 
Like mice, zebrafish mutant for tbx5a exhibit bradycardia (Garrity et al., 2002), but it is 
uncertain whether this was due specifically to sinoatrial defects. To investigate the 
function of the sinus venosus region, we visually examined hearts of tbx5am21 and 
tbx5as296 mutants in live embryos from 30-72 hpf for arrhythmias indicative of 
pacemaker dysfunction. Bradycardia was noted in both mutants, but no evidence of sinus 
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pauses, AV block or other arrhythmia was found (n = 30 mutant embryos per allele). 
Thus, both gene expression and functional assays suggest that during early chamber 
formation stages, posterior SHF cells were added to the heart tube and sinoatrial function 
was not severely defective in hst mutants.  
 
Pectoral fin outgrowth is absent in homozygous tbx5as296 embryos 
Along with cardiac defects, pectoral fin dysgenesis is a hallmark of Tbx5a depletion in 
zebrafish (Ahn et al., 2002, Garrity et al., 2002). Wildtype embryos begin differentiating 
pectoral fin tissue by 28 hpf, and limb buds are easily identifiable by 32 hpf (Gibert et al., 
2006). Small fins with defined proximal/distal axes are observed by 72 hpf (Fig. 2.5G). 
As reported for tbx5am21 mutants, we find homozygous mutant tbx5as296 embryos at 72 
hpf completely lacked morphological evidence of pectoral buds or fins (Fig. 2.5H, I).  
Investigation by in situ hybridization confirms that homozygous tbx5as296 mutant 
embryos did not express the early fin field marker bmp4 by 36 hpf (Fig. 2.5A-C) nor the 
later fin fold marker, vcana, by 48 hpf (Fig. 2.5D-F).   Taken together, these molecular 
data on cardiac and fin phenotypes confirm our initial impression of equivalently strong 
loss-of-function phenotypes for the tbx5am21 and tbx5as296 alleles. 
 
The m21 and s296 mutations in tbx5a encode null alleles 
A possibility remained that the tbx5am21and tbx5as296 alleles encoded proteins that 
retained at least some residual Tbx5a function. For accurate interpretation of phenotypes, 
it was important to definitively test whether tbx5am21and tbx5as296 encoded null alleles. 
Therefore, protein extracts from mutant embryos were assayed by immunoblot analysis 
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Fig. 2.5: Pectoral fin development is absent in tbx5as296 mutant embryos. A 
developmental series of in situ hybridization experiments examining fin initiation. (A-C) 
Mutants do not express bmp4 in the fin field at 36 hpf. Normal expression in pharyngeal 
arches provides an internal control. (D-F) Mutants do not express the apical fin fold 
marker vcana at 48 hpf, but show normal expression in the otic placodes. (G-I) 
Brightfield images taken at 72 hpf indicate the absence of pectoral fins even at this later 
stage. o:otic placode. Brackets indicate the location where expression of fin markers or 
pectoral fin outgrowth was expected.  
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using an antibody against zebrafish Tbx5a (Fig. 2.6). The predicted size of wildtype 
Tbx5a is 54 kDa. If translated, the tbx5am21 allele would encode a 31 kDa truncated 
protein, and tbx5as296 allele would encode a 15 kDa truncated protein.  Tbx5b, a 
paralogous zebrafish T-box protein, has a predicted size of 47.4 kDa.  Because the 
antibody used in this analysis is a polyclonal antibody targeted to the first 15 amino acids 
of the zebrafish tbx5a sequence, and the Tbx5a and Tbx5b proteins are only 20% similar 
in this region, it is unlikely the antibody will cross-react with Tbx5b. This expectation 
was confirmed with the detection of a ~54 kDa protein for wildtype Tbx5a, but no protein 
of 47 kDa. No proteins were detected in tbx5am21/tbx5am21or tbx5as296/ tbx5as296 samples, 
indicating that both constitute protein null alleles (Fig. 2.6). This finding is consistent 
with genetic data including a lack of stronger phenotypes obtained via several different 
zebrafish tbx5a morpholinos (Ahn et al., 2002, Garrity et al., 2002, Ghosh et al., 2009).    
 
Tbx5a is not required for regulation of cardiomyocyte number, nor addition to the 
arterial pole 
One important physiological activity of Tbx5 is its regulation of cardiomyocyte 
proliferation (Brown et al., 2005, Hatcher and McDermott, 2006). With confirmed null 
alleles in hand, we therefore investigated the effects of tbx5a depletion on cardiomyocyte 
number in zebrafish. To assess cardiac cell number, we intercrossed the tbx5a mutant 
lines with a transgenic line in which the nuclear DsRed reporter gene is driven by the 
heart-specific myl7 (formerly cmlc2) promoter (Tg(myl7:nDsRed2/myl7:EGFP)(Mably et 
al., 2003)).  Cardiomyocytes were quantified by counting the total number of DsRed-
positive nuclei in 48 hpf transgenic fish of several genotypes, including homozygous 
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Fig. 2.6: Mutations in Tbx5a represent protein null alleles. Immunoblot analysis was 
performed on protein extracts isolated from wildtype or homozygous tbx5am21 or 
tbx5as296 embryos. The blot was probed with a polyclonal antibody against zebrafish 
tbx5a.  Wildtype Tbx5a is predicted to be 54 kDa.  The faint bands between 54 and 31 
kDa are most likely degradation products that were consistently observed in other 
wildtype protein preparations. The Tbx5am21mutant protein has a predicted size of 31 
kDa, while the Tbx5as296 mutant protein has a predicted size of 15 kDa. As a control for 
specificity of the Tbx5a antibody, tbx5a antibody pre-incubated with the original 
immunizing peptide was tested on wildtype extracts.  Bands in this control lane indicate 




















wildtype, homozygous mutant tbx5am21, homozygous mutant tbx5as296, phenotypically 
wildtype siblings (the offspring of a cross of tbx5am21 heterozygotes), and tbx5a 
morphant embryos (Fig. 2.7). We observed no significant differences in total cardio-
myocyte numbers at 48 hpf among any of these fish (p=0.399).   
 
Cardiomyocyte size is reduced in hst embryos 
In order to determine if tbx5a plays a role in growth and differentiation of individual 
cardiomyocytes, we measured the size and shape of hst cardiomyocytes in the heart 
during the chamber ballooning stages. Regional cell shape changes play an important role 
in determining overall morphology of the developing heart tube (Auman et al., 2007). As 
the ventricle undergoes chamber morphogenesis, the cells located within the outer 
curvature of the chamber (OC) elongate perpendicular to the direction of blood flow, 
while cells in the inner curvature (IC) retain a smaller, cuboidal shape (Auman et al., 
2007). In both atrium and ventricle, OC cells continue to express the marker natriuretic 
peptide precursor A (nppa), whereas IC cells lose this expression of nppa (Auman et al., 
2007). In mice and chick, cells of the OC grow to a larger size than the IC (Manasek et 
al., 1972, Meilhac et al., 2004). Therefore, following the precedent of Auman and 
colleagues, we defined the ventricular OC as the region of cells that retain nppa 
expression and the IC as the region of cells that are not expressing nppa. To quantify cell 
size and shape in zebrafish hearts, we used ImageJ software and the Tg(myl7:EGFP-
HsHRAS)  line (Chi  et  al.,  2008),  in  which  cardiomyocytes  express  GFP  at  the  cell 
periphery (Fig. 2.8).  ImageJ software was used to calculate the size (that is, the surface 
area) and the circularity of cardiomyocytes in each region. Although Auman and  
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Fig. 2.7: tbx5a is not required for regulation of cardiomyocyte number. 
Quantification of total cardiomyocyte numbers in homozyogous wildtype embryos, 
phenotypically wildtype siblings from a cross of two hst heterozygotes, or homozygous 
tbx5a mutant or morphant embryos at 48 hpf. Cardiomyocytes were identified by 
quantifying nuclei from inverted fluorescent images of Tg(myl7:nDsRed2) embryonic 
hearts. Data are expressed as means ± SEM (*p<0.05). n=20 for WT, n=12 for WT 































colleagues reported that by 52 hpf OC cells are larger than IC cells (Auman et al., 2007), 
a difference in wildtype ventricular OC and IC cell size was not yet apparent by 48 hpf 
(p=0.87). In the atrium at 48 hpf, OC cells were already notably larger than IC 
cardiomyocytes (p<0.001) (Fig. 2.8C). Upon examining tbx5am21 mutants,  we  find  that  
cells  of  IC  and  OC  were  statistically smaller  in both chambers relative to the cognate 
region in wildtype controls (Fig. 2.8C). The cell size reduction was not due to general 
developmental delay as wildtype and hst mutant embryos show equivalent expression of 
markers in non-tbx5a expressing tissues such as the otic placodes and pharyngeal arches 
(Fig. 2.5D-I) (Garrity et al., 2002). Moreover, this phenotype is not likely to be a 
secondary consequence of altered blood flow, since circulation in hst mutants remains 
relatively robust prior to 48 hpf, although it typically decreases substantially over the 
following 24 hpf.  Instead, the overall smaller size of cells in both chambers of hst 
mutants appears to indicate a block in continued cell growth and differentiation of 
chamber cardiomyocytes by 48 hpf. Dampened or arrested cardiomyocyte cell growth is 
consistent with the deteriorating cardiac function observed for the zebrafish hst heart at 
72 hpf, which includes a collapsed ventricle, lesions in atrial tissue, decreased 
contractility of the heart, and loss of circulation in the more severe hst mutants (Garrity et 
al., 2002).  
 
Assessment of cell shape changes associated with chamber ballooning 
As measured in the ImageJ program, “circularity” is a measure of cell shape, with a value 
of 1.0 indicating a perfect circle and smaller values indicating an increasingly elongated 
polygon. Circularity values indicated that in wildtype ventricles, OC cells became more 
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Fig. 2.8: Cardiomyocyte size is reduced in 48 hpf hst embryos. (A) Hearts from 
Tg(myl7:EGFP-HsHRAS) wildtype and tbx5am21 embryos were imaged in situ to quantify 
cardiomyocyte dimensions. IC and OC were determined as described in Auman et al.
(2007). (B) Representative images of cardiomyocytes taken at 400x magnification, 
selected from each chamber to illustrate their relative size and shape. (C) Quantification 
of cardiomyocyte size in the ventricle or atrium, based on the surface area of individual 
cells. (D) Quantification of cardiomyocyte shape for each chamber, in which higher 
numbers indicate a more circular shape. Data are expressed as means ± SEM (*p<0.05, 
**p<0.001). n=10 wildtype embryos 369 total cells, n=10 for hst embryos with 337 total 
cells. IC = Inner Curvature, OC = Outer Curvature cells. Red lines in (A) denote the 







































































elongated than IC by 48 hpf (p=0.002)(Fig. 2.8B,D), a change associated with chamber 
ballooning (Auman et al., 2007). In tbx5am21 mutant hearts, the ventricular OC cells 
showed typical elongation whereas IC cells remained rounded. Compared to wildtype, no 
significant differences were detected in the circularity values for tbx5am21 ventricular OC 
cells (p=0.12) or ventricular IC cells (p=0.11). Therefore, the ventricles of tbx5am21 
mutants appear to be undergoing normal chamber ballooning. 
 
Cells of the wildtype atrium also undergo changes in cell shape as ballooning proceeds. 
In this chamber, both IC and OC cells became elongated, and displayed circularity values 
even smaller than the ventricular OC cells (Fig. 2.8D). At 48 hpf, IC and OC were 
equally elongated (p=0.55), although OC cells were already substantially larger than IC 
cells (Fig. 2.8C). In tbx5am21 mutants, atrium OC cells were elongated to the same degree 
as wildtype (p=0.37). However, tbx5am21 mutant atrium IC cells showed a more rounded 
phenotype compared to wildtype atrium IC cells (p=0.027). This difference identifies the 
atrial IC as one region of the heart that may especially require Tbx5a activity for 
continued differentiation of cell shape. Overall, these data suggest that although looping 
morphogenesis remains stalled in hst embryos, most cell shape changes associated with 




Here we describe a new mutant hst/tbx5a allele in zebrafish, termed tbx5as296. This 
nonsense allele encodes a stop codon within the T-box region, compared to the more C-
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terminal location of the mutation in tbx5am21previously described. Our phenotypic studies 
using these two null hst mutants support the findings that tbx5a is not required for cardiac 
cell number during chamber morphogenesis stages, for differentiation of the venous pole 
of the heart, or for the correct proportion of atrial versus ventricular cells. However, 
Tbx5a is required for cardiomyocytes of both chambers to attain their normal size by 
chamber ballooning stages. Examination of the atrium as it enters chamber ballooning 
indicated that both IC and OC cells of this chamber normally undergo a substantial 
elongation in cell shape. By contrast, previous studies showed that ventricle OC cells 
elongate substantially more than IC cells during this period (Auman et al., 2007). Tbx5a 
appears to influence cell shape changes within the atrium IC, but does not affect atrium 
OC, nor within the ventricle. While the hearts of hst/tbx5a mutants never complete 
looping morphogenesis, they nevertheless display characteristic changes associated with 
chamber ballooning (with the exception of the atrium IC), suggesting that chamber 
ballooning and looping morphogenesis are not interdependent processes. 
 
Four lines of evidence support the conclusion that both the tbx5as296 and tbx5am21 alleles 
are null and that neither exerts any dominant-negative effects. First, biochemical 
evidence indicates the absence of signal on an immunoblot, indicating these mutations 
encode null alleles. Second, homozygous tbx5am21and tbx5as296 embryos do not represent 
more than 25% of progeny in a monohybrid cross, indicating the phenotype is fully 
recessive. Moreover, homozygous tbx5am21 and tbx5as296 embryos are phenotypically 
identical in their cardiac and fin phenotypes, and age of lethality. Finally, the phenotypes 
of a transheterozygous embryo (tbx5am21/tbx5as296) are indistinguishable from a 
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homozygote of either allele, providing genetic evidence that both are equivalently strong 
alleles. The capacity of Tbx5 to demonstrate dominant-negative activity has been 
observed for mutations in human Tbx5 that yield a truncated protein lacking the 3’ end of 
the T-box (Basson et al., 1999, Herrmann and Kispert, 1994, Kispert and Herrmann, 
1993, Kispert et al., 1995, Li et al., 1997, Muller and Herrmann, 1997). In zebrafish, 
however, tbx5a transcripts can be weakly detected by whole-mount in situ hybridization 
for only a few hours after the expected onset of transcription, but are non-detectable 
beyond 26 hpf (Garrity et al., 2002). Nonsense-mediated mRNA decay (NMD) is a 
cellular fidelity mechanism which prohibits the translation of mRNAs with premature 
stop codons or incorrect splicing (Hentze and Kulozik, 1999).   NMD, a conserved 
mechanism found in all eukaryotes, may help ensure that aberrant proteins which could 
have dominant-negative or deleterious gain-of-function activities are not produced 
(Chang et al., 2007, Cheng et al., 1994, Zhang et al., 1998). For both tbx5am21 and 
tbx5as296 transcripts, the location of the premature stop codon within an internal exon 
located more than 50 basepairs upstream of the end of the last spliced exon suggests that 
these transcripts are candidate targets for NMD (Fig. 2.2). Thus, NMD is likely 
mechanism that could account for the observed lack of Tbx5a protein in these mutants. 
Alternatively, the truncated Tbx5a proteins may be extremely unstable and thus 
undetectable by immunoblot.  
 
We find that tbx5a is not essential for determining normal cardiomyocyte number in 
zebrafish during early chamber morphogenesis. It is therefore likely that tbx5a is 
dispensable for functions regulating cardiomyocyte proliferation in zebrafish, although 
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we have not yet tested this directly. In contrast, depletion of TBX5 by morpholino in 
Xenopus resulted in a ~30-40% decrease of total cardiac cells in hearts undergoing early 
chamber formation (stage 37), indicating that TBX5 positively regulates cardiomyocyte 
proliferation in this system (Brown et al., 2005, Goetz et al., 2006). Decreased numbers 
were due to a delay or arrest in G1/S-phase, which was followed later by an increase in 
apoptotic cells (Goetz et al., 2006). On the other hand, overexpression of wildtype TBX5 
in chick (beginning at HH 17-18, early cardiac looping stages) also reduced 
cardiomyocyte proliferation by 40% (Hatcher et al., 2001). These data support a model in 
which TBX5 functions as a growth arrest signal that negatively regulates cardiomyocyte 
proliferation. At a somewhat later stage in human development (10-15 weeks), Hatcher et 
al., noted a reciprocal relationship of TBX5 expression with proliferating cell nuclear 
antigen (PCNA), an indicator of mitotic activity, providing additional support for the idea 
that TBX5 functions as a growth arrest signal (Hatcher et al., 2001). Overall, genetic 
studies of Tbx5 in various organisms have emphasized that embryos are quite sensitive to 
Tbx5 dosage and that alterations leading to increases or decreases relative to the normal 
amount are associated with phenotypes.  In addition, the timing of depletion or over-
expression of Tbx5 may affect the phenotypic outcome, especially if Tbx5 has a dual role 
as an activator in early stages and a growth arrest signal in later stages, as has been 
proposed (Goetz et al., 2006). Indeed, studies of cardiac T-box factor tbx2 have 
demonstrated the principle that the same T-box gene can have either activating or 
repressive effects on cardiomyocyte proliferation depending on the developmental timing 




Mice lacking Tbx5 showed pronounced defects in the formation of the posterior end of 
the heart, including hypoplastic sinoatrial structures (Bruneau et al., 2001). Our 
experiments here examining zebrafish posterior cardiac differentiation and pacemaker 
functionality suggested that sinoatrial structures were not severely affected in tbx5a 
mutants. In zebrafish, the cells of the first heart field (FHF) form the linear heart tube, to 
which cells derived from the second heart field (SHF) are later added, both at the arterial 
and venous poles (de Pater et al., 2009; Hami et al., 2011; Lazic and Scott, 2011). While 
total FHF proliferation in the heart tube is proposed to be low over the 24-48 hpf period 
(de Pater et al., 2009), contributions from the SHF may equal as much as one-third of the 
ventricle cell number (Lazic and Scott, 2011). Thus, our observation of equivalent 
numbers of cardiomyocytes in tbx5a mutant heart tubes suggests that SHF addition to the 
arterial pole was not substantially affected in these mutants.   
 
In vertebrates, the venous pole of the heart develops pacemaker function (Arrenberg et 
al., 2010; Moorman and Christoffels, 2003). Functional defects in pacemaker activity can 
result in sick-sinus syndrome, leading to sinus pauses or arrest, bradycardia, and other 
types of arrhythmia (Dobrzynski et al., 2007). Sinus dysfunction phenotypes were noted 
in adult heterozygous tbx5 mice, which were reported to exhibit over 100 sinus pauses 
per hour, as well as primary and secondary atrioventricular block (AVB)  (Bruneau et al., 
2001). Due to embryo transparency, arrhythmias can be easily detected in zebrafish 
embryos from a young age (Ebert et al., 2005; Milan and MacRae, 2008). Mutants such 
as Islet-1 (isl1), that are defective in cardiomyocyte differentiation specifically at the 
venous pole, also showed sinus dysfunction phenotypes including bradycardia and 
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frequent sinus pauses (de Pater et al., 2009). The hst phenotypes were mild in this regard, 
with no detectable change in a marker of sinus venosus development, and no evidence of 
sinus pauses or AV block, or sporadic arrhythmia. Bradycardia, which can be associated 
with sinoatrial dysfunction, was observed, but was not nearly as severe as in isl-1 mutants 
which have known defects in venous differentiation (de Pater et al., 2009; Garrity et al., 
2002), and might be due to any of several factors. Bradycardia itself can be a sign of 
sinus dysfunction, yet mice defective in any of several genes required for normal 
pacemaker activity usually show bradycardia in combination with some other type of ar-
rhythmia (Dobrzynski et al., 2007), but this was never observed for hst mutant embryos. 
 
The zebrafish genome contains two paralogous tbx5 genes (Albalat et al., 2010), tbx5a 
and tbx5b. Therefore, the potential remains that tbx5b paralog could share a redundant 
function with tbx5a in modulating cardiac cell number in early chamber morphogenesis 
stages, and that this function masks a cell proliferation phenotype in hst mutants. tbx5b is 
expressed in the embryonic eye and heart, but not in the pectoral fins (Albalat et al., 
2010). Testing the hypothesis of genetic redundancy awaits functional studies of tbx5b. 
However, it is clear that alteration of cardiac cell number is not a primary defect 
contributing to the hst cardiac phenotype by chamber morphogenesis stages. The 
specification of an adequate population of cardiac precursors comprising the first heart 
field occurs in vertebrates at early gastrulation and somitogenesis stages (Marques and 
Yelon, 2009, Zaffran and Frasch, 2002). Although cardiomyocytes do continue to divide 
once the heart tube is established, rates of division during this period are not high (de 
Pater et al., 2009, Lazic and Scott, 2011). Thus, the normal number of cells detected in 48 
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hpf hst heart tubes appears to indicate that these embryos appropriately specify an 
adequate pool of cardiac progenitors, and that the extent of apoptosis in the heart tube 
prior to ballooning is not prohibitive. The neutrality of the tbx5a mutants with regard to 
cardiomyocyte numbers makes an interesting contrast to the phenotypes described for 
one of Tbx5’s conserved binding partners, Nkx2.5. Simultaneous depletion of zebrafish 
nkx2.5 and its paralog nkx2.7 by led to a surplus of atrial cells and a depletion of vent-
ricular cell numbers (Targoff et al., 2008). Knockdown of only one of these genes led to 
much milder phenotypes, suggesting a probable compensatory function by the paralog. 
 
Recently it has become appreciated that continued differentiation of cardiomyocytes 
derived from the secondary heart field serves to elongate the zebrafish heart tube at both 
the venous and arterial poles (de Pater et al., 2009, Hami et al., 2011, Lazic and Scott, 
2011). Based on the hypoplastic phenotype of mouse hearts at the venous pole, we 
investigated potential phenotypes associated with this region in the zebrafish. The hst 
phenotypes were mild in this regard, with no detectable change in a marker of sinus 
venosus development, and no evidence of sinus pauses or AV block, or sporadic 
arrhythmia. Bradycardia, which can be associated with sinoatrial dysfunction, was 
observed, but was not nearly as severe as in isl-1 mutants which have known defects in 
venous differentiation (de Pater et al., 2009, Garrity et al., 2002), and might be due to any 
of several factors. Bradycardia itself can be a sign of sinus dysfunction, yet mice 
defective in any of several genes required for normal pacemaker activity usually show 
bradycardia in combination with some other type of arrhythmia (Dobrzynski et al., 2007), 
but this was never observed for hst mutant embryos. 
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Cardiac looping is a dynamic process that begins roughly as early as 30 hpf zebrafish and 
continues through about days 5 post-fertilization. Concomitantly, as early as 36 hpf, cells 
of the future ventricular OC begin to show differences in F-actin distribution relative to 
cells of the future ventricular IC (Deacon et al., 2010). Genetic studies suggest that F-
actin cytoskeletal rearrangements are necessary to drive the regional changes in cell size 
and shape that culminate in chamber ballooning (Deacon et al., 2010, Latacha et al., 
2005, Taber, 2006). Regional changes in cells shape and alignment have been proposed 
as a mechanism that mediates cardiac looping in vertebrates (Latacha et al., 2005, 
Manasek et al., 1972, Taber, 2006), but have also been proposed as a key determinant of 
chamber ballooning (Auman et al., 2007). The hst mutants provide new insight into this 
question. Embryos lacking Tbx5a stall early in looping morphogenesis, yet still are able 
to initiate several cardiomyocyte cell shape changes in a fashion consistent with chamber 
ballooning in both atrium and ventricle. An exception is that cells of the hst atrium IC 
remained more rounded than their wildtype counterparts, indicating a requirement for 
Tbx5a function specifically in this region. Overall, our data argue against a model in 
which looping morphogenesis is an essential prerequisite for chamber ballooning, and 
point instead to separable mechanisms driving each process. Cell shape changes in that 
occurred normally in the IC and OC were not sufficient to mediate looping to any 
significant degree.  
 
Our data support an essential role for Tbx5a in the sustained growth of cardiomyocytes of 
both chambers. This phenotype is not likely to be a secondary consequence of altered 
blood flow, since circulation in hst mutants remains relatively robust prior to 48 hpf, 
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although it typically decreases substantially over the following 24 hpf.  Previous reports 
in zebrafish and other vertebrates have similarly indicated that cell size is an important 
factor influencing cardiac morphogenesis (Soufan et al., 2006).  
 
In summary, the hst null alleles provide a valuable genetic model for dissecting exactly 
how Tbx5 contributes mechanistically to the forming heart. Comparative analyses of 
Tbx5 function using different model systems is advantageous given that each model has 
its own limitiations, and the task of ascertaining primary versus secondary phenotypes is 
often far from simple. Because this study identifies Tbx5a as a critical regulator of cell 
growth, follow-up studies examining growth factor signaling, MAPK/ERK signaling 
pathways, or cell cycle regulation in tbx5a mutants will be of interest. 
 
Materials & Methods: 
Zebrafish husbandry 
Zebrafish were raised and staged as described previously (Westerfield, 1995, Nusslein-
Volhard and Dahm, 2002) and as per Colorado State University Animal Care and Use 
Protocols. Developmental time at 28.5°C was determined from the morphological 
features of the embryo as described by (Kimmel et al., 1995). 
 
Identification of tbx5as296 allele  
The tbx5as296 mutation was recovered in a screen for ENU-induced mutations on a TL 
background, as described previously (Beis et al., 2005). Mutant alleles were maintained 
by outcrossing to the WIK wild-type line.  
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tbx5as296 allele cloning and sequencing 
mRNA from tbx5as296 homozygous mutant embryos was extracted using the Trizol 
method (Chomczynski and Sacchi, 1987). Reverse transcription and polymerase chain 
reaction was performed as described (Ebert et al., 2005).  Resulting cDNA was TA-
cloned into the pCRII vector (Invitrogen) and sequenced using m13 universal primers, 
and deposited in Genbank (ID pending, to be provided by final submission).  
 
In situ hybridization 
Embryos were fixed in 4% paraformaldehyde solution in PBS (PFA) and prepared for 
whole mount in situ hybridization as described (Thisse et al., 1993).  The digoxigenin-
labled (Roche) riboprobe for tbx5b was prepared as described (Albalat et al., 2010) with 
the following additions: the cDNA was cloned into pCRII (Invitrogen), linearized with 
ApaI restriction enzyme, and synthesized using T7 RNA polymerase.  Other RNA probes 
used include amhc, versican, bmp4, and dhand. Presence of mRNA expression was 
visualized in whole mount using NBT/BCIP chromogenic reagents (Roche). 
 
Zebrafish Imaging 
Live larvae (48 and 72 hpf) were immobilized using MESAB and placed on agarose 
injection plates for imaging. To quantify cardiac looping, wildtype and mutant lines were 
crossed with Tg(myl7:EGFP) to allow for cardiac-specific fluorescence.  Looping angles 
were determined by measuring the angle of the AV junction or the chamber offset angle 
as compared to the anterior/posterior axis of the embryo. All samples were visualized 
using a Spot Insight IN1120 digital camera on an Olympus SZX12 fluorescent stereo-
60 
 
microscope.  Post-processing was done using Adobe Photoshop software. Hearts of 
embryos were scored visually at least three times from the onset of contraction (~26 hpf) 
through 72 hpf in order to assess the incidence of arrhythmias of types previously 
reported in zebrafish, including atrial fibrillation, sporadic irregular contractions, 2:1 
atrioventricular block, or sinus pauses (Ebert et al., 2005; Kopp et al., 2005; 
Langheinrich et al., 2003; Peal et al., 2011; Rottbauer et al., 2001). 
 
Immunoblot analysis 
Immunoblot analysis was performed as previously described (Mizuno et al., 2001). For 
separation of whole protein lysate, 60 mg of total protein was loaded into 4-12% Tris–
acetate gradient gels (Lonza) and electrophoresis accomplished at 150 V for 
approximately 1.5 h. Following separation, the proteins were transferred to a 0.45 µm 
nitrocellulose membrane (Sigma) in a submerged transfer apparatus according to the 
instructions provided by the manufacturer (Enduro, Labnet Intl).  Membranes were 
blocked in 1×TBST (1×TBS with 0.1% Tween-20) and 5% non-fat dry milk (NFDM) for 
1 hr at 25°C before incubation with primary antibodies. Membranes were incubated with 
commercially available antibodies in 1×TBS: Zebrafish Tbx5a-NT (1:500 dilution, 
Anaspec) and Human beta-actin (1:3000, Pierce). For blocking control anti-Tbx5a-NT 
was incubated with 2x blocking peptide (Anaspec) for 30 min at room temperature before 
use. Membranes were incubated with primary antibodies for 1 h at 25°C then washed 
twice quickly and three times for 10 min with 1×TBST. An anti-rabbit conjugated goat 
HRP secondary antibody (1:5000, Thermo Scientific) was used to detect both primary 
antibodies. Membranes were incubated in secondary diluted in block solution (1×TBST 
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and 5% NFDM) for 1 h at 25°C before washing three times for 10 min with 1×TBST. 
The blots were incubated with Dura Chemiluminescence Reagent Plus (Fisher) as 
described by the distributor and imaged using UVP for up to 30 min. Signal comparisons 
were made as described in the text. 
 
Cardiomyocyte quantification 
The number of cardiomyocytes in the heart was quantified in wildtype and mutant 
embryos crossed into a Tg(myl7:nDsRed2/myl7:EGFP) homozygous background.  At 48 
hpf, embryos were pressed between a glass coverslip and slide to gently flatten the heart. 
Intact flattened hearts were immediately imaged using a Leica 5500 microscope. 
Differences in the means were analyzed by Student’s t-test. 
 
Assay of cardiomyocyte morphology 
To investigate volumetric cell growth, we crossed the mutant tbx5a lines with a GFP-
transgenic line (Tg(myl7:EGFP-HsHRAS) in which the reporter gene product is 
associated with the plasma membrane, thereby clearly outlining cell shape.  We 
quantified cardiomyocyte shape directly in 48 hpf embryos (n=10 each WT and tbx5am21) 
and evaluated cell size/volume using imaging software (Image J) (Abramoff et al., 2004, 















Mechanisms affecting chamber morphogenesis 
During cardiac morphogenesis, the vertebrate heart acquires a characteristic three-
dimensional shape well-suited for efficient function. The morphology of the developing 
cardiac organ reflects a series of changes in the cardiomyocytes. These cells must become 
specified, migrate, proliferate, grow in size, alter their shape and adhesive properties, and 
develop ultrastructure (myofibrils), among other differentiated characteristics. Three 
levels of regulation ultimately affecting cardiac size: 1) spatio-temporal regulation of 
specification of cardiac precursors, 2) rate of cell division, or rate of apoptosis within the 
developing heart, and finally 3) amount of volumetric growth of individual cardio-
myocytes (Bryant and Simpson 1984, Conlon & Raff 1999, Day and Lawrence 2000).  
 
Specification of cardiac precursors occurs early in zebrafish development. During the 
blastula stage, between 256- and 540-cell stages, mesodermal cells are still able to 
contribute to future ventricle or atrial cell fates (see Stainier et al. 1993). However, after 
the mid-blastula transition (i.e. the onset of zygotic transcription, which occurs at 
approximately the  1000-cell  stage),  individual  mesodermal  cells  can  only  contribute  
to  either  the ventricular or the atrial precursor population (Stainier et al. 1993). 
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Although the timing of specification is known, the signaling pathways that produce this 
initial chamber precursor assignment are still not well understood. Several genes are 
expressed throughout early development, and their functions can change depending on 
the timing and region of expression (Zhou et al. 2008, Sedletcaia and Evans 2011).  
 
One gene family whose signals are important in establishing cardiac chamber 
proportionality is the bone morphogenic protein (Bmp) group (Marques and Yelon 2009). 
Bmps belong to the transforming growth factor-beta (TGF-β) superfamily of signaling 
molecules, and play roles in controlling cell proliferation, differentiation, and laterality 
(van Wijk et al. 2007). Bmps regulate dorsal/ventral patterning in early embryonic 
development. In early cardiac development, bmp2 influences activation of nkx2.5 
signaling (Prall et al. 2007). Ectopic expression of bmp2 (and the resulting increase in 
nkx2.5) is associated with increased cardiac progenitor specification, but also a decrease 
in cardiomyocyte proliferation, ultimately resulting in smaller hearts. Elimination of 
bmp2 expression results in cessation of cardiac formation (Marques and Yelon 2009). 
Another important Bmp molecule for cardiac formation is bmp4, which plays an 
important role in laterality and is known to interact with Tbx5a in segmentation stages 
(Liu and Stainier 2010). bmp4 is expressed throughout both chambers until chamber 
cushions are specified in the atrioventricular junction (AVJ), starting after 36 hpf (Beis et 
al. 2005). At this time bmp4 expression begins to restrict to the area surrounding the 
AVJ. Evidence that bmp4 contributes to AVJ formation includes lack of bmp4 results in 
valve and septation defects in mice (Jiao et al. 2003) and AV canal differentiation is 
dependent upon Bmp4-Has2 signaling in zebrafish (Patra et al. 2011).  
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Another pervasive morphogen regulator of cell proliferation and specification is fgf8, a 
growth factor expressed in the bilateral heart fields before fusion (Marquest et al. 2008). 
Fgf8 functions in a spatio-temporal specific manner: if fgf8 is reduced prior to 
cardiomyocyte specification, both chambers exhibit a reduction in total cardiomyocytes. 
However, if fgf8 is depleted after 19 hpf, cardiomyocyte reduction is only observed in the 
nascent ventricle. Additionally, if fgf8 is overexpressed, total cardiomyocyte number 
increases, but only if expression is begun before chamber specification (Marques et al. 
2008).  
 
Molecular genetic studies in chick and mouse have examined the effects of tbx5 mutation 
on cell proliferation, migration, and specification as mechanisms to account for defects in 
chamber formation (Hatcher and Basson 2001, Hiroi et al. 2001, Hatcher et al. 2004). 
However, our studies of the hst mutant showed that bilateral cardiac precursors correctly 
expressed several markers of early specification, and that they successfully migrated to 
the midline to generate a linear heart tube of normal morphology (see Chapter 2). 
Therefore, as specification and migration are not detectably altered, consideration of 
other potential mechanisms is warranted to explain the hst phenotype.   
 
Mechanisms regulating cell growth 
Importance of cellular adhesion in cardiomorphogenesis 
Development of tissues into organs is dependent upon cells forming and maintaining 
connections with neighboring cells as well as to the extracellular matrix (ECM). 
Intercellular connections are especially important for organs such as the heart, which 
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undergoes expansion/contraction movements, nearly from the moment it is formed.  In 
cardiac development, cardiomyocytes additionally must withstand the added mechanical 
force of blood flow on intracellular connections. Blood flow and contractility 
independently influence ventricular cell shape, ultimately affecting chamber morphology 
(Auman et al. 2007). One mechanism that tissues use to maintain integrity is the cellular 
connections achieved through adherens junctions. In cardiomyocytes, a primary 
molecular component of adherens junctions is the calcium-dependent N-cadherin, which 
is connected intracellularly to the sarcomere (Noorman et al. 2009). Therefore, 
contracting sarcomeres transduce force to the adherens junctions, but also to the ECM 
through connections to integrins via costameres (Samarel 2005). An additional, important 
function of adherens junctions is that they are able to transduce signals, via secondary 
messenger molecules, to regulate cellular differentiation (Chopra et al. 2011). Defects in 
adherens junctions can also result in congenital cardiac defects (Bagatto et al. 2006). 
 
In experiments conducted for Chapter 2 and 4 we observed an increase in expression of 
vcana and hand2 in hst mutant lines (Fig. 2.4, 4.7). vcana, a large proteoglycan important 
in cell adhesion, migration, and proliferation, also interacts with zebrafish ECM (called 
“cardiac jelly” in heart development). vcana binds hylauronan, a polysaccharide molecule 
that contributes to restriction of cardiac cushion formation (Lagendijk et al. 2011, 
Matsumoto et al. 2003). In zebrafish, hand2 is required for polarization of myocytes and 
regulates the expression of fibronectin1 (fn1), thereby controlling ECM formation (Trinh 
et al. 2005, Yin et al. 2010). fn1 is downregulated in hand2 mutants, leading to loss of 
epicardial integrity (Barnes et al. 2011). Interestingly, hand2 is also essential for gut-
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looping in zebrafish embryogenesis (Yin et al. 2010), which demonstrates a role for 
hand2 in tissue movement. These genetic studies provide ample evidence that 
transcription factors and cytoskeletal structures can impact development. 
 
Myofibrillogenesis 
The heart is the first organ to function in an embryo (Lyons 1996). Zebrafish provide a 
useful model for studying the generation of myofibrils, as they develop ex utero and 
myocytes develop in a monolayer. In zebrafish, cardiomyocytes begin contracting by 24 
hpf, as the heart tube is still assembling (Bakkers 2011). Cardiomyocytes contract by the 
use of myofibrils, comprised of sarcomeres which are the functional subunits in striated 
muscle (Tokuyasu and Maher 1987).  The sarcomere is comprised of many proteins, 
including α-actinin, titin and actin (Fig. 3.2). There is contention as to how, exactly, these 
multiple components ultimately assemble into the complex myofibril structure (reviewed 
in Ono 2010). For example, in chick cardiomycocyte myofibrillogenesis no premyofibrils 
were observed, and instead all sarcomere proteins appropriately localized prior to onset 
of contractions (Ehler et al. 1999). However, zebrafish myocytes appear to utilize 
premyofibrils associated with the cell membrane (Fig. 3.1) in the process of 
myofibrillogenesis. A newly identified zebrafish mutant, futka (ftk), demonstrates 
abnormalities in cardiac myofibrillogenesis (Sultana et al. 2008). The mutation is located 
in an early cardiac connexin (Cx36.7/Ecx), which functions upstream of nkx2.5, as 
demonstrated by rescue of the ftk phenotype by nkx2.5 expression, although the 
mechanism for this signaling is not yet identified. The cardiac homeobox protein Nkx2.5 







Fig. 3.1: Classical model for the assembly of mature myofibrils. The position of 
alpha-actinin (green circles) relative to actin, myosin II, nonmuscle myosin IIB, and 
titin is shown for each stage of myofibril development. Near the spreading edge of the 
cell (far left), a-actinin is found in mini-sarcomeric arrays in the premyofibrils. In the 
nascent myofibril, the a-actinin-rich Z-bodies have begun to laterally associate, 
possibly through interaction with titin. Overlapping muscle myosin II filaments bound 
to titin are present at this stage. In the mature myofibril the a-actinin containing Z-
bodies fuse to form the wide lateral arrays of mature Z-bands; nonmuscle myosin IIB is 
lost, whereas muscle myosin filaments are now aligned into A-bands. From Dabiri et 




differentiation (Hiroi et al. 2001). Therefore, myofibril structure may also be altered in 
hst mutant embryos.  
 
Lu et al. (2008) found that decreased levels of zebrafish tbx5a expression lead to 
decreased expression of cardiac-specific genes, including several components of 
sarcomeres. These results would predict that myofibril structure would be disrupted in hst 
embryos. Therefore, in this chapter, I assay for myofibrillar ultrastructure by fluorescent 
methods. In addition, I investigate whether a zebrafish tbx5a loss-of-function mutation 
affects volumetric cell growth by a decrease in cell-cell adhesion or by defects in F-actin 
structures. The goal of this study is to investigate the cellular basis of tbx5 cardiac 
phenotype. 
 
Results and Discussion 
 
Cardiomyocyte adhesion is not reduced in hst mutant embryos: 
To investigate whether tbx5a mutation disrupted intercellular adhesion within hearts 
undergoing chamber morphogenesis and looping, I evaluated the integrity of heart tubes 
subjected to modest pressure provided by the weight of a cover slip laid upon them (a 
process known as “pressing”). Under these conditions, wildtype hearts maintain their 
integrity and all cardiomyocytes remain intact within their respective chambers (Fig. 3.2).  
I observed no difference in cardiomyocyte cell adhesion or heart tube morphology in 
presses of hst versus wildtype larvae at 48 hpf, indicating that there is no reduction in 
intercellular adhesion in embryos lacking functional tbx5a. As a “reduced-integrity” 
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Fig. 3.2: Cell adhesion is not reduced in hst cardiomyocytes. Inverted fluorescent 
images of hearts from 48 hpf Tg(myl7:EGFP-HsHRAS) embryos: (A) wildtype, (B) hst, 
or (C) injected with morpholino (MO) against the calcium channel CACNB2 subunit.  
Loss of CACNB2 function decreases cardiomyocyte adhesion and is used here as a 
positive control.  Arrows: detached, rounded cardiomyocytes in MO hearts provide 




control in this assay, calcium channel CACNB2 morphant Tg(myl7:EGFP-HsHRAS) 
embryos were similarly pressed. As previously shown in the lab, knock-down of 
CACNB2 reduced integrity of intercellular adhesion and, under slight pressure, 
individual cardiomyocytes readily dissociated from the heart tube, leading to a 
breakdown in organ structure (see Fig. 3.2, arrows). 
 
Another characteristic of loss of intercellular integrity in CACNB2 morphants was a 
deformation of nuclear shape in pressed heart tubes. We therefore assayed hst embryos to 
determine whether this abnormality was detectable. To examine nuclear shape, we 
pressed wildtype, hst, and CACNB2 morphant Tg(myl7:nDsRed2/myl7:EGFP) 48 hpf 
embryos. Pressed nuclei from both wildtype and hst embryos maintained their normal, 
rounded shape, indicating that the hst mutation does not affect intracellular integrity. 
However, cardiomyocyte nuclei in CACNB2 morphant Tg(myl7-dsRed2) hearts were 
elongated or even detached from the mass of heart tube cells (Fig. 3.3C), consistent with 
reduced intercellular or intracellular integrity within these heart tubes (Chernyavskaya et 
al. 2012). These data suggest that overall adhesion of cardiomyocytes is normal in hst 
embryos. It is important to note that presses only assay for a decrease in integrity and 
cannot illuminate structural organization.   
 
Myofibril structure is not altered in hst hearts 
In order to determine if cardiomyocyte morphology differences observed at 48 hpf in 
Chapter 2 resulted from myofibril defects, we examined cardiomyocyte ultrastructure at 
46-48 hpf (Fig. 3.4). Phalloidin-labeling in wildtype cardiomyocyte showed regular, 
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Fig. 3.3: Adhesion of 48 hpf hst mutant cardiomyocyte nuclei is not altered.                 
Inverted fluorescent images of hearts from (A) wildtype, (B) hst, (C) or CACNB2 MO-
injected Tg(myl7:nDsRed2/myl7:EGFP). Hearts were pressed for morphological 




organized sarcomere structure (Fig. 3.4A, B). This regular pattern was observed in hst 
ventricles and atria, regardless of the severity of the cardiac phenotype (Fig. 3.4C-E, see 
Chapter 2 for explanation of mild and severe hst phenotypes). Although it is apparent that 
cell shape is altered, myofibrillogenesis still occurred in the absence of functional Tbx5a, 
and myofibrils strongly resemble wildtype myofibril structure. Our results support the 
model present by Dabiri et al. (1997) in which dense Z-bodies form near the periphery of 
the cell (see Fig. 3.4C’). Huang et al. (2010) also observed that thin filaments associate 
with the zebrafish cardiomyocyte membrane at 48 hpf, indicating that, in zebrafish, 
myofibrillogenesis may occur via premyofibril formation.  
 
Alternate hypothesis for role of tbx5 in cardiomyocyte growth and differentiation  
An alternative mechanism for regulation of cell morphology is controlling presence of 
adhesion molecules at the cell surface (Takeichi 2011). Junctional polarization is 
responsible in early development for specification of epithelium versus mesenchyme 
(whose adherens junctions (AJ) are dispersed randomly) (Nishioka et al. 2009). Cells 
respond to mechanical forces, such as blood flow, by remodeling their adherens junction 
composition (Taguchi et al. 2011). Maintenance of tension at the junction appears to be a 
major factor in proper junction formation. F-actin-stabilizing proteins may function as the 
mechanosensitive regulator for this process (Taguchi et al.  2011). Absence of fn1, a 
major component of ECM, results in aberrant AJ formation, suggesting that myocardial 
function is dependent on epithelial organization and integrity in heart tube formation 
(Trinh and Stainier 2004). ECM proteins are also important for the promotion of 
adhesion-dependent cell growth. Because hand2 and vcana, genes with roles in ECM  
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Fig. 3.4: Myofibrillogenesis is not altered in hst hearts. Hearts of 72 hpf 
Tg(myl7:HsHRas-EGFP) embryos: (A,B) wildtype and (C-E) hst homozygous embryos. 
(A, C) Ventricular F-actin was visualized using rhodamine-labeled phalloidin. (C’) A 
representative area showing sarcomere structure magnified from (C). (B) Wildtype atrial 
F-actin. F-Actin from a phenotypically ‘severe’ hst atrium (D), as compared to a 
phenotypically ‘mild’ hst atrium (E). Arrowhead: putative Z-body, located adjacent to the 



















organization and mediation of intracellular signaling, are ectopically expressed in hst 
embryos, investigation into the role of ECM would facilitate our understanding of 
mechanisms that contribute to cardiac looping. 
 
In summary, we have determined that hst cardiomyocyte morphology deficiencies do not 
result from a decrease in cell adhesion or altered myofibril structure at chamber 
morphogenesis stage. Future investigation into the role of ECM or AJ molecules and their 
signaling may be valuable in understanding the cellular changes exhibited in hst mutant 
embryos. An additional area of exploration that may prove fruitful is examination of 
cellular morphology, adhesion, and myofibrillogenesis in tbx5bMO embryos to determine 
possible functional redundancy. These studies may help to determine if tbx5b also plays a 
role in cell growth and elucidate mechanisms for these changes. 
 
Materials and Methods 
 
Raising and Staging of Embryos 
Developmental time at 28.5°C was determined from the morphological features of the 
embryo as described by Kimmel (1990). 
 
Assay of cardiomyocyte adhesion 
To investigate a possible reduction in intercellular adhesion, I crossed the mutant hst line 
with the Tg(myl7:EGFP-HsHRAS) line, in which the reporter gene product is associated 
with the plasma membrane, thereby clearly outlining cell shape. The integrity of 
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cardiomyocyte nuclei was assayed in wildtype, hst, or CACNB2 morphant embryos 
crossed into a Tg(myl7:nDsRed2/myl7:EGFP) homozygous background. At 48 hpf, 
embryos were pressed between a glass coverslip and slide to gently flatten the heart 
(n=10 embryos each wt, hst, and MO). Flattened hearts were immediately imaged using a 
Leica 5500 microscope. 
 
Assay for myofibrillar structure 
Cardiomyocytes were visualized by removing hearts from wildtype or hst embryos fixed 
in 4% PFA. The hearts were washed in PBSTx, blocked for one hour, and incubated in a 
1:100 dilution of rhodamine-labeled phalloidin (Invitrogen) for 30 minutes prior to 



















CHAPTER 4: ZEBRAFISH TBX5 PARALOGS ARE NOT FUNCTIONALLY 




Genes of the T-box superfamily of transcription factors are present throughout nearly all 
of the animal Kingdom, from primitive invertebrates (including Hydra and jellyfish) 
through all tetrapods (Agulnik et al. 1995, Technau and Bode 1999). T-box genes 
encompass 5 subfamilies: Brachyury, T-brain1, Tbx1, Tbx2 and Tbx6 (Papaioannou 
2001). Members of the same subfamily most likely resulted from duplication events 
throughout evolution. T-box genes have diverse functions in development, including 
regulation of gastrulation, patterning of body axes, morphogenesis and organ 
development (Stennard and Harvey 2005). In general, T-box genes help specify the tissue 
in which they are expressed (Gruelich et al. 2011, Naiche et al. 2005). T-box genes are 
associated with human disorders including DiGeorge syndrome and cancer, among others 
(Naiche et al. 2005). They may play a role in metastasis of certain cancers by promoting 
epithelial-mesenchymal transition. Moreover, recent studies indicate that expression of 
Brachyury in early tumor stages predicts poor patient prognosis (Kilic et al. 2011, Naiche 
et al. 2005, Suzuki et al. 2011). All genes of this family include a highly conserved “T-
box” region that encodes a DNA binding domain that regulates expression of target 
genes. The transcriptional activation domain of T-box proteins is typically located in the 
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C-terminus, outside of the T-domain (Zaragoza et al. 2004). The C-terminus is important 
for the strength of an induction response, but not for the specificity (Marcellini et al. 
2002). The specificity of T-box proteins is conferred in part by their interactions with 
other transcriptional regulators, and in some cases involves an N-terminal interaction 
domain distinct from the T-domain itself (Wilson and Conlon 2002).  
 
Tbx5 is one of the earliest genes to be expressed in the cardiac field during embryonic 
development (Bruneau et al. 1999). Mutation of mammalian Tbx5 produces dominant 
phenotypes affecting cardiac septation as well as electrophysiological defects including 
atrioventricular conduction block, (Bruneau et al., 2001). Holt-Oram Syndrome (HOS) is 
a human congenital disease that results from mutations in Tbx5 (Mori and Bruneau, 
2004, Piacentini et al. 2007). HOS is characterized by cardiac and forelimb 
morphological defects, and progressive cardiac conduction disease. Mammalian models 
of HOS indicate an essential role for tbx5 in cardiac morphogenesis (Basson et al., 1999), 
Showell et al. 2004). In zebrafish, the tbx5a gene is expressed in the embryonic heart, 
dorsal optic cup, and pectoral fins (Begemann and Ingham 2000). The tbx5a/heartstrings 
(tbx5a) mutant displays a loss-of-function phenotype that recapitulates aspects of HOS in 
both the heart and forelimb (Garrity et al., 2002). Homozygous tbx5a mutation prevents 
initiation of pectoral fin formation, and conditional deletion of mouse Tbx5 in the 
forelimb buds similarly results in a complete lack of forelimb bud formation (Garrity et 
al. 2002, Rallis et al. 2003). Despite overtly normal heart tube formation and slight 
bradycardia, the hearts of homozygous tbx5a mutant embryos later fail to loop and 
progressively deteriorate, leading to heart failure and lethality. Although embryonic 
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lethal, the cardiac phenotypes in tbx5a mutants differ somewhat from those reported for 
Tbx5 mutation in the mouse, which particularly affect formation of the venous end of the 
developing heart (Bruneau et al. 2001, Ghosh et al. 2009, Parrie et al. in press).  
 
Recently, a second zebrafish tbx5 paralog has been described, termed tbx5b (Albalat et al. 
2010). Because a tbx5b-like gene is present in all known teleost genome sequences, this 
gene likely arose during the teleost-specific genome duplication event approximately 300 
million years ago (Hurley et al. 2007). Based on in situ hybridization (ISH) studies, 
Albalat et al. (2010) reported that zebrafish tbx5b, similar to tbx5a, is expressed in the 
embryonic eye and heart. However, within the eye, tbx5b expression is expanded as 
compared to tbx5a, to include a majority of the dorsal side. ISH was not sufficient to 
detect tbx5b expression in either the caudal-most portion of the lateral plate mesoderm 
which contributes to pectoral fin mesenchyme, or within the forming pectoral fins 
themselves (Albalat et al. 2010). 
 
Based on the overlapping expression patterns of tbx5a and tbx5b in the embryonic heart, 
we hypothesized that functional redundancy between these two paralogs might ameliorate 
the cardiac phenotype in tbx5a mutant embryos. To address this question, we first re-
visited the status of tbx5b as an authentic tbx5 paralog, as opposed to a divergent tbx5-
like gene. Second, we determined the embryonic functions of tbx5b during development 
using a morpholino knockdown approach. We report here that depletion of tbx5b is 
embryonic lethal due to heart failure. The cardiac phenotypes in tbx5b-depleted fish were 
similar, but not identical, to those of tbx5a mutants. Although tbx5b expression was not 
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detectable by ISH in the fins, we find that tbx5b-depletion led to defects in the timing and 
morphogenesis of pectoral fin development. Somewhat surprisingly, depletion of both 
gene products did not lead to more severe phenotypes. Overall, our data do not indicate 
that substantial genetic redundancy exists between the two genes. In the heart, tbx5a and 
tbx5b appear to have related essential functions that are nevertheless independently 
required. In the fin, tbx5a alone was required for fin bud initiation, but both genes are 





We isolated and sequenced full-length tbx5b mRNA from WIK wildtype Danio rerio 
embryos (Fig. 4.1; GenBank Accession number: HQ822122). The predicted Tbx5b 
protein is 430 aa in length, 55 residues shorter than D. rerio Tbx5a. The zebrafish Tbx5b 
amino acid sequence was aligned with other vertebrate Tbx5 proteins (Gallus gallus, 
Homo sapiens, Xenopus leavis) as well as to both Tbx5 paralog genes in three other 
teleost species (Gasterosteus aculeatus, Oryzias latipes, and Tetraodon nigroviridis) (Fig. 
4.1). As with other T-box genes (Papaioannou 2003) D. rerio Tbx5b was most similar to 
the other Tbx5 proteins within the T-box region (87.5% conserved with H. sapiens, for 
example). The degree of conservation within the D. rerio Tbx5b T-domain was thus 
lower than reported for other T-box gene family members, which typically display 95-
99% amino acid identity within this region (Bamshad et al. 2007, Bruneau et al. 2001, 
Holland et al. 1995, Horb and Thomsen 1999).   
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Fig. 4.1: The zebrafish Tbx5b protein sequence is not highly conserved. Comparison 
of Tbx5 proteins. Alignment of the predicted Tbx5 protein sequences from vertebrates G. 
gallus, X. leavis, and H. sapiens with the predicted Tbx5a and Tbx5b protein sequences 
from teleost species D. rerio, G aculeatus, O. latipes, T. nigroviridis. Amino acids that 
are identical are highlighted in blue. Red line underscores the T-box DNA binding 
domain. Asterisks indicate residues D. rerio Tbx5b does not share with other teleost 
Tbx5b proteins. Boxed region highlights a 9-amino acid conserved Tbx5-specific motif 
of unknown function. Black lines mark the two nuclear localization signals. Green line 
indicates the nuclear export signal. Orange lines denote the transactivation signal. The 








Interestingly, alignment of vertebrate Tbx5 amino acid sequences identified a highly 
conserved 9 amino acid motif within the C-terminus. Teleost Tbx5a genes encode 
QRQACMYAS, a motif that by BLASTP analysis shows 100% conserved in at least 26 
other vertebrate species (Fig. 4.1, box; and data not shown). In Tbx5b genes, three teleost 
species encode a closely related motif: QRQACMFA[S/G]. However, D. rerio Tbx5b 
encodes QHQPCMYGG, which contains 4 conservative amino acid substitutions, making 
it the most divergent Tbx5 gene in this motif relative to Tbx5a or the other Tbx5b 
sequences (Fig. 4.1, Fig. 4.2).  This motif is predicted to encode a beta-sheet secondary 
structure. It has not been reported so far for any other gene and although its function is 
unknown, it is near the activation signal reported by Zaragoza et al. (2004) (Fig. 4.1), and 
may therefore play a role in Tbx5a transactivation. A BLASTP search against the NCBI 
Reference Sequence database using only the 9 amino acid motif was sufficient to return 
exclusively Tbx5 of multiple vertebrate species as the top several hits, suggesting that the 
motif may be unique to the Tbx5 gene. Overall, this divergence of D. rerio Tbx5b may 
indicate that it has lost classical functions or evolved novel roles as compared to other 
Tbx5 proteins. This may also indicate a higher rate of evolution for D. rerio Tbx5b than 
found in the other teleost species.   
 
Although D. rerio Tbx5a and Tbx5b are proposed paralogs (Albalat et al. 2010), the 
degree of diversity in Tbx5b relative to other T-box genes made us re-visit this 
hypothesis. We directly compared the zebrafish Tbx5 genes in terms of amino acid 
sequence, genomic structure, and examined the position of D. rerio within the broader 
Tbx5 evolutionary family. Overall, the zebrafish tbx5a gene shows 74.6% amino acid  
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Fig. 4.2: Alignment and schematic comparison of zebrafish Tx5a and Tbx5b protein 
sequences and genomic structure.  (A) The Tbx5b T-box (aa 52-250, underlined in red) 
was highly conserved (86.5%), but the paralogs showed an overall amino acid identity of 
only 55.2%. Colors indicate similar types of amino acids: green = polar, orange = 
nonpolar, blue = basic, purple = acidic. Box denotes the conserved 9-amino acid motif, 
also identified in Fig. 1. (B) Schematic comparison of genomic structure of the zebrafish 
tbx5 paralogs. Numbers in blue boxes are exon sizes in basepairs. Blue arrow denotes the 
location of the start codon. Blue arrowheads indicate location of wildtype termination 
signal. Red underline identifies the region encoding the T-box DNA-binding domain. 































identity with human TBX5, whereas tbx5b is substantially more divergent, sharing only 
59% amino acid identity. While the length and sequence of N-terminal domain and T-box 
domains were reasonably similar between Tbx5a and Tbx5b, the latter protein has a 
substantially shorter, highly diverged C-terminus (Fig. 4.2A). The T-box DNA binding 
region was moderately conserved between the two genes, with identity in 174 out of 210 
aa (83%). Next, a comparison of the genomic structure showed that the two tbx5 genes 
both had five exons within the T-box region, all of which were nearly identical in size 
(Fig. 4.2).  This finding was consistent with a general trend that exons comprising the T-
box tend to be of similar size and number throughout evolution, although intron length 
varies between species (Wattler et al. 1998). Outside of the T-box domain, the number 
and sizes of exons was substantially different between the two genes, with tbx5b having 
fewer, smaller exons (Fig. 4.2B). These disparities suggested that Tbx5b may be either a 
rapidly evolving paralog, or that it was a T-box family member but not a true Tbx5 
paralog. To resolve this, we compared tbx5b with other vertebrate T-box genes, including 
conservation signaling domains specific to each T-box family. Analysis reveals that the 
tbx5b is more similar to tbx5a than other T-box genes including tbx4, tbx2, and tbx3 (data 
not currently shown). 
 
Morpholino Knockdown and Analysis of Cardiac Phenotypes 
To test the hypothesis that Tbx5b performs unique functions in zebrafish development, a 
translation-blocking morpholino (tbx5bMO) was designed for tbx5b knockdown. To 
validate the efficacy of tbx5bMO, we created a Tester mRNA consisting of the tbx5b 
morpholino target sequence fused to sequence encoding the GFP reporter. Whereas 
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embryos injected with 1000 ng/µl of capped Tester mRNA displayed green GFP 
fluorescence, 87% of embryos co-injected with Tester mRNA along with 100 uM of 
tbx5bMO lacked any detectable GFP fluorescence by 24 hpf, indicating that tbx5bMO 
efficiently targeted the expected mRNA sequences (Fig. 4.3). By 48 hpf, 79% (121/153) 
of embryos injected with 100 uM of tbx5bMO alone exhibited cardiac phenotypes, 
including defective cardiac looping, reduced contractility, and abnormal chamber 
morphology (Fig. 4.4C,G,K). By 72 hpf, cardiac phenotypes for tbx5b morphant embryos 
overtly resembled those of homozygous tbx5a mutants (Fig. 4.4B,F,J and Garrity et al. 
2002), including a collapsed, dysmorphic heart surrounded by pericardial edema. 
Depletion of Tbx5b was lethal by 6-7 days post-fertilization.  
 
To determine if double knockdown of tbx5a and tbx5b would result in more severe 
cardiac defects, such as a reduction in cardiac tissue or absence of circulation, as was 
previously described for double knockdown of Xenopus Tbx5 and Tbx20 (Brown et al. 
2005), we injected tbx5bMO into tbx5a mutants or co-injected tbx5bMO and tbx5aMO. 
The end-stage cardiac phenotypes of zebrafish tbx5a/tbx5b double knockdown embryos 
overtly resembled those of both tbx5a mutant and tbx5b morphant embryos displaying a 
dysmorphic, weakly contracting heart surrounded by pericardial edema (Fig. 4.4D,H,L). 
 
Next, we used additional tools to examine the tbx5b morphant and tbx5a/tbx5b double 
knockdown embryos to determine whether there were more subtle phenotypic differences 
from tbx5a mutants, which could support a hypothesis of independent function within the 




Fig. 4.3: Confirmation of tbx5b morpholino knock-down using GFP-tagged mRNA 
containing the tbx5bMO target site. The efficacy of tbx5b morpholino knock-down was 
confirmed using a Tester mRNA constructed by inserting the tbx5b MO target site cloned 
in front of EGFP coding sequences.  (A, A’) 30/30 embryos injected with 1000 ng/µl 
Tester mRNA displayed normal body morphology and expressed GFP.  (B) Embryos co-
injected with 100 µM morpholino and 1000 ng/µl Tester mRNA displayed normal body 
morphology, but (B’) 26/30 failed to detectably express GFP, indicating that the 
tbx5bMO efficiently targeted the expected binding site.  
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expressing GFP in the heart. Hearts in live Tg(myl7:EGFP-HsHRAS) embryos injected 
with tbx5bMO were visualized at 48 hpf (Fig. 4.5). The cardiac cardiac “looping angle” 
has been defined as the angle created between the plane of the cardiac atrioventricular 
junction (AVJ) and the embryo A/P axis, as diagrammed (Fig. 4.5B, Chernyavskaya et al. 
2012). Near the onset of looping, 34 hpf wildtype hearts showed an average looping 
angle of 47° ± 4 (Chernyavskaya et al. 2012). By 48 hpf, wildtype larvae undergoing 
normal morphogenesis have reduced the average looping angle to 14° (Fig. 4.5). As 
previously reported, homozygous tbx5a mutant larvae demonstrated an average looping 
angle of 54° (Parrie et al. submitted). Note that although the chambers in mutant hearts 
frequently remain linearly aligned, or only slightly displaced, the plane of the AVJ still 
shows tilting in the direction expected for normal looping. Hearts of tbx5b morphants 
exhibited an average looping angle of 58°, indicating greatly reduced looping. The 
looping angle for embryos with depleted for both tbx5a and tbx5b was 57°, indicating no 
difference from loss of either tbx5 alone. Next, to address cardiac function, we quantified 
heart rate at early chamber morphogenesis stage (42 hpf), chosen as the optimal time for 
balancing maximal cardiac function prior to end-stage degeneration.  At 42 hpf, heart 
rates of tbx5b morphant embryos are significantly reduced as compared to controls, but 
not significantly different from tbx5a mutants or knockdown of tbx5b in tbx5a mutant 
embryos (Fig. 4.5D). Thus, based on both a morphological (heart looping) and a 
functional (heart rate) parameter, knockdown of both zebrafish tbx5 paralogs together did 
not result in a more severe cardiac phenotype than observed for singly depleted embryos. 





Fig. 4.5: tbx5 deficient embryos display similar cardiac looping angles and heart 
rates at 48 hpf.  At 48 hpf, the looping angles (defined as the angle created between the 
plane of the cardiac atrioventricular junction (AVJ) and the embryo A/P axis) were 
determined for control, tbx5a mutants, tbx5b morphants, and tbx5b MO-injected tbx5a 
mutant embryos. (A) GFP-expressing hearts imaged in the Tg(myl7:EGFP-HsHRAS) 
transgenic line. (B) Diagram of the looping angle as measured for the hearts in (A). (C) 
The average looping angle determined from at least 14 embryos per genotype. **, 
relative to controls, mutants and morphants exhibited a statistical difference of p<0.001. 
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Comparative analysis of phenotypes based on molecular markers of cardiac 
differentiation 
We next employed several molecular markers to determine whether cardiac 
differentiation proceeded in a parallel fashion in tbx5a versus tbx5b-depleted embryos. In 
order to determine the effects of tbx5b knock-down on chamber specification, we assayed 
for the expression of cardiac-specific markers by whole mount in situ hybridization. As 
seen by atrial myosin heavy chain (amhc) and ventricular myosin heavy chain (vmhc) 
expression, chamber specification had occurred normally in both tbx5a mutants and tbx5b 
morphant embryos by 42 hpf (Fig. 4.6). In all cases, the expression of both markers was 
precisely restricted to the expected chambers, with no evidence of ectopic expression. We 
next examined expression of natriuretic peptide precursor A (nppa), a known target of 
zebrafish Tbx5a (Camarata et al. 2010) as well as a conserved Tbx5 target for other 
vertebrates (Bruneau et al. 2001, Garg et al. 2003, Habets et al. 2002, Hiroi et al. 2001, 
Stennard et al. 2003). At 36 hpf, nppa was expressed throughout both chambers of 
control embryos, but expressed only in the anterior portion of the ventricle in tbx5a 
mutant embryos (Fig. 4.7A-C).  Expression of nppa was present in both chambers in 
tbx5b morphants, similar to controls.  
 
Next, we next investigated bmp4 expression to investigate the process of AVJ and sinus 
venosus (SV) patterning. By 42 hpf in wildtype bmp4 expression was restricted to the 
AVJ and was also present in the SV region of the inflow tract (Fig. 4.7D, Walsh and 
Stainier 2001). As previously shown (Garrity et al. 2002), tbx5a mutants at 42 hpf 




Fig. 4.6: Chamber-specific gene expression is normal in tbx5a mutant and tbx5b 
morphant embryos. (A-C) At 33 hpf, amhc is expressed only in the atrium of wildtype, 
tbx5a mutant, and tbx5b morphant embryos. (D-F) By 42 hpf, vmhc is expressed 
exclusively in the for both tbx5a mutants and tbx5b morphants. (a: atrium, v:ventricle). 















Fig. 4.7: Differential expression of putative target genes in tbx5a mutants versus 
tbx5b morphants. (A-C) At 36 hpf, expression of nppa (a conserved Tbx5 target) was 
reduced in the atrium of tbx5a mutant embryos, but expressed throughout both chambers 
in tbx5b morphant embryos. (D-F) At 42 hpf, bmp4 was misexpressed throughout the 
ventricle of homozygous tbx5a mutant embryos. In tbx5b morphant embryos, bmp4 
expression was similar to wildtype. (G-I) At 42 hpf, soon after looping has begun, 
wildtype embryos primarily expressed hand2 in the ventricle, but tbx5a mutant and tbx5b 
morphant embryos showed expanded expression encompassing both chambers. (J-L) At 
42 hpf, wildtype embryos showed vcana expression restricted to AVJ boundary, but 
mutant and morphant embryos showed expanded expression throughout the ventricle and 
atrium. Arrow: AVJ boundary, arrowhead: sinus venosus. 
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4.7E). In contrast, expression in tbx5b morphant embryos restricted normally to the AVJ 
and SV (Fig. 4.7F). bmp4 expression in the SV at this time occurs concurrently with the 
addition of cells derived from the second heart field to the venous pole of the heart, and 
bmp4 expression in the SV is missing in mutants such as isl-1 that that lack this addition 
(de Pater et al. 2009). Thus, this data suggests that second heart field cells are 
differentiating normally within the SV in tbx5b morphants.  
 
We next looked at expression of the transcription factor hand2, a gene that plays a role in 
the differentiation and polarization of myocardial precursors as well as in cardiac 
extracellular matrix assembly (Barnes et al. 2011, Trinh et al. 2005). Just after looping 
has initiated, control embryos expressed hand2 only in the ventricle (Fig. 4.7G). In 
contrast, tbx5a and tbx5b-depleted embryos displayed expanded expression 
encompassing both chambers (Fig. 4.7H, I). We also assayed for versican a (vcana), a 
structural protein involved in cell adhesion and migration that interacts directly with the 
extracellular matrix (Matsumoto et al. 2003). vcana expression is normally restricted to 
the AVJ boundary by 42 hpf in wildtype embryos (Fig. 4.7J) (Walsh and Stainier 2001), 
but was expanded throughout the ventricle and atrium in both tbx5a mutant embryos and 
tbx5b morphant embryos (Fig. 4.7K,L). Proper assembly of cardiac extracellular matrix 
(“cardiac jelly”) is important for proper cardiomyocyte precursor migration and 
restriction of the cardiac cushion formation (Barnes et al. 2011, Lagendijk et al. 2011). 
Therefore, ectopic expression of hand2 and vcana in both tbx5a and tbx5b depleted 
embryos may point to a possible pathway for regulation of the cardiac jelly formation. 
Because we observe proper restriction of bmp4 signal, but not vcana, to the AVJ in tbx5b 
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morphants, we hypothesize that each tbx5 paralog regulates a unique subset of target 
genes, while also maintaining regulatory function over a shared target group.   
 
Together this data demonstrates that although the cardiac phenotypes of tbx5a and tbx5b 
morphant embryos were similar morphologically, distinct differences exist in the way 
these morphants express molecular markers of cardiac differentiation. We therefore 
suggest that the two morphants differ in regard to the processes affected in each heart. 
Moreover, the fact that each morphant displays a fairly severe cardiac phenotype suggests 
that the remaining endogenous function of the paralog is not sufficient to rescue the 
defect, and argues against substantial genetic redundancy in the cardiac functions 
governed by these two genes.  
 
Comparative analysis of phenotypes based on gene expression using qPCR 
The Tbx5 transcription factor has several well-characterized target genes in mammals, 
many of which are conserved in other species (Greulich et al. 2011, Naiche et al. 2005, 
Stennard and Harvey 2005). If tbx5a and tbx5b share an recent evolutionary history and 
redundant functions in development, one would expect that they share a subset of the 
same target genes. To determine if tbx5b also regulates some of the same genes normally 
targeted by tbx5a, we selected six well-characterized Tbx5 target genes, and quantified 
their expression in zebrafish whole embryos using quantitative real-time PCR (qPCR). 
We compared mRNA expression levels for the six candidate genes in wildtype, tbx5a 
mutant (hst), and tbx5b morphant embryos. We tested two stages in development: 30 hpf 
(prior to overt cardiac phenotypes observed in tbx5a mutant and tbx5b morphant 
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embryos) and 36 hpf (after the onset of the looping and contractile phenotypes but before 
the severe degeneration of the heart). Therefore, this experiment will also test the 
hypothesis that tbx5a and tbx5b signaling is required in the heart tube even before the 
onset of overt cardiac phenotypes.   
 
The six candidate target genes were: tbx5a, tbx5b, nppa, bmp4, hey2 and tbx2b. We 
selected tbx5a and tbx5b to determine if depletion of one paralog spurred compensatory 
up-regulation of the alternate paralog. We chose nppa because this gene is directly 
regulated by Tbx5 in mammals (Bruneau et al. 2001) and nppa expression is reduced in 
tbx5a mutant embryos (Camarata et al. 2010). We selected bmp4 because Tbx5 acts 
cooperatively with the Nkx2.5 transcription factor in mammals to directly regulate bmp4 
expression (Puskaric et al. 2010). The fifth candidate, hey2, is a transcription factor 
involved in cardiac septation, proliferation inhibition, and cardiomyocyte differentiation 
(Plageman and Yutzey 2006). The last candidate, tbx2b, is known to be directly regulated 
by Tbx5a together with Pdlim7 or Foxn4 (Camarata et al. 2010, Chi et al. 2008) and 
tbx5a mutant embryos showed a total absence of tbx2b expression at the AVJ (Camarata 
et al. 2010). For each of the candidate genes, we identified at least one conserved Tbx5 
Binding Element (TBE) within 2 Kb of upstream sequences of the zebrafish gene, as 
would be expected if these genes were directly regulated by a T-box factor (see Appendix 
II, Fig. AII.2). For the hey2 gene, no T-box Binding Element (TBE) had been found in 
the proximal 10Kb upstream sequence of mouse, human, or chick (Rutenberg et al. 
2006), but we did identify a single TBE within 2 Kb of the zebrafish hey2 start codon. A 
known zebrafish housekeeping gene, ef1a, was used as a standard control for this assay. 
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We found no difference in ef1a expression levels between the between wildtype, tbx5a 
mutant, or tbx5b morphants at 30 or 36 hpf by ANOVA analysis (p=0.99), indicating 
consistent mRNA quantity and integrity among all reactions. . In tbx5a mutant embryos, 
all of the candidate genes displayed significant decreases in mRNA copy number (Fig. 
4.8A-F), reinforcing our expectation that tbx5a functions as a transcriptional activator, 
and that it would regulate these conserved vertebrate Tbx5 targets. In some cases, tbx5a 
mutant embryos showed a difference in target gene expression by 30 hpf and 36 hpf (Fig. 
4.8A,C,D), but for other genes the regulation was only apparent by 36 hpf (Fig. 
4.8B,E,F), consistent with some functions of tbx5a arising later in embryogenesis. The 
depletion of tbx5a did not result in a statistical increase in tbx5b expression (Fig. 4.8B), 
suggesting that no compensatory upregulation of the tbx5b paralog occurred in tbx5a 
mutant embryos.  
 
Previous ISH studies indicated tbx5a transcripts were detectable in tbx5a mutants, even at 
48 hpf (Garrity et al. 2002). Here, tbx5a transcripts were detected in tbx5a mutants, but 
were reduced relative to wildtype (Fig. 4.8A). Our data support the hypothesis that tbx5a 
contributes to regulation of tbx5b at 36 hpf (Fig. 4.8B), but tbx5b does not regulate its 
own expression, or that of its paralog. As opposed to the tbx5a mutants, the tbx5b 
morphant embryos showed no differences from wildtype in transcript levels of any of the 
tested genes, either at 30 or 36 hpf (Fig. 4.8), suggesting that tbx5b does not regulate any 
of these candidate genes at the timepoints tested. Based on these collective data, the tbx5a 










































































































































































































Fig. 4.8: Loss of Tbx5a or Tbx5b differentially 
affects the expression level of conserved Tbx5 
target genes tbx5a. mRNA levels for candidate 
target genes were quantified by qPCR. Data are 
represented as the mean ± S.E. Differences in 
expression, measured in log-transformed values of 
copy number per ug template RNA, were analyzed 
by ANOVA. A Tukey-Kramer post-hoc test was 
used to determine statistical differences between 
samples (* = p<0.05, ** = p<0.001). (A-B) the 
zebrafish Tbx5 paralogs; (C-F) candidate targets 
based on conservation among vertebrates; (G) a 
house-keeping gene used as a standard control. 
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Tbx5b depletion results in altered pectoral fin morphology 
We previously observed that injection of 12.4 ng of tbx5aMO caused lethal heart defects 
and blocked initiation of pectoral fin outgrowth (Garrity et al. 2002). In contrast, 
injection of a lower tbx5aMO dose (1.7 ng) resulted in fin deformities including up-
turned fins, delayed fin outgrowth, or development of only one fin. While Tbx5a has a 
known function in forelimb initiation (Bruneau et al. 2004), the lack of detectable tbx5b 
expression in the zebrafish pectoral fin fields (Albalat et al. 2010) at first suggested that 
fin phenotypes would be unlikely in tbx5b-depleted embryos. However, in our hands the 
tbx5b ISH probe generated a broad, low level staining in several regions of the embryo 
(including the pectoral fins) that was difficult to distinguish from background, suggesting 
that tbx5b transcripts might be present in the fin fields at low levels, and therefore 
difficult to detect by ISH. Indeed, injection of tbx5bMO generated malformations in 
pectoral fin formation in 86% of tbx5b morphant embryos by 72 hpf (n= 282) (Fig. 4.9A, 
B). Injection of tbx5bMO also resulted in upturned (6.2% of embryos) or unilateral 
(10.3%) pectoral fins (Fig. 4.9B). Upturned or unilateral fin phenotypes are rather 
unusual, but these phenotypes can also be produced by modest reduction of tbx5a through 
low-dose morpholino injection (Garrity et al. 2002, data not shown).  To further 
determine how fin bud initiation or patterning was affected, we quantified pectoral fin 
development from initiation through 72 hpf (Fig. 4.9). Although fin bud swellings should 
be apparent by 28 hpf (Hoffman et al. 2002), 71% of morphant embryos lacked any 
morphologically detectable fin buds at 30 hpf. However, fin bud formation was merely 
delayed, rather than absent as observed in tbx5a mutants, because scoring embryos at 




Fig. 4.9: Depletion of tbx5b delays pectoral fin initiation and reduces fin outgrowth.  
(A) Lateral brightfield images of pectoral fin area taken of control or tbx5bMO-injected 
embryos; anterior is oriented to the left. Arrowheads denote the tip of the pectoral fin and 
are color-coded based on size (see B). (B) Dorsal brightfield images of wildtype (wt) and 
tbx5bMO injected embryos at 72 hpf demonstrating altered pectoral fin morphology in 
morphant embryos. (C) Quantification of pectoral fin size for tbx5b MO-injected 

















































(Fig. 4.9C). Fewer than 15% of morphant embryos developed a normal pectoral fin by 72 
hpf, whereas the majority of morphants developed stunted, up-turned, or otherwise 
abnormal pectoral fins (Fig. 4.9B). No defects were observed in the tail fins of the tbx5b 
morphants. Therefore, tbx5b is dispensable for pectoral fin bud initiation, but is essential 
for fin bud outgrowth and patterning.  
 
tbx5b affects apical fin fold (AF) specification 
To investigate the patterning and differentiation of the fin bud on a molecular level, we 
performed in situ hybridization with a panel of markers indicative of differentiating 
ectoderm (apical fold) or mesenchyme. Zebrafish pectoral fin bud development begins 
with mesenchyme formation by 28 hpf which is covered by an apical fold (AF, analogous 
to apical ectodermal ridge in tetrapods) by 31 hpf (Grandel and Schulte-Merker 1998, 
Neumann et al. 1999). Control embryos expressed hand2 in the pectoral fin bud 
mesenchyme at 36 hpf (Fig. 4.10A). In contrast, tbx5a mutant embryos do not express 
hand2 or other fin field markers consistent with the observation that pectoral fin buds 
never develop in these embryos (Fig. 4.10B,F,I) (Garrity et al. 2002). The normal 
expression of hand2 in the pharyngeal arches, or vcana and bmp4 in the otic placdoes, 
provided internal controls to assure probe quality in these experiments. In contrast, tbx5b-
depleted embryos did express hand2, but the region of expression was reduced, consistent 
with the smaller fin buds that later developed (Fig. 4.10C). Therefore, tbx5b morphant 
embryos were beginning to differentiate fin bud mesenchyme. To investigate AF 
differentiation, we assayed for bmp4 and vcana, which are normally expressed in the AF 




Fig. 4.10: Differential phenotypes observed in fin differentiation in tbx5a mutants 
and tbx5b morphants. Embryos at (A-C) 40 hpf; (D-F) 42 hpf; (G-I) 46 hpf; (J) 36 hpf.
(A) hand2 is expressed in the mesenchyme of the wildtype finbud. (B) In tbx5a mutant 
embryos, no pectoral fins develop; hand2 expression was absent in fin buds (brackets 
indicate region of expected expression) although present in the pharyngeal arches. (C) In 
tbx5b morphants, fin buds expressed hand2 in the mesenchyme in proportion to fin bud 
size. (D) vcana expression in the apical fold (AF) and otic placode (o). (E) vcana 
expression missing in region of expected fin buds. (F) vcana expression missing or barely 
detectable (*) in fin buds. (G) bmp4 expression in the eye, otic placode and the AF of the 
pectoral fin. (H)  No bmp4 expression in fin bud region. (I) bmp4 expression can occur in 
AF (arrow); additional expression in the mesenchyme of the finbud. (J) In younger 
embryos bmp4 is present in the mesenchyme and beginning in the AF.  (e= eye, o= otic 
placode, p= pharyngeal arches, arrowhead = finbud mesenchyme, arrow = AF, * missing 
AF expression, brackets = region of missing finbud). 
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of vcana was present in the AF of the fin bud by 42 hpf (Fig. 4.10D). Although tbx5b 
morphants did initiate the outgrowth of pectoral fins, vcana expression remained absent 
or barely detectable even in embryos with morphological fin bud swellings at 42 hpf (Fig. 
4.10F). Assays for vcana in 36 hpf and 54 hpf embryos similarly failed to exhibit fin bud 
expression (data not shown). These data suggested that the AF was not properly specified 
in tbx5b morphants. In the wildtype fin, bmp4 expression occurred in the AF by 42 hpf 
and was faintly visible in the mesenchyme (Fig. 4.10G). In tbx5b morphants, bmp4 
expression was detectable in the mesenchyme but usually absent from the AF, although 
in a small minority of cases it was observed in one developing pectoral fin but not the 
other (Fig. 4.10I). This mesenchymal expression pattern was similar in a 36 hpf pectoral 
fin (Fig. 4.10J), further supporting the hypothesis that the pectoral fins of tbx5b 
morphants have initiated but are developmentally delayed. 
 
Heart and pectoral fin development are sensitive to altered levels of tbx5 
Previous studies have revealed that vertebrate cardiac and forelimb development are 
sensitive to transcription factor dose (Bruneau et al. 2001, Mori et al. 2006, Rallis et al. 
2003, Seidman and Seidman 2002). In zebrafish, varying the amount injected morpholino 
similarly indicated that both cardiac and pectoral fin formation are sensitive to tbx5a dose 
(Garrity et al. 2002, Ng et al. 2002).  To investigate cardiac and pectoral fin dose 
sensitivity, we increased tbx5 dose through injection of tbx5a or tbx5b mRNA (Fig. 4.11). 
By 3 dpf, control hearts demonstrated normal cardiac looping, rigorous blood flow, and 
pectoral fins that were angled posteriorly along the body axis (Fig. 4.11A,D). 
























Fig. 4.11: Cardiac and pectoral fin development are sensitive to tbx5a and tbx5b
overexpression. (A,D) Brightfield images of wildtype, (B,E) tbx5a mRNA-injected, or 
(C,F) tbx5b mRNA-injected larvae. Arrowheads denote pericardial edema; bracket 
represents missing pectoral fin; arrows denote pectoral fins of reduced size, * denote 




tbx5bMO also resulted in upturned (6.2% of embryos) or unilateral (10.3%) pectoral fins  
in cardiac phenotypes (pericardial edema, lack of looping, and eventual lethality), 
whereas pectoral fin development was always normal (n= 75) (Fig. 4.11B,E). 
Overexpression of tbx5b by injection of 1000 ng/µl mRNA into wildtype embryos 
generated phenotypes similar to tbx5a mutants, including  cardiac edema and a 
dysmorphic, unlooped heart (Fig. 4.11C) as well as stunted, upturned, or unilateral 
pectoral fins (Fig. 4.11F). These data are additional confirmation that both tbx5a and 
tbx5b are functionally required within the developing heart and pectoral fins, and that 
dose is related to the wildtype function. 
 
tbx5a and tbx5b are not functionally redundant 
Knockdown of either the tbx5a or tbx5b gene still generated phenotypes, indicating that 
these two genes are not fully compensatory in function. However, they both affect 
cardiac and pectoral fin formation (Fig. 4.4) and show similar expression of a subset of 
genes (Fig. 4.7), which suggests some redundancy could exist. As a further test for 
overlap in function, we attempted to rescue the tbx5a-depletion phenotypes by 
overexpression of tbx5b mRNA and vice versa (Fig. 4.12). For these “cross rescue” 
experiments, cardiac and pectoral fin phenotypes were scored separately. As a method to 
track the integrity of injected mRNAs, we created constructs encoding the tbx5a or tbx5b 
open reading frame fused with green fluorescent protein (GFP). The presence of GFP in 
injected fish will serve to confirm the stability and translation of injected mRNAs. To 
avoid the possibility that fusion of GFP would interfere with Tbx5a or Tbx5b function, a 
viral 2A (v2A) peptide sequence was inserted between the open reading frames of tbx5  
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Fig. 4.12: mRNA injection rescue studies suggest tbx5a and tbx5b are not 
functionally redundant in cardiac development. (A) Schematic of mRNA structure of 
rescue constructs, in which the coding sequence for tbx5a or tbx5b was connected to 
EGFP (with accompanying poly-adenylation signal) via a viral 2A peptide. The v2A 
peptide cleaves subsequent to translation, allowing two separate proteins to be produced 
from a single mRNA transcript. Blue arrow indicates location of translation start site. 
Blue arrowhead indicates termination signal. (B) Fluorescent images of 26 hpf embryos 
previously injected with combinations of either buffer (in wildtype, wt), tbx5aMO or 
tbx5b MO, and tbx5a or tbx5b mRNA to evaluate mRNA integrity and translation 
through GFP. (C) Brightfield images of 72 hpf embryos showing representative cardiac 
phenotypes for each group of injected embryos. (D) Quantification of morpholino 
injected embryos displaying a cardiac morphology phenotype at 54 hpf. (tbx5aMO 82.4% 
n=91; tbx5a MO+tbx5a mRNA 2.4% n= 84; tbx5a MO+tbx5b mRNA 78.9% n= 133; 
tbx5b MO 69.1% n= 220; tbx5b MO+tbx5a mRNA 84.6% n= 65, tbx5b MO+tbx5b 
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and GFP (Fig. 4.12A). v2A is a small, “self-cleaving” peptide, first described by Ryan et 
al. (1991) as a domain of the foot-and-mouth disease (FMD) virus. Effectively, insertion 
of the V2A peptide allows bicistronic expression from a single transcript because the 
ribosome skips the synthesis of the glycyl-prolyl peptide bond at the C-terminus of the 
v2A peptide, but still continues its translation of downstream codons. This process 
ultimately results in the production of two separate proteins (Tbx5-v2A peptide and GFP) 
from sequences on the single transcript (de Felipe et al. 2010, Donnelly et al. 2001).  
 
As expected, embryos injected with rescue mRNAs consistently showed fluorescence 
associated with the GFP reporter protein, indicating the mRNAs were stable and 
appropriately translated (Fig. 4.12B). Injection of tbx5aMO generated embryos with the 
expected cardiac and fin phenotypes in 82.4% of embryos (Fig. 4.12C,D). Co-injection of 
tbx5aMO along with 600 ng/µl tbx5a mRNA reduced the number of embryos with 
cardiac phenotypes to 2.4%, thereby demonstrating an efficient rescue of the phenotype. 
Co-injection of tbx5b mRNA into tbx5a morphants resulted in 78.9% of embryos with 
cardiac defects, showing that tbx5b mRNA could not rescue tbx5a morphant cardiac 
defects. In the converse experiment, injection of tbx5bMO generated cardiac phenotypes 
in 69.1% of embryos. Co-injection of 775 ng/µl tbx5b mRNA into tbx5b morphants 
decreased the incidence of cardiac defects to 40.6%, demonstrating a partial rescue of 
cardiac phenotypes (Fig. 4.12C,D). These experiments demonstrate that while zebrafish 
tbx5a and tbx5b mRNAs were capable of rescuing the cardiac phenotypes of their cog-
nate morpholino, they were not sufficient to compensate for the cardiac function of the 
paralog gene. Thus, tbx5a and tbx5b have evolved separate roles in cardiac development. 
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Because both Tbx5a and Tbx5b are required for pectoral fun outgrowth, we also used the 
rescue approach to investigate potential overlap in pectoral fin function. To evaluate 
pectoral fin rescue we quantified fin outgrowth at 72 hpf, by which time delayed fin buds 
should have initiated some outgrowth. As a control, embryos were injected first with 600 
ng/µl tbx5a or 775 ng/µl tbx5b (25% less than for overexpression experiments), fewer 
than 5% of embryos showed any detectable phenotype (data not shown). When embryos 
were co-injected with tbx5aMO and 600 ng/µl tbx5a mRNA, we found that 65% of 
embryos had no pectoral fin and only 16% of embryos had a stunted pectoral fin (Fig. 
4.13). Thus, although tbx5a mRNA efficiently rescued heart development, it did not have 
a large ability to rescue fin initiation or fin outgrowth at this concentration. Higher 
concentrations of tbx5a mRNA resulted in non-specific body-axis defects or death at pre-
gastrulation stages (data not shown). In the “cross-rescue” experiment, injection of 775 
ng/µl tbx5b mRNA into tbx5a morphants showed 79% of total embryos failed to initiate 
pectoral fin initiation, showing that tbx5b mRNA likewise could not rescue pectoral fin 
initiation. As previously shown, injection of tbx5bMO resulted in a majority (86%) of 
embryos with stunted pectoral fins at 72 hpf. Injection of tbx5b mRNA with tbx5bMO 
decreased the percentage of embryos with stunted pectoral fin phenotypes to 23%, with 
the remainder of embryos showing normal fins. Thus, tbx5b mRNA did substantially 
rescue fin phenotypes produced by tbx5bMO. In the “cross-rescue” experiment, injection 
of tbx5a mRNA into tbx5b morphants resulted in 76% of embryos that completely lacked 
pectoral fin bud initiation, indicating no ability of Tbx5a to function in the stead of Tbx5b 
in the fin. In fact, injection of tbx5a mRNA into tbx5b morphants made the fin phenotype 




Fig. 4.13: tbx5a and tbx5b are not functionally redundant in pectoral finbud 
outgrowth. (A) Brightfield images of lateral pectoral fin region at 54 hpf. Arrowheads 
outline the buds and are color-coded according to legend (see B). (B) Percent of embryos 
exhibiting each phenotype (normal, partial or no pectoral fin outgrowth) at 54 hpf. (tbx5a 
MO 82.5% n= 91; tbx5a MO + tbx5a mRNA 78.6% n= 84; tbx5a MO + tbx5b mRNA 
89.5% n= 133; tbx5b MO 79.1% n= 220; tbx5b MO + tbx5a mRNA n= 65, tbx5b MO + 
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we note that in all cases of morphants coinjected with the paralogous mRNA, no rescue 
occurred for either cardiac or fin phenotypes. Indeed, both phenotypes were at least 
slightly increased in severity and numbers. We suspect that not only are the coinjected 
mRNAs ineffective in compensating for the paralogous tbx5-depletion, but that their 
presence along with the endogenous tbx5a and tbx5b mRNA in the embryo may confer a 
low level of overexpression that provides a small additive effect to the morpholino 
phenotypes. Overall, these experiments are consistent with our other data indicating no 
substantial redundancy exists in the functions of Tbx5a or Tbx5b in the heart or fin. 
 
Tbx5 is does not regulate total cardiomyocyte number in zebrafish 
In various species, Tbx5 function impacts the numbers of cardiomyocytes as 
development proceeds. To evaluate cardiomyocyte numbers in zebrafish, we first crossed 
tbx5a heterozygous adults with a transgenic line in which the heart-specific myl7 
(formerly cmlc2) promoter drives expression of the nuclear DsRed reporter gene 
(Tg(myl7:nDsRed2/myl7:EGFP) (Mably et al., 2003)).  Cardiomyocytes were quantified 
in 48 hpf transgenic fish of several genotypes, including: homozygous wildtype, 
homozygous mutant tbx5am21, tbx5a morphant, tbx5b morphant, tbx5a+b double-
morphant, or tbx5bMO into tbx5a mutant embryos (Fig. 4.14). We observed no 
significant differences in total cardiomyocyte numbers at 48 hpf among any of these fish 
(p=0.4), suggesting that normal cardiac cell numbers had developed for all genotypes.  
Collectively, this data suggests that neither zebrafish tbx5a nor tbx5b has any 






























Fig. 4.14: Cardiac proliferation is not affected by a lack of functional Tbx5a or 
Tbx5b. Quantification of total cardiomyocyte number in wildtype (wt) and tbx5-deficient 
embryos at 48 hpf. Data are expressed as means ± S.E. and there were no statistically 
significant differences among these treatments (*p>0.05). For the columns listed, left to 





























tube through early chamber morphogenesis stages (48 hpf), and further supports our 




The two primary conclusions of this study are that the zebrafish T-box transcription 
factor tbx5b is essential for cardiac development and pectoral fin morphogenesis, and 
secondly that the tbx5a and tbx5b paralogs have distinct and non-redundant functions in 
development of the heart and pectoral fins. Multiple lines of evidence support these 
conclusions. First, knock-down of tbx5b via morpholino injection results in lethal 
deficiencies in cardiac morphogenesis that ultimately affect looping morphogenesis, 
contractility and blood flow. In addition, reduction of tbx5b causes a resolvable delay in 
the onset of pectoral fin initiation, followed by irresolvable defects in fin patterning and 
outgrowth. Second, overexpression studies indicate that the dose of both tbx5a and tbx5b 
can impact morphology and function in the developing heart and fin. Third, although 
tbx5a and tbx5b depletion results in some overt morphological similarities, ISH studies 
evaluating several markers of differentiation indicate that both the heart and fin show 
distinct phenotypic differences. Fourth, qPCR studies support this finding, indicating that 
whereas tbx5a depletion decreases mRNA levels of tbx5b, nppa, hey2, bmp4 and tbx2b, 
the depletion of tbx5b does not alter mRNA levels for any of these genes, of tbx5a or of 
itself. Thus, tbx5b does not regulate the same cohort of genes as does tbx5a. Fifth, dual 
depletion of both tbx5a and tbx5b by morpholinos does not result in more severe or 
additive cardiac phenotypes, such as severe depletion or lack of cardiac tissue, nor does it 
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affect cardiomyocyte cell numbers more adversely than does single gene knockdown. 
Finally, the inability of each tbx5 paralog to “cross-rescue” the knock-down phenotype of 
the other paralog demonstrates minimal redundancy in function exists between the two 
paralogs.  
 
We are in the process of addressing several questions. First we will analyze the 
conservation within the T-box as compared to the whole gene of tbx5a, tbxb, human 
TBX5, and closely related zebrafish T-box genes tbx4, tbx2, and tbx3. This genomic 
analysis will be used to confirm that tbx5b is truly a tbx5 paralog. We are also 
investigating which tbx5 is evolving more quickly in zebrafish, and whether one of these 
tbx5b is evolving faster than the expected rate for this gene, as compared to other fish 
species. 
 
Approximately 300 million years ago, teleost genomes underwent a duplication event 
(Taylor et al. 2001, Hurley et al. 2007). Since tbx5 paralogs are present in several teleost 
genomes, tbx5a and tbx5b may have arisen at this time (Albalat et al. 2010). Following a 
duplication event, in many cases one gene tends to accumulate degenerative mutations 
over time, and ultimately becomes non-functional or devolves into a pseudogene (van 
Noort et al. 2003). In other cases, the two paralogous genes undergo 
‘subfunctionalization’; that is, they evolve separable patterns of expression or separable 
functions, so that both genes remain intact within the genome. In the case of the zebrafish 
tbx5 paralogs, the regions of embryonic expression appear highly similar, and the organs 
of embryonic function are the same. Yet, a more detailed analysis examining the 
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expression of putative targets for these transcription factors suggests that mechanistically, 
the functions of these two genes have already diverged. We propose therefore that the 
tbx5a and tbx5b genes have undergone or are currently undergoing subfunctionalization. 
 
Functional studies of Tbx5 in human, mouse, chick, frog and zebrafish have emphasized 
that embryos are sensitive to Tbx5 dosage. Alterations leading to decreased Tbx5, 
relative to the endogenous amount, are associated with phenotypes (Bruneau et al. 2001, 
Garrity et al. 2002, Ng et al. 2002). Haploinsufficiency of Tbx5 can cause HOS, a human 
congenital disease characterized by cardiac and forelimb defects (Basson et al. 1997, Li 
et al .1997).  Mutations in mouse Tbx5 are also dominant, and studies show that Tbx5-
null embryos die by E11 because of the severity of heart defects (Bruneau et al. 2001). 
Similarly, a conditionally-induced homozygous deletion of Tbx5 in the developing 
mouse forelimb resulted in a complete lack of forelimb bud formation (Rallis et al. 2003). 
Tbx5 is required not only for forelimb initiation, but also for continued limb outgrowth. 
As shown in the chick model, expression of dominant-negative Tbx5 after forelimb bud 
initiation produced a severely truncated limb. This reduction of Tbx5 solely in the bud 
mesenchyme was sufficient to alter Fgf8 signaling in the AER required for continued 
limb outgrowth (Rallis et al. 2003). Alterations leading to increased Tbx5 dose are 
likewise associated with phenotypes. In mouse embryonic stem cells and Xenopus 
embryos, overexpression of Tbx5 mRNA led to a decrease of Bmp4 and Hand2 
(Hermann et al. 2011). In chick, overexpression of constitutively-active Tbx5 causes 
forewing enlargement, particularly in the anterior portion of the limb (Rallis et al. 2003), 
and could lead to formation of extra limb buds (Ng et al. 2002). Increase and decrease of 
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tbx5 expression prevents migration of the chick proepicardium, a progenitor cell 
population that gives rise to multiple cell types in the adult heart, including the 
epicardium and coronary vasculature (Hatcher et al. 2004). We demonstrate here that 
zebrafish cardiac and pectoral fin bud formation are sensitive to the over- or under-
expression of either tbx5a or tbx5b. Therefore, for many species, the functions of Tbx5-
family genes appear to be intimately connected to dose.  
 
An important cellular function for Tbx5 in the heart concerns its effect on cardiomyocyte 
cell number. Depletion of TBX5 by morpholino in Xenopus resulted in a ~30-40% 
decrease of total cardiac cells in hearts undergoing early chamber formation (stage 37), 
indicating that TBX5 in frogs positively regulates cardiomyocyte proliferation in this 
system (Brown et al. 2005, Goetz et al. 2006). On the other hand, overexpression of 
wildtype TBX5 in chick (beginning at HH 17-18, early cardiac looping stages) also 
reduced cardiomyocyte proliferation by 40% (Hatcher et al. 2001). These data support a 
model in which TBX5 functions in chick as a growth arrest signal that negatively 
regulates cardiomyocyte proliferation. However, the timing of depletion or over-
expression of Tbx5 may affect the phenotypic outcome, especially if Tbx5 has a dual role 
as an activator in early stages and a growth arrest signal in later stages, as has been 
proposed (Goetz et al. 2006). Previously, we reported that in zebrafish Tbx5a is 
dispensable for cardiomyocyte cell number during early chamber morphogenesis, but 
necessary for growth of cardiomyocyte size during early-chamber morphogenesis stages 
(Parrie et al. in press). A role for Tbx5 regulation of cell growth has recently been 
defined for mice as well (Georges et al. 2008). As a caveat to our findings on cell 
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number, we hypothesized that the zebrafish tbx5b paralog might share a redundant 
function with tbx5a in modulating cardiac cell number in early chamber morphogenesis 
stages, and that this function could mask a cell proliferation phenotype in tbx5a mutants. 
However, we here demonstrate that reduction of both tbx5 paralogs together did not alter 
total cardiomyocyte number at mid chamber morphogenesis stages, providing no support 
for the above hypothesis. Instead, our data suggests that reduction of cardiomyocyte cell 
number is not a primary defect contributing to the cardiac phenotypes by chamber 
morphogenesis stages. Additionally, regulation of cell proliferation by tbx5 may reflect a 
role specific to tetrapods, perhaps contributing to the development of additional cardiac 
chambers, while the zebrafish tbx5 genes retain more ancestral functions. 
 
Proper assembly of cardiac extracellular matrix (“cardiac jelly”) is important for proper 
cardiomyocyte precursor migration and restriction of the cardiac cushion formation 
(Barnes et al. 2011, Lagendijk et al. 2011). Therefore, ectopic expression of hand2 and 
vcana in both tbx5a and tbx5b-depleted embryos may point to a possible pathway for 
regulation of the cardiac jelly formation. Because we observe proper restriction of bmp4 
signal, but not vcana, to the AVJ in tbx5b morphants, we hypothesize that each tbx5 
paralog regulates a unique subset of target genes, while also maintaining regulatory 
function over a shared target group.   
 
Despite the probable low levels of tbx5b expression in the fin fields, we find that tbx5b 
function is indeed required for the correct timing of pectoral fin bud initiation, and for the 
normal outgrowth and patterning of fins. Importantly, the tbx5b morphant fin phenotypes 
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are a specific outcome of tbx5b gene knockdown, since they can be rescued by co-
injection of tbx5b mRNA. Although fin bud initiation was delayed in tbx5b morphants, 
this defect was resolvable by 72 hpf when 85% of morphant embryos had developed at 
least a small fin bud. In contrast, the complete loss of tbx5a function definitively 
eliminates (rather than delays) pectoral fin initiation (Ahn et al. 2002, Garrity et al. 
2002). A similar feature between the tbx5b and hypomorphic tbx5a loss-of-function 
phenotypes is that pectoral fin outgrowth (if initiated) remains stunted, and buds can later 
develop abnormal morphologies such as upturned fins. Nevertheless, several differences 
in the expression of molecular markers in pectoral fins suggest that different mechanisms 
may be impaired when Tbx5b versus Tbx5a is depleted. In particular, our results pinpoint 
a requirement for tbx5b function in differentiation of the AF, since embryos lacking tbx5b 
fail to express two markers for the AF. In contrast, at least one marker of the fin bud 
mesenchyme appeared to be expressed normally in the smaller morphant fin bud.  
Interestingly, bmp4 expression was missing or highly downregulated in the AF but 
potentially expanded within the fin bud mesenchyme, relative to controls (Fig. 9).  A 
similarly altered bmp4 expression pattern combined with stunted and/or asymmetrical 
pectoral fin morphology was reported for embryos depleted of CaMK-II by morpholino 
injection (Rothschild et al. 2009). CaMK-II is a type II multifunctional Ca2+/calmodulin-
dependent protein kinase. Rothschild et al. determined that CaMK-II acts downstream of 
tbx5a in zebrafish. Whether tbx5b similarly regulates CaMK-II is currently unknown. In 
sum, Tbx5b now joins the cohort of several Tbx-family transcription factors with roles in 




In conclusion, although the tbx5b gene is expressed in similar tissues to tbx5a, including 
the embryonic heart, eye and  the pectoral fin buds, it differs from its paralog on several 
levels, including genomic organization, sequence, and function. We find little evidence to 
postulate a mechanistic overlap or redundancy in function between these two genes. The 
paralogs appear to fit the evolutionary model of duplication followed by 
subfunctionalization. Although both genes function in the embryonic heart and forelimb, 
as does human TBX5, the zebrafish Tbx5a protein appears to demonstrate a closer parallel 
to humans in its conserved regulation of mammalian Tbx5 target genes than does Tbx5b. 
However, transcriptional network studies for both genes may be required to fully 
comprehend the range of functions carried out by T-box genes during organogenesis.  
 
Materials and Methods 
 
Zebrafish husbandry 
Zebrafish were raised and staged as described previously (Westerfield 1995; Nusslein-
Volhard and Dahm 2002) and as per Colorado State University Animal Care and Use 
Protocols. Developmental time at 28.5°C was determined from the morphological 
features of the embryo as described by Kimmel (1990). 
 
Zebrafish Imaging 
Live larvae (48 and 72 hpf) were immobilized using tricaine anesthetic (i.e. MESAB) and 
placed on agarose injection plates for imaging. All samples were visualized using an 
Olympus SZX12 Fluorescent stereo-dissecting microscope. Photographs were taken 
117 
 
using a microscope-mounted Olympus U-CMAD3 digital camera and captured using 
SPOT software imaging (Diagnostic Instruments, Inc.). Post-processing was done using 
Adobe Photoshop software to correct white balance and image sizes.  
 
Tbx5b WIK allele cloning and sequencing 
Wildtype tbx5b mRNA was extracted from WIK embryos using the Trizol method (see 
below), reverse transcription and polymerase chain reaction was performed as described 
(Garrity et al. 2002, Ebert et al. 2008) using primers described by Albalat et al. (2010). 
Resulting cDNA was TA-cloned into the pCRII vector (Invitrogen) and sequenced using 
m13 universal primers. Alignments were prepared using ClustalW and Jalview (Larkin et 
al. 2007, Waterhouse et al. 2009).   
 
RNA extraction 
Total RNA was extracted from 30-42 hpf embryos by a modified Trizol method.   
Samples were collected and immediately immersed in Tri-Reagent (Invitrogen) that had 
been equilibrated to room temperature.  Tissue did not exceed 10% of the Tri-Reagent 
volume. Embryos were homogenized slowly on ice until cloudy. The sample was pelleted 
in a refrigerated centrifuge at maximum speed for 10 minutes. The supernatant was 
removed to a new 1.5 ml eppendorf tube, 200 ul of chloroform was added, and the 
sample was shaken vigorously. The sample was incubated on ice for 3 minutes and then 
spun for 15 minutes, 4° C at maximum speed. The upper phase was removed to a new 1.5 
ml eppendorf tube, being careful to not remove the interphase. This aqueous phase is 
used for RNA extraction. The original 1.5 ml eppendorf tube and sample can be kept for 
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DNA extraction (DNA and protein are in the interphase). To reduce phenol 
contamination the upper aqueous phase was spun for an additional 10 minutes at 
maximum speed at 4° C, and the upper phase of this was removed to a new 1.5 ml 
eppendorf tube. 500 ul of isopropanol was added and the sample was incubated on ice for 
10 minutes. This sample was pelleted at 4° C for 10 minutes. The supernatant was 
discarded, the RNA pellet was washed with 1 ml cold 75% ethanol, and spun again at 
half speed for 5 minutes at 4° C. The pellet was air dried and resuspended in 
RNase/DNase-free water or DEPC-treated water.  RNA samples were stored at -80° C 
after assessing quantity and purity by nanospec analysis. 
 
Plasmid DNA Purification 
Following transformation, white colonies were transferred to 5 ml LB broth containing 5 
μl ampicillin (1:1000 dilution) and incubated overnight in a 37°C shaker. The broths were 
then purified using Promega Wizard® Plus SV Miniprep solutions and protocol. The 




Translation blocking morpholino (tbx5bMO: GGATTCGCCATATTCCCGTCTGAGT) 
was designed against the region of tbx5b encoding the translational start site, and 
synthesized by Genetools (California). The translation blocking tbx5a morpholino 
(tbx5aMO: GCCTGTACGATGTCTACCGTGAGGC) was selected because it targets 
sequences slightly upstream of the initiation codon, thus making it possible to use with 
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mRNA for rescue experiments. This morpholino was designed by Lu et al. (2008), 
modified from Ahn et al. (2002), and the efficacy and specificity are described therein. 1-
4 cell embryos were injected with 100 µM tbx5bMO, 150 µM tbx5aMO, or coinjected 
with 75 µM tbx5bMO and 100 µM tbx5aMO together. 
 
Prior to injection, embryos were transferred from petri dish to an injection plate using a 
fire-polished Pasteur pipette.  Morpholino was injected into 1-2 cell embryos using a 
Femtojet (Eppendorf). Injection needles were pulled from 0.75mm inner diameter 
borosilicate capillary tubes (World Precision Instruments, Sarasota, FL) on a Sutter P97 
Flaming/Brown Micropipette puller using the following program:  Heat: 715, Pull: 60, 
Vel: 80, Time: 200.  Needles were backfilled with a mixture of 2-3 ul of rhodamine (to 
identify well-injected embryos) and 150uM Tbx5-ATG morpholino. 
 
At this stage of development, although the animal and vegetal poles are easily 
distinguishable, it is not possible to determine the dorsal-ventral position, or longitude of 
a cell. Nevertheless, if the embryo is allowed to free-fall from the Pasteur pipette, it is 
likely to land with the lateral margin facing the surface, and the dorsal (0°) and ventral 
(180°) poles positioned at the edges (Stainier et al. 1993). 
 
Cardiac Morphology 
48 hpf larvae were immobilized using MESAB and placed in agarose-containing petri 
dishes for imaging. To quantify cardiac looping, wildtype and mutant lines were crossed 
with Tg(myl7:EGFP-HsHRAS) to image cardiac-specific fluorescence.  Looping angles 
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were determined by measuring the angle of the AV junction relative to the 
anterior/posterior axis of the embryo. All samples were visualized using a Spot Insight 
IN1120 digital camera on an Olympus SZX12 fluorescent stereo-microscope.  Post-
processing was completed with Adobe Photoshop software. 
 
Whole Mount In situ Hybridization 
Embryos were fixed in 4% paraformaldehyde solution in PBS (PFA) (1:10 dilution of 
40% paraformaldehyde (Electron Microscopy Sciences, Hatfield, PA) at room 
temperature for 2 hours or at 4° C overnight and stored in 100% methanol at -20° C.  
Samples were prepared for whole mount in situ hybridization as described (Thisse et al. 
1993).  The digoxigenin-labled riboprobe for Tbx5 was synthesized using the T3 RNA 
polymerase. The digoxigenin-labled riboprobe for tbx5b was prepared as described 
(Albalat et al. 2009) with the following additions: the cDNA was cloned into pCRII 
(Invitrogen), linearized for probe synthesis with the ApaI restriction enzyme, and 
synthesized using the T7 RNA polymerase.  Other RNA probes used include amhc, vmhc, 
vcana, bmp4, and dhand, and synthesized as described previously (Ebert et al. 2008).  
 
Phenol/Chloroform Extraction and Overnight Ethanol Precipitation  
If purity of DNA was low, or to remove restriction digest enzymes the following protocol 
was used:  
The reaction volume was increased to 300ul with nuclease-free water. An equal volume 
(300ul) of phenol/chloroform was added, shaken hard for 1 minute, and spun for 2 
minutes at full speed. The top aqueous layer was removed into a clean 1.5 ml eppendorf 
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tube and an equal volume (300 ul) of chloroform was added to extract, shaken and re-
spun. The top aqueous layer was removed again and 1/10th the total reaction volume of 
3mM sodium acetate (pH 5.2), 1ul glycogen, and 2.5 volumes (750ul) cold 100% ethanol 
was added. This mixture was precipitated at -80˚C 2 hours to overnight. The tube was 
spun at full speed in the 4 ˚C refrigerated centrifuge for 30 minutes to pellet the DNA. 
The supernatant was decanted and the pellet was washed with cold 70% ethanol and spun 
for 5 minutes, repeated 2 to 3 times. The pellet was then air dried and re-suspended in 
20ul RNase/DNase free water and stored at -20˚C.  
 
Quantitative Real-time PCR 
Total RNA was isolated using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) 
according to the manufacturer's protocol. Briefly, total RNA was treated with DNase I 
(Invitrogen) to remove genomic DNA. After DNase treatment, total RNA was subjected 
to phenol:chloroform extraction, followed by precipitation of RNA to remove DNase, 
salts and digested DNA. Total RNA was precipitated with 1 volume of isopropanol and 
resuspended in 30 μl of nuclease-free water. Nucleotide concentration was determined by 
absorbance at 260 nm and 3 μg was used for 20 μl cDNA synthesis reaction using AMV 
reverse transcriptase (Fisher Scientific) and Oligo(dT)12-18 primer (Invitrogen). Resulting 
cDNA was treated with RNase H (New England Biolabs, Ipswich, MA, USA) to remove 
any residual complementary RNA.  
 
Quantitative analysis of tbx5b [GenBank Accession HQ822122], tbx5a [GenBank 
NM_130915 (Tamura et al. 1999)], tbx2b [GenBank NM_131051 (Ruvinsky et al. 
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2000)], hey2 [GenBank NM_131622 (Zhong et al. 2000)], bmp4 [GenBank NM_131342 
(Strausberg et al. 2002)],  nppa [GenBank NM_198800], and eF1-alpha [GenBank 
NM_131263 (Gao et al. 1997)] was conducted using LightCycler FastStart DNA Master 
Plus SYBR Green I reaction mix and a LightCycler 480 thermal cycler (Roche Applied 
Science, Indianapolis, IN, USA). Triplicate reactions consisted of 1 μl first strand cDNA, 
5 μl 2× SYBR Green Master Mix, 0.5 μl each of forward primer and reverse primer (10 
μM each, sequences in Table 4.1), and 3 μl PCR-grade water.  
          Table 4.1: Quantitative PCR primer sequences. 
tbx5a 85(f3) 5’-GGA ATT TAA GGC CTC ACG GTA-3’ 
tbx5a 272r 5’-GAT TTG CTG ACG GCT GCA TTC TGT-3’ 
tbx5b 323F 5’-ATT CAG GAC ATC ACG GAC GGA ACA-3’ 
tbx5b 338R 5’-TTT GTA GCT GGG AAA CAT GCG TCG-3’ 
tbx2b 196f 5’-GTC CCT TTC CCT TTC ATC TGT CTC -3’ 
tbx2b 197r 5’-CTG GGA GCT GAT AAG GGT TGA ATC-3’ 
nppa 204f 5’-CAG ACA CAG CTC TGA CAG CAA CAT -3’ 
nppa 205r 5’-CTC TGT GTG TCA AAT CCA TCC GAG -3’ 
hey2 206f 5’-GAA AGA AGC GGA GAG GGA TCA TTG -3’ 
hey2 207r 5’-AGA AGT CCA TGG CCA GAG AAT GAG -3’ 
bmp4 208f 5’-CAC AGT ATC TGC TCG ACC TCT A-3’ 
bmp4 208r 5’-GAT ATG AGT TCG TCC TCT GGG ATG -3’ 
ef1a 48F2 5’-CGG TGA CAA CAT GCT GGA GG-3’ 
ef1a 49R2 5’-ACC AGT CTC CAC ACG AC CA-3’ 
 
PCR conditions included an initial denaturation at 95°C for 5 min, followed by 45 cycles 
of denaturation at 95°C for 10 seconds, annealing at 55°C for 15 seconds, and extension 
at 72°C for 15 seconds. At the end of each run, an analysis of the PCR product melting 
temperature was conducted. Amplicon specificity was also verified by sequencing. 
Transcript concentrations were calculated with LightCycler 480 software (Roche; version 
1.2) using standards curves produced by serial dilution of purified PCR product (10 zg/μl 
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to 10 ng/μl). Use efficiencies for all reactions were confirmed to be between 1.86 and 
1.96 and transcripts were confirmed by sequencing. Statistical analysis was performed 
using JMP software v9.0.2 (SAS Institute, Inc., Cary, NC, USA). qRT-PCR data were log 
transformed prior to analysis to reduce differences in variance from the mean. Means for 
transcript abundance were compared between wildtype, tbx5a, and tbx5b MO embryos 
using analysis of variance (ANOVA). Post-hoc multiple comparisons were made using 
Tukey–Kramer HSD tests. All data not plotted as individual points are presented as mean 
± S.E. and the level of significance was set at α=0.05 for all statistical analyses.  
 
Capped mRNA Synthesis and Injection 
For creation of the Tester mRNA the tbx5bMO recognition site was fused to EGFP via 
PCR amplification with the following primers: #331TbMOGFPF 5’-ACT 
CAGACGGGAATATGGCGAATCAGGTGAGCAAGGGCGAGGAGCTGTTC-3’ and 
#304GFPR 5’-AAAAAAGGGCCCCCCGGGAAAAAACCTCCCACAC-3’. The 
resulting amplicon was TA-cloned into pCRII and confirmed by DNA sequencing. For 
the rescue mRNAs the v2A peptide sequence was inserted 5’ of EGFP using a two-step 
PCR reaction and the following primers: #316F 5’-AAGTCTGCTAACATG 
CGGTGACGTCGAGGAGAATCCTGGCCCAACCATGGTGAGCAAG-3’, #317F2 5’-
GGCGGCCGCTTGGCAGTGGAGAGGGCAGAGGAAGTCTGCTAACATG-3’. The 
#366 3’EV plasmid from the Chien Lab Gateway kit, which contains EGFP, was used as 
template for amplification using the EGFP-specific reverse primer and a forward primer 
contained a portion of the v2A and a portion of the 5’ end of GFP (primer #316F). The 
resulting band was gel-extracted and used as template for the second PCR using the same 
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GFP-specific reverse primer and a second forward primer contained the remainder of the 
v2A sequence (primer #317F2). This primer set contained SmaI, ApaI, and NotI 
restriction sites to facilitate cloning in frame with tbx5a and tbx5b. The resulting 
amplicons were TA-cloned into pCRII (Invitrogen). The full-length constructs containing 
the tbx5 gene, v2A peptide sequence, and EGFP sequence were confirmed by DNA 
sequencing and were termed pCRII-tbx5a-v2A-EGFP or pCRII-tbx5b-v2A-EGFP. Full-
length mRNAs were prepared using mMessage Machine kit (Ambion) according to the 
manufacturer’s instructions. mRNA was injected into the one-celled embryo at the 
following concentrations: tbx5bMOsite-GFP tester mNRA (1000 ng/µl), tbx5av2A-GFP 
(800 ng/µl), and tbx5bv2A-GFP (1000 ng/µl).  
 
Cardiomyocyte Quantification 
The number of cardiomyocytes in the heart was quantified in wildtype and mutant 
embryos crossed into a Tg(myl7:nDsRed2/myl7:EGFP) homozygous background (Mably 
et al. 2003).  At 48 hpf, embryos were pressed between a glass coverslip and slide to 
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I hypothesize that for optimal function, the Tbx5 protein must be expressed in a restricted 
spatial and temporal pattern, and that the amount of Tbx5 expressed within the cell must 
be within a restricted, optimal range. Two lines of evidence support a requirement for 
spatial regulation of the Tbx5 protein. First, in several vertebrate species, tbx5 expression 
within the heart tube occurs as a gradient, with highest expression at the atrial end of the 
heart and with lower levels of expression in the ventricular end (Liberatore et al., 2000; 
Yelon, 2001; Stennard and Harvey, 2005). Second, Liberatore et al., (2000) noted that 
overexpression of tbx5 throughout the linear heart tube of chick embryos caused a loss of 
chamber-specific gene expression and a delay in ventricular chamber morphogenesis. 
Several lines of evidence suggest that the dose of Tbx5 within the cell is critical. In this 
context, “dose” refers both to the number of functional copies of an allele present, as well 
as overexpression by mRNA injection or knock-down by morpholino injection. First, 
injection of a low tbx5-MO dose (17 ng) into hst siblings is sufficient to convert hst 
heterozgyotes to a hst cardiac phenotype (Garrity et al. 2002). This was also observed by 
Lu et al. (2008), where a partial- to full-knockdown of tbx5a using increasing doses of 
tbx5a morpholino resulted in increased severity of cardiac phenotypes. Second, 
145 
 
haploinsufficiency of Tbx5 in both mice and humans results in non-embryonic lethal 
cardiac defects, while mice homozygous for Tbx5 mutations die at gestation day 10 (E10) 
due to the severity of the heart defects (Bruneau et al. 2001). Furthermore, increased 
TBX5 dosage, such as chromosome 12q2 duplication, is reported to also result in HOS 
(Vaughan and Basson, 2000; Hatcher and Basson, 2001). Finally, experiments performed 
in Chapter IV also demonstrate that zebrafish cardiac development is sensitive to altered 
tbx5b dose. 
 
In contrast to above, the existing evidence in support of the idea that Tbx5 is temporally 
regulated is not clear, as the following data indicate. First, the onset of tbx5 expression in 
the hearts of vertebrates is early and clearly precedes the onset of recognized phenotypes 
in cardiac morphology. In zebrafish, tbx5a expression first occurs in the bilateral cardiac 
progenitor cells (11 hours post fertilization (hpf)), prior to formation of the heart tube 
(24-26 hpf) (Camarata et al. 2010). However, when assayed prior to heart tube formation, 
tbx5a homozygous mutant embryos showed no difference in expression of several 
cardiac markers, or in the timing or morphology of heart tube formation (Garrity et al. 
2002, Parrie et al. submitted), suggesting these early events were all normal in zebrafish. 
Morphological defects in the tbx5a mutant heartstrings (hst) hearts first appear at mid-
cardiogenesis stages (~48 hpf; chamber morphogenesis), and are followed in the 
subsequent 24 hours by substantial deterioration of cardiac morphology, weakening 
contractility, and loss of circulation. These data suggest Tbx5a is dispensable for early 
morphogenic events including cardiac specification and migration of bilateral cardiac 
precursors to the midline to create the heart tube. However, once the heart tube has 
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formed, cells undergo differential gene expression that contributes to cell fate and 
regional differentiation. I hypothesize that the degeneration of hst embryos at 48-72 hpf is 
the consequence of an earlier requirement for tbx5a in patterning of the heart tube (24-30 
hpf), but that tbx5a expression in cardiac precursors prior to heart tube formation is 
dispensable for survival and normal cardiac morphogenesis.   
 
The aim of this project is to directly test whether tbx5a expression in the linear heart tube 
(but not earlier) is sufficient for normal cardiac development. The zebrafish system offers 
an excellent opportunity to assay for phenotypes resulting from altered tbx5a expression 
because they develop ex utero, in transparent eggs, which facilitate experimental access, 
especially to the heart, throughout development. In order to study the timing of Tbx5 
function, we utilize several powerful genetic tools, including the tbx5a mutant hst, tbx5 
morpholino knock-down, and new transgenic lines that induce tbx5a expression in 
cardiac tissue. My strategy is to restore expression of wildtype tbx5a in hst mutant 
embryos at selected times in cardiac development by inducing a temporally controllable 
tbx5a transgene. Following timed induction of tbx5a expression, I will assay whether 
tbx5 deficient embryos then develop normally or with hst cardiac phenotypes. I will assay 
cardiac phenotypes by in situ hybridization or morphological assays to investigate cell 
shape, adhesion, differentiation and proliferation. A number of well-defined markers of 
cardiac development will help me assess the effects of manipulating tbx5a dose. In 
particular, I will assay several chamber-specific markers, to determine whether uniform 
high expression of tbx5a throughout the heart tube results in a “caudalization” of the 
rostral (anterior) regions of the heart. The primary strategy for this set of experiments is 
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to “rescue” (i.e. restore to normal development, in varying degrees) the wildtype 
phenotype upon induction of tbx5 expression in transgenic hst or tbx5b morphant 
embryos. Previous experiments (see Chapter 4) provide proof in principle that rescue of 
mutant and morphant phenotypes is possible via injection of wildtype mRNAs. This 
project therefore extends previous work by defining more precisely the critical expression 
of tbx5 required for cardiac development, by examining both dose and timing.  
 
This work will test two hypotheses related to the critical timing and dose of Tbx5 
function in the developing heart. First, we will test the hypothesis that Tbx5 activity is 
required in the linear heart tube (24 -30 hpf) for normal differentiation and 
morphogenesis, but dispensable at earlier stages (7 -24 hpf) including initial cardiac 
specification. Second, we will test the hypothesis that the differentiation of 
cardiomyocytes within the heart tube is responsive to the level (“dose”) of tbx5 mRNA 
present within cardiomyocytes. Defining the critical timing for Tbx5 function in the heart 
is a logical prerequisite to understanding the significance of its cellular functions. 
 
Results / Discussion 
 
This project is divided into three stages: 1) Construction of the transgene cassettes (see 
Figs. AI.1,3,5,6). 2) Generation of stable transgenic lines (Figs. AI.7,10,11). 3) Execution 
of the induction experiments on transgenic hst mutant embryos of various ages, followed 
by analysis of heart function and morphology by biochemical and molecular biological 
techniques. At the time of my defense I have not successfully finished stage 2 (generation 
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of stable transgenic lines). Therefore, these Results will primarily discuss the 
troubleshooting involved in this project, briefly touching on future work, assuming we 
are ultimately able to generate these lines. 
 
Project design:  
For this project I have employed three general approaches to create the transgene 
cassettes for injection into zebrafish embryos (see Fig. AI.8). The first approach was to 
sub-clone the tbx5a coding sequences into a vector containing meganuclease restriction 
sites (pI-SceIhspMCSpa), which could then be used as a substrate for the I-SceI 
meganuclease Method for generating genomic insertions (Thermes et al. 2002), described 
below. The second approach was to employ the Tol2 Gateway system (Invitrogen), which 
relies upon DNA recombination to create transgenes and Tol2 transposable elements to 
generate genomic insertions (Kwan et al., 2007). My third approach was to use a newly 
created modified Gateway system (termed “vSlick” and “vSlack”) developed by Drs 
Ashok Srinivasan and Ken Kramer, which is currently unpublished. For all three 
methods, the goal was to create a transgenic construct encompassing the coding regions 
of wildtype tbx5 (either a or b) adjacent to green fluorescent protein (GFP) reporter, and 
to obtain transgenic fish carrying this construct. Within the construct, inducible 
expression of tbx5 would be driven by either 1) the zebrafish heat-shock protein 
(hsp70/1), 2) cardiac-specific (cmlc2) regulatory elements, or 3) a cardiac-specific 




Integration of the various transgenes would occur when the prepared DNA was co-
injected into the one-celled embryo, along with either I-SceI meganuclease or Tol2 
transposase mRNA to facilitate integration. The primary method of identifying germ-line 
transgenic founder adults is by breeding, and visually detecting the fluorescent transgene 
marker in resulting offspring. Alternatively, I test adult founder fish by screening tail fin 
genomic DNA by PCR to detect the presence of the transgene in at least some cells (see 
Fig. AI.2).   
 
The following is a detailed description of each of these methods and the associated 
results. 
 
Method 1: I-SceI meganuclease 
Initially, researchers hoping to generate transgenic fish simply injected the linearized 
gene of interest into a one-celled embryo and screened these founder fish or their progeny 
for those with transgene insertion (Culp et al. 1991). The drawback of this method is the 
low frequency of mosaic expression in the injected embryo and the extremely low rate of 
germ-line transgenesis (<5%). In 2002, a new protocol, using a rare-cutting mega-
endonuclease was described for fish (Thermes et al. 2002). This endonuclease, called I-
SceI, was isolated from the yeast Saccharomyces cerevisiae by Jacquier and Dujon 
(1985). I-SceI has an 18 bp recognition site that statistically is expected to occur only 
once in 7×1010 bp of random sequence. Therefore, this site is not likely to be found in the 
7x108 bp sized Danio rerio genome, and thus is not likely to fraction it if I-SceI is used in 
transgenic injections. When investigators co-injected plasmids containing meganuclease 
150 
 
recognition sites flanking the gene of interest along with the I-SceI meganuclease they 
observed an increase in the number of mosaic founder embryos (F0 generation) (76% as 
compared to 26% without the meganuclease) (Thermes et al. 2002). They also reported 
an efficient rate of stably transfected lines (i.e. the F1 offspring that were germline 
transgenic) with single copy integrations (approximately 30%). 
 
Therefore, my initial approach was to design a construct consisting of the tbx5a gene 
flanked by I-SceI sites that could be used with the I-SceI meganuclease method. I created 
two constructs with different promoters driving expression of a tbx5a-GFP fusion 
product. First, to engineer uniform tbx5a expression solely within the heart, I selected the 
cardiac-specific myl7 promoter (referred to as its previous name “cardiac myosin light 
chain 2 (cml2c)” for clarity) to drive tbx5a expression (Fig. AI.1). This construct is 
referred to as “pIcmlc2:tbx5a-GFP,” where pI refers to the plasmid that contains the 
transgene, and cmlc2 is the minimal promoter, and tbx5a-GFP is the encoded fusion 
protein. As previously reported, cmlc2 drives robust expression in cardiac precursors by 
18 hpf (Huang et al., 2003, Burns et al., 2005), is expressed throughout the heart tube at 
26 hpf, and within the atrial and ventricular myocardium and atrioventricular canal at 
later stages (Yelon et al., 1999). Thus, the cmlc2 promoter is suitable for driving high-
level whole-heart tbx5a expression (i.e. obliterating the normal graded expression of 
tbx5a in the heart), without the potentially confounding effects of ectopically expressing 
the gene throughout the entire embryo. My second construct was designed to determine 
the developmental timepoints in which tbx5a is required for normal cardiac development. 
For this construct I utilized the heat-shock70 (hsp70) promoter (Fig. AI.1), in order to 
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induce expression of tbx5a-GFP throughout the embryo by heat-shock at 37° C. This 
construct is named “pIhsp70:tbx5a-GFP.” These, and all subsequent constructs, were 
confirmed by a mixture of restriction digest and sequencing.   
 
To create germ-line transgenic embryos, I co-injected 10ng/ul of either pIcmlc2:tbx5a-
GFP or pIhsp70:tbx5a-GFP plasmid with the I-SceI enzyme (NEB). I screened 260 
pIcmlc2:tbx5a-GFP (C12 – see lab notebook) and 156 pIhsp70:tbx5a-GFP (H4) F0 adult 
founders by breeding and/or PCR genotyping either the tailfin DNA or offspring. A large 
number of clutches had 10-50% of embryos perish prior to gastrulation, the same percent 
of offspring one would expect to see from a stable germ-line founder fish (Anne 
Handschy, personal communication). Therefore, I extracted DNA from batches of 
decling embryos from clutches that had previously demonstrated this early lethality 
immediately after fertilization and used PCR to screen for the transgene (Fig. AI.2). This 
experiment demonstrated the perfect correlation of declinging embryos with the presence 
of the transgene. Therefore, these data stongly suggest that the presence of the wildtype 
tbx5a fused with GFP transgene was embryonic-lethal. This lethality is most likely due to 
problems associated with integration (either location or loss of promoter specificity), 
since we know that the transgene was present in some F1 offspring. As additional 
laboratories have attempted to use the I-SceI method, researchers have found that I-SceI 
meganuclease is extremely unstable and therefore seriously problematic for its intended 
use in these experiments (Dr. Hazel Sive, Semil Choksi personal communication). In 
view of these two intractable issues, we decided to abandon this technique in favor of the 
Tol2 Gateway method for creating transgenic zebrafish.  
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Method 2: Tol2Gateway (Constructs 1 & 2) 
This method involves a series of plasmids that was originally created by Invitrogen and 
subsequently modified by Koichi Kawakami and Chi-Bin Chien with promoters and 
reporters suitable for use in the zebrafish (Kwan et al. 2007). Components from each of 
these plasmids (promoters, reporter genes, etc.) can be combined to suit the needs of the 
researcher. This method uses proprietary recombinase enzymes (Invitrogen) which 
provide extremely high cloning and transgenesis efficiencies. For detailed information on 
plasmids, methodology, etc. please see the page maintained by the Chien Lab:  
http://chien.neuro.utah.edu/tol2kitwiki/index.php/Main_Page.  
 
I generated two constructs for use in the Tol2 Gateway method, which I named 
hsp701:tbx5a-GFP (Gateway construct #1; Figure 5.8) and cmlc2:tbx5a-GFP (#2) 
(Fig.5.3). These constructs were generated using plasmids obtained in the “starter kits” 
provided by Dr. Chi-Bin Chien and/or Dr. Nathan Lawson or were generously provided 
by others as noted in text. Plasmid numbers that begin with “c” refer to those from the 
Chien kit, while the plasmids that begin with “L” originated in the Lawson kit. First, I 
amplified plasmids containing the cmlc2 promoter (plasmid “Lister p5E”; generously 
provided by Dr. James Lister) or the hsp701 promoter (plasmid c222). I cloned the tbx5a-
GFP module from Method 1 into the c237 middle entry vector (MEV) using restriction 
enzymes. Utilizing 2-way multisite LR recombination with the L465 Destination plasmid, 
I created the final Injection Constructs (Fig. AI.8 constructs 1, 2). In the Tol2Gateway 
technique, circular plasmid DNA is co-injected with mRNA of the final transposase 
(synthesized from plasmid c396) that will recombine the cassette of interest into the 
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zebrafish genome. I therefore injected 75 pg plasmid DNA/embryo (either construct #1 or 
#2), along with 50 pg transposase mRNA/embryo, rhodamine for determining injection 
success, and danieaus embryo medium. Use of nuclease-free water results in a high rate 
of death in injected embryos, thus we use danieaus embryo medium. Injected embryos 
were raised to adult breeding age and pproximately 100 founders of each injection type 
were screened for presence of the transgene. Transgenesis was determined by breeding 
injected fish and screening offspring for the presence GFP.  
 
I observed an approximately 50% death rate in injected (F0) embryos, which resembles 
that seen by others (Kwan et al., 2007). The high rate of death is most likely due to the 
trauma incurred when injecting the cell itself, as opposed to the yolk. Transient 
expression of the hsp701:tbx5a-GFP (#1) construct was observed in mosaic-F0 founder 
fish at a much higher rate (~70%) than observed with the I-SceI meganuclease (~45%) 
(Fig. AI.4). The Tol2 Gateway method has a reported germline transgenesis rate of 30-
50% (Kwan et al., 2007). However, in my hands the germline transgenesis rate was 0% 
(0 out of the ~200 founders screened). I hypothesize that we did not observe stable germ-
line transgenesis due to integration problems, most likely due to the vector L465 
backbone. In contrast, the lab has obtained transgenic lines with the c394 Destination 
vector; therefore, I would recommend this Destination vector in the future.  
 
Around this time, Dr. Ashok Srinivasan and Ken Kramer had begun developing a 
Gateway-compatible Destination vector termed “vSlick” for use with an ecdysone-
dependent (EcR) induction method developed for use in zebrafish by Esengil et al. 
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(2007). This vector offered two substantial improvements over our Gateway constructs, 
described in detail below. We therefore began a collaboration with these researchers to 
create tbx5 fusion constructs using their methodology.   
 
EcR agonist regulation of zebrafish gene expression.   
A substantial advantage offered by the EcR Method is the potential for combining 
cardiac-specific expression with the ability to conditionally induce the construct. 
Esgengil and colleagues were the first to adapt the arthropod-specific ecdysone receptor 
(EcR) dependent Gal4 system used in Arabidopsis as new tool in an inducible gene 
expression system for use in zebrafish (Esengil et al. 2007). The EcR regulates gene 
transcription in a small molecule-dependent manner (Esengil et al. 2007). One benefit of 
this inducible system is that vertebrate genomes do not encode an EcR analog, and 
several EcR agonists including the pesticide Tebufenozide were tested and found to have 
no apparent abnormal effects on zebrafish development (Esengil et al. 2007). Although 
EcRs normally heterodimerize with retinoid X receptors (RXRs) in the cell, and are 
therefore dependent on endogenous RXR levels, Esengil et al. modified a chimeric 
transactivator that included a viral activation peptide to generate an RXR-independent 
expression system.  
 
The overall scheme works as follows (Fig. AI.9): the transactivator construct, known as 
GVEcR, is comprised of three main components: the yeast transcription activator protein 
Gal4 (G), the activation domain of the herpes simplex virus regulatory protein VP16 (V), 
and the ligand-binding domain of the Bombyx mori EcR. To obtain tissue-specificity, 
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tissue-specific promoters are used to drive expression of GVEcR. In this system we use 
the minimal myl7 promoter (formerly cmlc2). Once translated, the GVEcR transactivator 
protein is inactive unless EcR agonist is provided. Thus, temporal inducibility is provided 
by adding EcR agonist to the embryo at the desired time. I used Tebufenozide as the EcR 
agonist since it is inexpensive and effective in zebrafish (Esengil et al. 2007). The Gal4 
portion of GVEcR recognizes the Upstream Activation Sequence (10xUAS, because the 
sequence in our construct includes a 10x tandem repeat), which can be fused to the target 
gene of choice. Therefore, once GVEcR has been activated by addition of Tebufenozide, 
transcription of the target construct proceeds and reporter or target protein will be 
produced. My target construct consisted of the 10xUAS promoter fused to Tbx5a and 
GFP codons. With this method, described below, the GVEcR and 10xUAS:tbx5a-GFP 
cassettes can be cloned into the same Destination plasmid for use in injections.  
 
Method 3: vSlick/vSlack GVEcR Gateway (Constructs 3 & 4) 
The basic approach was based on the Tol2Gateway technology, but now included the 
vSlick Destination vector provided by Dr. Srinivasan as well as the cardiac-specific 
GVEcR construct. The benefits of this method were twofold. First, GVEcR allows for 
exquisite control of our transgene, both spatially and temporally, which up to now has not 
been widely available in the world of zebrafish transgenics. This dual level of control will 
reduce secondary effects produced by whole-embryo transgene expression. Second, the 
vSlick (and second generation vSlack) Destination vector contains “insulators” that 
reduce self-recombination and therefore increases the probability of integration into the 
zebrafish genome.  
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This transgenesis scheme required the generation of two transgenes (Figs 5.5, 5.6, 5.8 
construct 4). The first was a “Driver” cassette which contains the myl7:GVEcR cassette, 
cloned into a 5’ entry vector. The second transgene included tbx5a-GFP under the control 
of a 10xUAS promoter. For this construct I cloned the 10xUAS promoter, tbx5a-GFP 
gene, and bovine growth hormone (BGH) poly-A signal into the pCRII TA cloning 
vector (Fig. AI.5). It is important to note that during this sub-cloning process, I re-
amplified tbx5a from wildtype cDNA and that sequencing showed this new sequence to 
be identical to that published for wildtype tbx5a. Next, using primers that contained 
Gateway BP recombination att sites, I PCR amplified the entire transgene and 
immediately performed a BP recombination to place this cassette in the 3’EV (plasmid 
c220). The next step involved simultaneously recombining the GVEcR Driver 5’EV, bi-
directional β–globin polyA signal (in a MEV), and the 10xUAS:tbx5a-GFP modules in 
the 3’EV into the vSlick Destination vector. I used the bi-directional poly-A sequence in 
the MEV to facilitate a 3-way LR recombination into the vSlick destination vector, and to 
ensure proper expression of the GVEcR gene.  
 
As a backup approach, we simultaneously generated a tbx5a-GFP cassette under the 
control of the hsp701 promoter, also cloned into vSlick (Fig. AI.8 construct #3). This 
construct also contained a fluorescent protein under the control of its own promoter as a 
reporter for transgenesis. Dr. Srinivasan suggested the use of TurboRFP under the control 
of the Crystallin (Cry) promoter to drive expression exclusively in the lens of the eye. 
TurboRFP (tRFP) is a dimeric red/orange fluorescent protein originally isolated from the 
sea anemone Entacmaea quadricolor. It is a short, 231 aa (26.1 kDa) protein that is 
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excited at 553 nm and emits at 574 nm. TurboRFP has several advantages over DsRed, 
including reduced maturation time, increased fluorescence intensity, and no abnormal 
aggregations or localization. Also, TurboRFP matures rapidly; fluorescence is detectable 
8 hours after introduction of DNA (Merzlyak et al., 2007). The use of this reporter in our 
constructs facilitates screening of founders since it is expressed continuously in the lens 
after 36 hpf. Therefore, it does not need to be induced in order to identify germ-line 
transgenic animals, and it has the added benefit of not interfering with our tissue of 
interest. 
 
Following their creation through multi-recombinant events, injection construct (3 & 4) 
sequences were confirmed by restriction digestion and sequencing. Plasmid DNA was co-
injected with transposase mRNA according to our standard procedure to generate founder 
fish with the transgene integrated into somatic cells and potentially, into germ cells. 
Mosaic embryos (i.e. F0 fish with transgene integrations into one or more somatic cells) 
were raised to adulthood, bred, and their offspring were screened either by Tebufenozide 
treatment or for presence of the tRFP reporter in the lens. Previous reports using the 
Gateway system for zebrafish transgenesis suggested this method should produce 
approximately 50% of F0 founders showing germline transgenesis (Kwan et al. 2007). In 
our hands, the dual transgene construct (tbx5a-GFP under GVEcR #4) resulted in 0% 
transgenesis (of ~188 founders screened) based on detection of GFP after Tebufenozide 
treatment. As for the second, hsp701:tbx5a-GFP (#3) construct, we observed expression 
of tFRP in F1 offspring of 15% (6/40) of the F0 mosaic embryos. While much lower than 
the reported 50%, this is very feasible for use in our laboratory. Although we were not 
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able to utilize this transgenic line for our experiments (explained below), it provided us 
with some much needed insight during the trouble-shooting process. 
 
The major discovery I made while working on this aspect of the project was that fusion of 
wildtype tbx5a with GFP resulted in unexpected steric effects that eliminate the 
fluorescence of the GFP. Steric effects occur when atoms from molecules that do not 
normally associate interfere with each other’s preferred shape (Weinhold 2001). In the 
Tg(hsp701:tbx5a-GFP)g1 (#3) transgenic fish, we expected to see heat-shock inducible 
expression of tbx5a-GFP. In actuality, we did not even observe GFP in the retina at 48 
hpf (where hsp701 is endogenously expressed), indicating that although the transgene had 
integrated (as seen by tRFP reporter expression in the lens and confirmed by PCR 
amplification) any GFP that was produced was apparently not functional (Fig. AI.7). 
Additionally, although the hsp701 promoter should have also produced high levels of 
tbx5a expression throughout the embryo, including in the heart, fins, and eye, these fish 
did not reproduce the overexpression phenotype observed in other experiments (see Fig. 
4.10). Similarly, injection of the original pIhsp70:tbx5a-GFP and hsp701:tbx5a-GFP (#1) 
constructs, which both produced GFP expression, did not produce tbx5a-overexpression 
phenotypes either. Together, this data indicates that Tbx5a function was altered in these 
constructs. 
 
 We hypothesize that the lack of overexpression phenotype in the pIhsp70:tbx5a-GFP and 
Gateway #1/2 injected embryos was most likely due to the presence of a single-base pair 
mutation in tbx5a, which we discovered upon re-sequencing of the plasmid DNAs. This 
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mutation resulted in an asparagine (N) to serine (S) substitution at residue 32 (both small 
polar amino acids), one apparently severe enough to alter tbx5a function and/or tertiary 
structure. Upon discovery of this mutation, I re-amplified wildtype tbx5a and used this 
non-mutated gene in all future constructs. Direct fusion of wildtype tbx5a with GFP (such 
as used in Gateway constructs #3 and #4) ultimately resulted in a lack of detectable GFP 
fluorescence. We know that GFP was also negatively affected by this fusion, due to the 
lack of fluorescence. This fusion may also result in inability of tbx5a to fold into its 
functional tertiary structure, but our inability to easily screen for transgenics (due to a 
lack of GFP) makes testing this hypothesis more difficult. Because this question was not 
one of the main goals of this project, we did not pursue this line of investigation. 
 
Second attempt using an improved vSlick GVEcR Gateway method (constructs 5-8) 
Next, my collaborators and I made two improvements to vSlick approach. The first 
improvement involved generating two separate transgenic lines (see Fig. AI.8, #5), one 
containing the GVEcR driver, and the other containing a 10xUAS:tbx5a-GFP with the 
Cry:tFP cassette as a marker of  transgenesis. This approach provided the advantage that 
we would have a dedicated “Driver line” that could be used to drive cardiac-specific 
expression of any UAS-containing transgenic lines we chose to create, and we would also 
have a separate transgene reporter for our gene of interest. Construct #5 was made with 
these improvements during the time I was confirming that fusion of tbx5a directly with 
GFP does not work. While it was useful to confirm our steric hindrance hypothesis, we 
quickly moved on from this construct. 
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The second improvement was utilization of a viral 2A peptide, a “self-cleaving” peptide, 
at the recommendation of Dr. Hazel Sive (personal communication). Effectively, 
insertion of the the 18 aa v2A peptide between two genes allows bicistronic expression 
from a single transcript because the ribosome skips the synthesis of the glycyl-prolyl 
peptide bond at the C-terminus of the v2A peptide. This skip ultimately results in the 
“cleavage” of the Tbx5-v2A peptide from the GFP peptide encoded by downstream 
residues (de Felipe et al. 2010, Donnelly et al. 2001, Trichas et al. 2008). Therefore, 
presence of GFP would be indicative of Tbx5 protein in the cell, but this independent 
reporter protein would not specify the intracellular location of Tbx5. 
 
To begin generation of construct #6 the v2A peptide sequence was PCR amplified using 
primers containing the v2A nucleotide sequence as well as a portion of the 5’ end of GFP 
and the c366 plasmid. The amplicon was then TA-cloned into pCRII, and the 
10xUAS:tbx5a coding sequence was then cloned in frame into the multiple cloning site 
using restriction enzymes. After cloning the 10xUAS:tbx5a-v2A-GFP cassette into a 
middle entry vector (plasmid c237), an LR reaction was performed with plasmids c228, 
c302, and vSlick to create the final injection construct (Fig. AI.8 construct #6).     
 
Once the injection construct was sequenced to confirm the expected recombination 
events had occurred, I co-injected myl7:GVEcR Driver mRNA (because we did not yet 
have a germline Driver line), transposase mRNA, and the 10xUAS:tbx5a-v2A-GFP #6 
injection plasmid. After 2.5 uM Tebufenozide treatment (addition of 10 µl of 10 mM 
Tebufenoxide to petri dishes containing 24 hpf embryos) I was able to confirm cardiac-
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specific GFP expression in mosaic founder fish. This result indicated several things: first, 
both the myl7:GVEcR Driver and 10xUAS:tbx5a-v2ApGFP (#6) constructs translated 
functional products; second, the Tebufenozide drug treatment was adequate to stimulate 
the EcR portion of GVEcR; third, that GVEcR bound the UAS promoter and produced a 
functional GFP at levels easily detected by eye (see Fig. AI.10). Unfortunately, the 
10xUAS:tbx5a-v2A-GFP construct did not integrate into the genome, resulting in 0% 
transgenesis (of ~60 fish screened). At the time I was confirming the practicality of the 
v2A fusion, Dr. Srinivasan created a germline transgenic “Driver line” using vSlack and 
Cry:tFP to confirm the integration of the myl7:GVEcR cassette. Two lines, generated 
from two separate integration events of this construct, are now maintained in our system. 
 
Because I did not identify any germ-line transgenic fish using the construct #6, I made 
two final constructs (Fig. AI.8 constructs 7 and 8). I decided to create these lines because: 
1) there was no reporter for integration of the 10xUAS:tbx5a-v2A-GFP construct; 2) I 
had not identified any germ-line transgenic founders from construct #6 injections; 3) I 
had recently cloned and sequenced the full-length tbx5b from zebrafish and thought I 
could easily add this gene to my cloning scheme. For these constructs I put tbx5a- v2A-
GFP (construct 7) or tbx5b-v2A-GFP (construct 8) under the control of the 10xUAS 
promoter, as well as the hsp701 promoter. In this scenario, either heat-shock or 
Tebufenozide-induction could be used to stimulate production of the separable tbx5-v2A-
GFP transgene. Transgenic animals could be easily identified by screening for the non-
induced (endogenous) hsp701 expression in the lens. Experimentally, either heat-shock or 
EcR-induction could be used to elicit timed expression of Tbx5a or Tbx5b, and could be 
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used to test both original hypotheses. To create constructs 7 & 8 I directly sub-cloned 
hsp701:10xUAS:tbx5[a/b]-v2a-GFP into vSlick to circumvent LR clonase issues. In 
mosaic founders, I was able to obtain very robust, specific expression of GFP in the heart 
(Fig. AI.10,11). 95 founders were screened. Unfortunately these constructs did not 
integrate into the genome (~200 founders screened to date).  
 
Future Work: 
Our original experimental question of temporal requirement for cardiac Tbx5a function 
was answered in part by Liu and Stainier (2010). They generated a heat-shock inducible 
dominant-negative tbx5a transgenic line and used it to determine that tbx5a is required in 
early somite stages for normal cardiac development. However, this series of constructs 
may still be useful for generation of other constructs. Because we have a stable Driver 
line, it would be fairly easy to generate other UAS-fused lines. I would recommend 
utilizing the c394 Destination vector when creating any injection constructs, as we have 
successfully generated two stable transgenic lines using this vector, whereas we have not 
had any success with L444, L465, or vSlick. 
 
If one were to continue with this project, there are several experiments that would still be 
worthwhile. With transgenic embryos in hand, a future researcher will first need to 
optimize conditions of induction. For the first pilot experiment, one would need to titrate 
the duration and concentrations of Tebufenozide to obtain maximal gene activation (i.e. 
tbx5a mRNA expression) without inducing secondary defects (such as altered body axis). 
This could be carried out by Tebufenozide-treating embryos for a period of 5 to 120 
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minutes and then assessing body shape versus GFP expression every hour up to 48 hpf 
(protocol based on Connors et al., 2006; Wu et al., 2008). Both the magnitude and the 
duration of the Tbx5a-v2A-GFP response to a given heat-shock regime would be tracked 
and optimized. In the second pilot experiment, one would determine the lag time between 
heat-shock and the appearance of GFP (indicative of Tbx5a-v2A-GFP proteins present in 
the cardiomyocytes). These pilot experiments should give a clear idea of whether our 
system achieves a robust expression of the transgene, and how long it persists in the 
embryo. Understanding these two parameters will help the researcher carefully interpret 
future results.   
 
Once the pilot studies have been completed, the next step would be to characterize the 
timepoint(s) at which conditional activation of Tbx5a function is sufficient for proper 
cardiac development. To do this, one should chemically induce expression in batches of 
hst embryos (~40 per batch), using optimal protocols based on the pilot experiments, at 
regular intervals between 16 hpf and 48 hpf. These ages represent the period from the 
onset of endogenous tbx5a expression and the beginning of the hst cardiac phenotype. 
Additional stages should be tested as needed. Experiments should be performed on entire 
clutches of embryos, in order to include the non-hst transgenic embryos as internal 
controls for possible gain-of-function or non-specific phenotypes. Parameters of cardiac 
function (heart rate, cardiac output, stroke volume) could be assessed by analysis of short 
video clips of heart motion, as described (Bagatto et al., 2006; Ebert et al., 2005, Kopp et 
al., 2005). Where appropriate, one should perform statistical analysis (ANOVA or 
Student’s t-test) to assess for significant differences.  Cardiac morphology can be 
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assessed by visualizing transgenic hearts, as described in previous chapters. To evaluate 
patterning and differentiation in the heart, one would use our standard panels of in situ 
hybridization probes. Pertinent probes include vcana, hand2 and bmp4, as well as 
chamber- and atrioventricular (AV) canal-specific probes (Marques et al., 2008). A 
careful analysis of chamber-specific markers would be important, because 
“caudalization” of the heart tube would potentially expand the presumptive atrium at the 
expense of the presumptive ventricular domain. 
 
Materials and Methods 
 
Staging of Embryos 
Developmental time at 28.5°C was determined from the morphological features of the 
embryo as described by Kimmel (1990): somitogenesis starts around 10 hours post-
fertilization (hpf), reaches the 18-somite stage around 18 hpf and the 26-somite stage 
around 22 hpf. At 24 hpf, embryos have between 29 and 30 somites (Stainier et al. 1993). 
 
Generation of transgene cassettes 
pI-Scel 
The tbx5a open reading frame was cloned into the pG1 plasmid, which includes the 
minimal cmlc2 promoter and mGFP. The two final injection constructs were obtained 
through subcloning into the pI-SceIhspMCSpa plasmid. For cmlc2:tbx5a-mGFP, I used 
restriction enzymes Sac/lI and NotI, while for hsp70:tbx5a-GFP I used XhoI. Both 
constructs are flagged by the I-SceI recognition site TAGGGATAACAGGGTAAT to 
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facilitate integration into the 1-celled embryonic genome. Injection mix was as follows: 
plasmid DNA: 10 μg/μl; commercial I-SceI meganuclease buffer (New England Biolabs): 
0.5×; I-SceI meganuclease: 1 units/μl; 0.1% rhodamine. 
 
Transformation: 
For routine cloning, chemically competent Escherichia coli were transformed with at 
least 10ng of plasmid DNA. Typically 2-5 µl of plasmid were added to 25 μl of the E. 
coli and placed for thirty minutes on ice. Following a 45 second heat shock at 37°C, the 
transformation mixture was incubated in 250 μl SOC medium in a 37°C shaking 
incubator for one hour. The cells were then plated on LB plates containing the 
appropriate antibiotic (usually ampicillin, kanamycin, and/or chloramphenicol) along 
with 40 μl of 40 mg/ml X-Gal (5-bromo-4-chloro-3-indolyl-beta-D-galactopyranoside), 
and incubated overnight at 37°C. X-gal was added to the plates if LacZ –mediated color 
screening was possible, to ensure that colonies did indeed have the gene of interest. 
 
Tol2Gateway 
See http://chien.neuro.utah.edu/tol2kitwiki/index.php/Protocols for detailed protocols and 
information on the structure and sequence of plasmids. The particular plasmids I used are 
in mentioned by number in the text. 
  
Capped Tol2 transposase mRNA synthesis 
The c396 plasmid (pCS2FA-transposase) was linearized using NotI for 1 hour and 
purified using the Qiagen PCR Purification Kit. A minimum of 1 μg of linearized DNA 
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was used in each transcription reaction (2 μg is preferable). Capped transposase mRNA 
was synthesized in vitro using the Ambion mMessage mMachine SP6 Kit (catalog 
#1340). In vitro transcribed RNA was purified using lithium chloride precipitation, 
subsequently ethanol precipitated, and resuspended in a final volume of 20 μl of RNase, 
DNase-free Danieaus solution. 
 
vSlick/vSlack 
The methodology for this was nearly identical to that of the other Gateway method, with 
the following exception: the “Driver” line was produced by the Ken Kramer Lab (NIH, 
Bethesda, MD). 
 
Screening for germ-line transgenic zebrafish 
Heat-shock 
Mosaic-injected embryos were raised to sexual maturity (approximately 3 months) and 
outcrossed to wildtype fish in order to identify stable transgenic carriers. F1 offspring 
were heat-shocked for 1 hr at 37° C, by incubating the entire clutch in their original petri 
dish, and observed for the presence of GFP. It was essential to place the dish on the top 
shelf of the incubator, as well as place it on a rack, to prevent overheating and death of 
the embryos. Alternatively, F1 embryos could be allowed to mature to 48 hpf at 28° C 
and scored for the presence of GFP in the eye. The basis for this is that the hsp70/1 
promoter is active under non-heatshock conditions in the lens; thus, transcription from 
hsp70/1:tbx5-GFP transgenes, if present in the genome, generates a small amount of GFP 




To detect the transgene using PCR, genomic DNA was extracted from the tail-fin or 
whole embryo using a modified Trizol method (see Chapter II) with an additional “back-
extraction” step. This back-extraction allows you to isolate DNA out of the aqueous 
phase. Primers against tbx5a (246F), tbx5b (323F), and EGFP (254R) were selected to 
amplify the transgene but not the endogenous tbx5 gene. Reactions to amplify the usual 




10 µl of 10mM Tebufenozide (Sigma) was added to embryos in their existing E3 media. 






Fig. AI.1: First method of creating transgenic zebrafish embryos via I-SceI 
meganuclease. I-SceI Method: (1) Schematic of full-length wildtype tbx5a to include 
additional restriction sites. Lane 1: Amplified full-length wildtype Tbx5, Lane 2: wt 
tbx5a amplified with primers introducing restriction sites. (2, 3) Digested tbx5a and pG1 
plasmids with EcoRI, ligated, and checked for direction. (4) Sub-cloned tbx5a-GFP into 
the pI-SceI plasmid, thereby putting the cassette under the control of the hsp70 or cmlc2 
promoter, as well as positioning it between the two I-SceI restriction sites. These 


















































Fig. AI.2: Genotyping hsp701:tbx5a-GFP F1 generation by PCR amplification.  
Embryos with irregular development were collected at 2 hpf and screened for the 
tbx5-GFP transgene. Samples 2, 3, and 5 have the transgene in dying embryos, 
suggesting a correlation of transgene and lethality. The surviving siblings did not 
fluoresce after heat-shock (i.e. GFP was not inducible, suggesting by this second 
method that these embryos were non-transgenic). + lane: positive control 
amplification off of pIhsp70tbx5aGFP plasmid. NTC lane: no template control 
amplification.  




Fig. AI.3: Second method for creating transgenic zebrafish: the Gateway 
approach. (A) The initial pIhsp70:tbx5a-GFP plasmid with tbx5a cloned in frame 
with GFP. (B) To create the Gateway transgene constructs: 1) The XhoI-digested 
tbx5a-GFP segment (from A) was sub-cloned into Gateway middle entry (ME) vector 
c237, containing L and R recombination sites. 2. Inserts from the c222 (hsp701 
promoter) or Lister5’ (cmlc2 promoter) and the tbx5a-GFP c237 were combined in an 
“LR” reaction with the L465 Destination vector using recombinase enzyme. This 
placed the tbx5a-GFP cassette under the control of either the hsp701 or cmlc2 
promoters and the entire transgene is now flanked by Tol2 recombination sites.  3. 
This final injection constructs [#1 hsp701:tbx5a-GFP or #2 cmlc2:tbx5a-GFP] were 
co-injected with RNA for the Tol2 recombinase enzyme into one-celled embryos. 
Recombinase should catalyze a recombinant event, mediated at the Tol2 sites, that 




  Gateway Method: 
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Fig. AI.4: The pIhsp70:tbx5a-GFP and hps701:tbx5a-GFP (#1) constructs both 
express GFP and are inducible. When injected at the one-cell stage the Gateway 
transgene (B, construct #1) was expressed more robustly than the same DNA in the pI 
meganuclease plasmid (A). Mosaic-transgenic embryos at 30 hpf were 5-6 hours post-
heatshock (phs) and exhibit the strongest tbx5a-GFP expression at this phs interval. (C, 
D) Endogenous induction of the hsp701 protein in the retina also drives tbx5a-GFP 
expression. This retinal expression is used as an indication of integration into the 
genome. There is less retina GFP expression in pIhsp70:tbx5a-GFP mosaic embryos (C), 
indicating less efficient integration.
A B 
C D 
30 hpf 30 hpf







































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Fig. AI.7: Wildtype tbx5a fused with GFP does not fluoresce. (A) Top panels show a 
mosaic-founder embryo injected with the hsp701:tbx5a(N-S)-GFP (#1) construct. This 
construct contains a mutant tbx5a transgene where asparagine (N) mutated to serine (S) at 
residue 32. (A’) Construct #1 does not contain Cry-tFP, therefore this embryo did not 
have lens-specific tRFP expression. (A’’) True lens-specific GFP expression at 72 hpf as 
a result of endogenous hsp701 induction (note: this embryos was not heat-shocked). (B) 
The bottom panel shows an hsp701:tbx5a-GFP (#3) germline embryo 5 hr phs. (B’) For 
easier founder screening, Cry-tRFP was subcloned in Construct #3 and presence of tRFP 
in the lens shows that this embryo contains the hsp701:tbx5a-GFP transgene. (B’’) When 
the tbx5a mutation was corrected, the tbx5a-GFP fusion protein no longer fluoresces as 
seen by the absence of GFP in any area of the embryo.  The “GFP” in the eye is only 











































Fig. AI.8: Schematics of Injection Constructs used in attempts at creating viable 
transgenic animals. The Gateway constructs (1-3) were made using components from I-
SceI constructs as well as Tol2 kit components.  Constructs (4-6) were made using 
components the Tol2 kit as well as “vSlick” and “vSlack” Destination vectors that 
containing insulators, created by the Dr. Srinivasan in Dr. Kramer’s lab at the NIH. 
Constructs 5-8 require the generation of two separate transgenic lines, which need to be 
intercrossed to “drive” expression of tbx5-GFP in the heart. Red heart: heart specific 
expression; lightning bolt: heat shock-induced whole-embryo expression (with 
endogenous eye expression); eye: eye-specific expression; yellow heart: Gal4 
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Fig. AI.9: Schematic of construct #6 cardiac-specific induction system. Schematic 
diagram of the interaction between the two #6 transgenes to generate Tbx5 expression 
solely in the heart following Tebufenozide induction. Photograph from Esengil et al. 
2007). Protein structures from: 
 (http://zeiss.magnet.fsu.edu/articles/probes/anthozoafps.html, 
http://www-bioc.rice.edu/Bioch/Phillips/Papers/gfpbio.html).  
  myl7             GVEcR 
10xUAS         tbx5a GFP pA
Cry   tFP 
v2A
GVEcR  
(exclusively in the heart) 
Eye-tRFP expression 
functions as a reporter 
for integration of the 
transgene  Tebufenozide (ecdysone analog) 
 Gal4
 EcR 





Tbx5a and GFP present only in the 
heart when chemically induced  




Fig. AI.10: Confirmation that the Drive Line construct is inducible and stimulates 
construct #6 to encode cardiac specific GFP (vSlick Method).  Embryos were co-
injected with (tbx5a-v2A-GFP, construct #6) DNA, (myl7-GVEcR/Cry tRFP, Driver 
Line) mRNA and transposase mRNA.  At 28 hpf, the injected embryos were treated with 
2.5 µM tebufenozide to induce tbx5a-v2A-GFP expression solely within the heart (i.e. 
wherever GVEcR protein is made). Two examples (siblings) are shown. (A, B) 
Brightfield of 36 hpf mosaic-embryos; (A’, B’) several cardiac cells expressing tbx5a-
v2A-GFP; (A’’, B’’) overlay. 
B’’ B’ B 
A A’ A” 
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Fig. AI.11: Confirmation of doubly- inducible tbx5b-v2a-GFP (construct #8), 
demonstrating cardiac- and lens-specific GFP expression. vSlick(hsp701-
10xUAS:tbx5a-v2A-GFP, construct #8) DNA was injected into vSlack(cmlc2-
GVEcR/Cry-tRFP, Driver Line) embryos at the one-celled stage. At 48 hpf, embryos 
were then treated with 2.5 µM Tebufenozide. (A) Brightfield image of an injected 
embryo. (A’) tbx5a-v2AGFP expression.  GFP expression is present in the eye 
(arrowhead) as a result of endogenous activation of hsp701 in the lens from 48 hpf to 76 
hpf. Cardiac GFP expression (arrow) is a result of the Tebufenozide induction through 


















The T-box transcription factor tbx5 is one of the earliest genes to be expressed in cardiac 
development and has several known functions in the heart (Stennard and Harvey, 2005; 
Hatcher and McDermott, 2006).  The regulation of tbx5 is still not completely 
understood, and the identification of the targets, regulators, and cofactors of Tbx5 would 
provide a mechanistic framework for researchers to utilize when investigating mutant 
phenotypes including human HOS and zebrafish heartstrings. One surprising regulator of 
tbx5 may be Tbx5 itself – a phenomenon described as “autoregulation.”  One intriguing 
line of evidence that tbx5 undergoes autoregulation is found in chick forelimb formation, 
in which ectopic Tbx5 expression induced Tbx5, Wnt2b, and Fgf10 expression (Ng et al. 
2002). In cell culture Sun et al. (2004) demonstrated the ability of human TBX5 to 
regulate its own promoter, and further demonstrated direct DNA-protein interactions with 
potential T-box Binding Elements (TBEs) within the putative Tbx5 promoter. Finally, 
our lab has found evidence of autoregulation using in situ hybridization in the zebrafish 
hst mutant embryo (Krista Lewiki, unpublished). Understanding the mechanisms 
underlying regulation is important because not all HOS patients have mutations within 
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the coding region itself (Borozdin et al. 2006, Heinritz et al. 2005), raising the possibility 
that mutations in promoter elements could also cause HOS phenotypes.  
 
The aim of this project was to elucidate the cis-regulatory elements that are necessary and 
sufficient for tbx5a expression in the developing zebrafish heart.  The work of this 
chapter was completed by myself and undergraduate researchers Anne Handschy, Kara 
McCoy and Krista Lewicki. To directly assess cis-regulatory control of cardiac-specific 
expression, we cloned and sequenced regions of the zebrafish tbx5a upstream regulatory 
region (UPR) and assayed their ability to drive expression of a GFP reporter in the 
embryonic heart. We show that 5.5 Kb of genomic sequence located 5’ to the tbx5a 
coding region is sufficient to drive GFP expression in the heart. No consistent expression 
was observed in the other sites of endogenous tbx5a expression, namely the dorsal retina 
and pectoral fins, suggesting tbx5a expression in these tissues is controlled by separate 
regulatory modules.  
 
Here, I summarize our findings that although alternative tbx5a mRNA transcripts exist in 
zebrafish, with evidence of 5’ alternative splicing. Furthermore, I reveal the presence of 
TBEs in the enhancer regions of several known and putative Tbx5 target genes. Finally, I 
provide an update on our tbx5a promoter search and demonstrate that use of the Tol2 






Results and Discussion 
 
5’ RACE reveals the presence of additional exons in the UTR of tbx5a mRNA 
We hypothesized that zebrafish encodes variant tbx5a transcripts using alternative first 
exons. Human TBX5 has three alternatively spliced first exons, with one isoform used 
predominantly (Basson et al. 1999). Because the start codon is present in the second 
exon, substitution for any these first exons would not affect the protein composition, 
rather it may affect regulation of tbx5a expression. To assay for alternative splicing in 
zebrafish, I continued work in our lab initiated by Anne Handschy. I amplified tbx5a 
transcripts from 5’ RACE-ready cDNA provided by Dr. Srinivasan and cloned three 
variants.  At least three clones from each transcript variant were sequenced.  Comparison 
of these transcript sequences, combined with those found by Anne, to the zebrafish 
genome revealed additional exons existed at the 5’ end of the tbx5a mRNA (Fig. AII.1). 
Variation existed in sequences at the 5' end, although all transcripts (with the exception of 
transcript variant 2) were identical from exon 4 onward. Comparison of the 5' mRNA 
sequence found matches within the genome, with the exception of exon 2, which 
suggested these sequences were in fact zebrafish tbx5a exons. They were located in cis 
with the tbx5a coding sequence on chromosome 15, upstream of the published first exon 
(labeled as "exon 3" in figure 6.2). The genomic sequence, available on the Ensembl and 
UCSC Genome Browsers, between exon 1 and exon 3 contained gaps, which may 
account for the inability to find a match for exon 2 in the zebrafish genome. Exon 2 did 
not match sequences from the vector database (VecScreen, at NCBI) either. However, 
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exon 2 was identified independently in clones sequenced by both Anne and myself, 
which lends strength to the argument that it is a true exon.  
 
An additional anomaly is that exon 3 varied in size between the different transcripts. That 
is, while the 3’-most exon 3 basepair always aligned with genomic basepair 74125422, 
the 5’-most exon 3 basepair matched several different genomic basepairs, such that the 
apparent size of exon 3 ranged from 327 to 440 basepairs in transcripts that also 
contained an exon 2. Since this sequence is contiguous in the genome, it does not appear 
to represent additional alternative exons.  In addition, we noted transcript variant 2 had 
exon 2 spliced directly to exon 7, indicating the potential to splice out exon 3 entirely. 
Potentially, this variation may be due to an artifact in the RACE reaction (i.e. incomplete 
reverse transcription) or during cloning. Alternatively, these mRNAs suggest the 
presence of alternative exon acceptor sites, which would then create transcripts with exon 
3’s of different sizes. 
 
Mice demonstrate two Tbx5 protein isoforms, encoded either by a long transcript with the 
standard cardiac transcription factor function or a transcript truncated in the activation 
domain of the C-terminus that has roles in negatively regulating cell proliferation 
(Georges et al. 2008). Our immunoblot studies, which were performed using an antibody 
against the first 15 translated amino acids (encoded in exon 4) (Anaspec, zebrafish 
tbx5(NT)) do not support the existence of C-terminus truncated splice variants in 
zebrafish (Fig. 2.6) because we observed a darkly stained, Tbx5a-specific band at the 
expected size of 54 kDa. There were several smaller, faint bands, but they were not 
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present in all wildtype protein preparations and most likely represent degradation 
products due to the presence of potent proteases in zebrafish embryos. The other, darker 
bands are not Tbx5a, as they are still present in the immunizing peptide lane. However, 
this antibody cannot be used to identify alternatively spliced Tbx5a products that do not 
include the exon 4 start site, because the zebrafish antibody is against the first 15 amino 
acids of the known protein.  There is a second, zebrafish-specific antibody available 
(Anaspec) that recognizes C-terminal resudes that could be used to look for the presence 
of these isoforms, including variant 2. 
 
Defining the minimal tbx5a cardiac promoter 
To complement the above experiments, I initiated a second approach to identify enhancer 
elements that are necessary and sufficient for cardiac-specific tbx5a expression. One of 
the elements we were looking for was TBEs that would provide evidence for Tbx5a 
autoregulation. The conserved TBE sequence for Tbx5 is (A/G)GGTGT(C/G/T)(A/G) 
(Ghosh et al. 2001). Using the rVista program (rvista.dcode.org), I identified TBEs in the 
zebrafish tbx5a enhancer region as well as in promoter regions of known and putative 
downstream targets (Fig. AII.2). To begin fine-mapping of the full 5.5 Kp upstream 
region of tbx5a, we selected 500 bp fragments to sublcone in frame with a GFP reporter 
and tested them in vivo for tbx5a-like cardiac-specific expression.  The specific 
constructs we investigated were GFP1, GFP2, GFP3, GFP5, GFP7, and GFP15 (Fig. 
AII.3). The ultimate goal of these experiments was to narrow down the location of 
cardiac-specific enhancer elements within a ~500 bp region, similar to the approach taken 
to identify the minimal myl7 promoter (Huang et al. 2003). This fine mapping will 
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involve cloning these 5 fragments into the Tol2 Gateway system to drive expression of a 
GFP reporter (provided by a 3’ Entry Vector (EV)). 
 
To create the Gateway clones, Anne cloned “GFP1,” the full 5.5 Kb fragment, into 
plasmid c237 (note: this construct does not contain GFP. “GFP1” originally referred to a 
plasmid that contained the 5.5 Kb fragment cloned into the pG1 (GFP-containing) 
plasmid, and the nomenclature became synonymous with the size of the tbx5a-promoter 
fragment being investigated). [Note: plasmid numbers beginning with “c” refer to 
plasmids received in the starter kit from Dr. Chi-Bin Chien while those beginning with 
“L” refer to those from the kit from Dr. Nathan Lawson.  A full description of all plasmid 
sequences and components can be found online at http://chien.neuro.utah.edu/ 
tol2kitwiki/index.php/Main_Page]. Anne named this plasmid c237J. The next step was to 
perform an LR reaction with the c237J plasmid and the c366 plasmid (a 3’EV that 
contains GFP), confirm the recombination reaction, and perform injections to assay for 
transient gene expression in F0 mosaic animals. I found that injection of this GFP1-LR 
construct resulted in expression of GFP predominantly in the developing heart tube at 
early (24 hpf) and late (48 hpf) timepoints (Fig. AII.4). This was dramatically different 
from injection of linearized GFP1 in the pG1 plasmid (see Fig. AII.4 top panels) in which 
GFP is ectopically expressed in cells of the yolk, trunk, and head. This increased 
specificity in expression is most likely due to earlier integration of the entire transgene 
when using the transposase in the Tol2Gateway system. GFP expression was not 
consistently observed in the dorsal retina or pectoral fin, indicating that the 5.5 Kb region 
was not sufficient to drive expression in those tissues.  One possible pectoral fin-specific 
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module was found by Ng et al. (2002), who reported a transcription factor binding site 
7.3 Kb upstream of the tbx5a start codon that was necessary for wnt regulation of tbx5a 
expression in pectoral fin. Transient expression of both GFP1 constructs diminished 
rapidly after 48 hpf. Surviving embryos were placed in to our system for rearing and 
screening for stable, germ-line transgensis. Unfortunately, there were no instances of 
germ-line transmission in the approximately 80 fish screened.  
 
In the process of generating the remaining five promoter constructs various technical 
issues arose. LR reactions to combine GFP2 and GFP3 with plasmid c366 (which 
contains EGFP) were unsuccessful, even with new LR clonase II reagents.  Sequencing 
and restriction digest analysis demonstrated that the 3’EV typically did not recombine 
with the middle entry vector. This appears to be a problem associated with the att sites.  
There is only a 1 basepair difference between the att site on the 3’ EV and the destination 
vector, which may allow for preferential omission of 3’ EV vectors.  This phenomenon 
was observed in other LR reactions (observed in experiments for Appendix I and John 
Fitts, personal communication). It may also be due to deficiencies in the proprietary LR 
clonase mix, which contains several recombinases. 
 
In addition to the difficulties with the LR reactions, the limited number of restriction sites 
in the Gateway vectors made the creation of the smaller promoter fragments difficult.  
PCR amplification of smaller fragments also proved difficult.  Ultimately, attempting to 
troubleshoot all of these technical issues proved logistically unfeasible due to remaining 




Our collaborator Ashok Srinivasan at the NIH also hoped to create three “minimal 
promoter” constructions for use with his vSlick transgenes. The rationale for these 
constructs was that the tbx5a gene is expressed considerably earlier in the developing 
heart than is myl7, the most commonly used promoter available for cardiac-specific 
transcription studies. The three regions we wished to test were the whole 5.5 Kb 
fragment, and the two halves, either the distal 3.1Kb or proximal 2.8 Kb length 
fragments, fused with the GFP reporter.  Our lab provided the 5.5 Kb and 2.8 Kb 
fragments, but we encountered difficulty in regenerating the 3.1 fragment from our 
stocks. I was to inject the Gateway constructs once they were made and screen for 
germline transgenesis. However, the project was put on hold when Dr Srinivasan moved 
to a new position. 
   
Future studies: 
 
Although this series of experiments has proved technically challenging, not only for our 
lab but also for our collaborators, I would recommend this as a project only to someone 
who is experienced with various cloning techniques and has a significant amount of time 
to contribute to it. Because use of the Tol2 Gateway kit increased specificity and strength 
of the transient expression, I would recommend continuing with this technique, but 
utilizing plasmids that have previously worked in our lab (c366, c394, etc). I would also 
recommend determining a more efficient method of inserting promoter fragments in to 




Once the ability of genomic fragments to drive GFP expression in mosaic embryos has 
been established, it will be important to determine whether conserved transcription factor 
binding sites (such as TBEs) within the promoter fragments are necessary for cardiac 
expression in vivo expression or for luciferase in vitro. To identify candidate binding 
sites, the regulatory elements that displayed the most consistent GFP expression in 
transient transgenics (i.e mosaic embryos) would be analyzed for conserved (or cardiac-
specific) transcription factor binding sites using the rVista program (Fig. AII.2).  These 
sites would be mutated using site-directed mutagenesis (Strategene Quikchange kit) to 
alter 1 to 3 base-pairs to effectively destroy transcription factor binding and determine if 
these sites are functionally relevant to tbx5a expression in the developing heart. This 
experiment would also allow us to definitively address tbx5a autoregulation in zebrafish 
cardiac development. 
 
In conclusion, our studies to date suggest that there is no single, cardiac-specific enhancer 
region that independently drives robust tbx5a expression. Instead, we observed that the 
degree of cardiac expression correlated with the length of the enhancer fragments, where 
longer portions correlated with increased frequency of cells showing cardiac GFP 
expression. This result is consistent with a potential requirement for multiple interacting 
regulatory elements that collectively drive tbx5a cardiac expression. In contrast, the 5.5 
Kb fragment provided no consistent expression of GFP in the eye or pectoral fin, 




Materials and Methods 
 
RACE amplification and sequencing 
5’ RACE-Ready cDNA was prepared by Dr. Ashok Srinivasan.  Using Advantage 2 
polymerase, primers 239F (UPM) and 238R, 5’ RACE was performed as recommended 
by the manufacturer (Clontech). Resulting bands were gel extracted, purified (Qiagen) 
and sent to the Proteomics and Metabolomics Facility at CSU. Sequences were then 
blasted against the zebrafish genome to assign exon-intron boundaries. 
 
Creation and analysis of transient transgenics  
The original pG1 vector containing the 5.5 Kb of tbx5a promoter/enhancer region fused 
upstream the green fluorescent protein (GFP) gene was kindly provided by Dr. Chi-Bin 
Chien (University of Utah). This construct, designated pG1-5.5Kb, also contains an 
ampicillin resistance gene. This 5.5 Kb fragment was sub-cloned to create all subsequent 
constructs. See the notebook of Anne Handschy for methods on creating the First 
Generation constructs.  For the Gateway clones, we performed EcoRI restriction digests 
of “GFP1” to insert the fragment into c237.  This clone was called c237J by Anne (and it 
is important to note that it does not contain GFP) and was used in an LR recombination 
reaction with c366 for insertion into the L444 backbone. This is a “2-way” recombination 
reaction. This construct was injected into wildtype embryos at the one-celled stage and 
the resulting mosaic embryos were quantified for presence of cardiac-specific GFP 





All injections were performed using a Femtojet micro-injector (Eppendorf). Injection 
volumes ranged from approximately 30 picoliters to 5 nl.  Borosilicate microinjection 
needles were pulled using 0.74 mm capillaries (World Precision Instruments) on a Sutter 
P97 Flaming/Brown Micropipette puller.  Settings were: Heat (715), Pull (60), Velocity 
















Fig. AII.1: Alternative splicing occurs in the 5’ region of tbx5a. The largest transcript 
variant was designated as Splice Variant 1.1. Our numbering of the exons in this figure 
represents new nomenclature, as published reports denote that transcription begins in 
“Exon 2,” which is equivalent to Exon 4 in this diagram. All exons except the new Exon 
2 matched sequences found on the 15th chromosome.  Exon 2 was present in multiple 
different clones, but did not find any match in a genome blast search. Splice variant 4.2 
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Fig. AII.2: T-box Binding Elements (TBEs) are present in the promoter regions of 
candidate downstream target genes. Arrowheads denote the presence of TBE(s) in the 
upstream promoter sequence of both known and candidate Tbx5a target genes. The list 






















Fig. AII.3: Identifying the necessary cis-regulatory domains upstream of tbx5a. 
Diagram showing 5.5Kb of upstream non-coding sequence, as well as the first two exons 
(Ex, gray boxes). Black bars represent portions of genomic fragments cloned in frame 
with GFP coding sequence. Dotted lines represent excised sequence. Blue boxes 



































Fig. AII.4: Use of Gateway technology increases level and specificity of transient 
expression of tbx5aUE-GFP transgenes. Transiently transgenic fish expressing GFP, 
injected with GFP1 DNA that was either linearized (A, B) or co-injected with transposase 



















List of Abbreviations: 
 
AP  anterior-posterior (refers to fish axis) 
BCIP  5-bromo-4-chloro-3-indolyl-phosphate 
BSA  bovine serum albumin 
DEPC  diethyl pyrocarbonate 
dH2O  distilled water 
DIG  digoxigenin 
DMSO  dimethyl sulphoxide 
dpf  days post fertilization 
D-V  dorso-ventral 
E3  embryonic medium 
EDTA  ethylenediaminetetraacetic acid 
EtOH  ethanol 
EV  entry vector, used in the Tol2Gateway system (designated 5’, ME, or 3’) 
GFP  green fluorescent protein 
GVEcR Gal4- Virus regulatory protein- Ecdysone Receptor transactivator 
hpf  hours post fertilization 
hst  heartstrings, tbx5 mutant line 
HRP  horseradish peroxidase 
HS  heat shock 
hst   heartstrings (Tbx5a.1 homozygous mutant embryos) 
ME  middle entry vector, used in the Tol2Gateway cloning system 
MeOH  methanol 
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MESAB ethyl-m-aminobenzoate methanesulphonate 
NaAc  sodium acetate 
NBT  4-nitroblue tetrazolim chloride 
NFDM  non-fat dry milk  
 PBS  phosphate-buffered saline 
PCR  polymerase chain reaction 
PTU  1-phyenyl-2-thiourea 
RT  reverse transcription 
TBS  Tris buffered saline 
TE  Tris, EDTA 
WIK  wildtype strain of zebrafish 
YSL  yolk syncytial layer 
 
 
 
 
 
 
 
 
